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Engineering surfaces for biocompatibility and cell adhesion is an important 
challenge facing the biotechnology industry.  Whether it is developing new tools for 
discovery or making highly defined materials for clinical applications, the rational design 
of biomaterial surfaces is of paramount importance.  Through the control of chemical and 
biomolecular moieties on metals, polymers, and hydrogels, cell-material interfaces can 
be engineered to exhibit specific characteristics.  These highly defined surfaces can be 
used to either decouple the complex interplay between cells and a myriad of extracellular 
matrix (ECM) components adsorbed onto material surfaces, or prevent unwanted 
signaling through immobilization of specific biomolecules or chemical chelators.  Using 
model systems such as poly(ethylene glycol) [PEG], that offer a “clean slate 
background”, we are able to investigate specific receptor-ligand interactions and their 
effects on downstream cell behavior, signaling, and ultimately tissue/organ level 
responses.   
We demonstrated a new method and technology to investigate the role of 
spatiotemporal ligand presentation in in vitro as well as in vivo settings.  Biomaterial 
associated inflammation and the foreign body giant response (FBGC) are critical limiters 
of the performance of implantable biomaterials.  Downstream fibrous encapsulation limits 
the lifetime of all tissue-material interfaces, and leads to premature implant failure and 
undesirable fibrous tissue formation. Novel caged-compounds that can modulate their 
presentation of ligands in situ, after implantation, offer a novel platform for in vivo 
research.  Precise triggering of ligands in vivo allowed for new studies into the role of 
spatiotemporal control in modulating cellular response into implanted constructs.  In the 
context of both biomaterial implant associated inflammation and cell infiltration into 
 xviii 
implanted materials, the caged-RGD ligand, in conjunction with PEG-based hydrogels, 
provided insights into previously unanswerable questions. 
We also demonstrated a new research tool that probed the specific relationship 
between ligand presentation and subsequent cellular events such as focal adhesion 
formation and cell traction force generation/reinforcement.  This work was the first 
system that provided precise spatiotemporal modulation of ligand presentation in situ 
while also tracking protein localization/activation and traction force generation to a single 
focal adhesion.  This new methodology provided both valuable insights into specific 
cellular mechanotransduction events and future researchers with new questions and 
platforms for discovery. 
Ultimately, future research into the spatiotemporal presentation of biomolecules 
will rely heavily on novel caged compounds.  Once the caging larger biomolecules and 
chemicals become more technologically accessible, the applications of this technology 
are truly overwhelming.  Whether it is modulating antigen presentation for 
immunomodulation or generating novel biochemical assays for single chip diagnostics, 




INTRODUCTION AND SPECIFIC AIMS 
 
1.1 INTRODUCTION 
Cells rely on time-dependent binding and activation by the ECM to initiate downstream 
signal transduction.  It is unknown whether adhesion to a ligand is required throughout 
various cell processes, or only during a specified time period (“temporal threshold”).  
Current approaches to ligand presentation often comprise of static, constant densities of 
ligands.  In contrast, natural cell adhesive interactions with ECMs exhibit spatiotemporal 
patterns of binding and activation.  Therefore, a key to future research in controlling cell-
material interactions will be the development of materials that can respond to external 
stimuli.   
The objective of this project is to engineer biomaterials that present a UV-labile 
caged-Arginine-Glycine-Aspartic Acid (RGD) ligand and evaluate the effects on cell 
activities.   RGD is the minimal adhesive sequence of fibronectin.  By dynamically 
modulating adhesive ligand presentation, the effects of temporal control on cell 
processes can be elucidated.  In this caged-peptide, a photo-labile group adjacent to the 
aspartic acid residue of RGD effectively “masks” a cyclo(RGDfk) peptide.  Upon UV 
irradiation (360 nm), the caging group is released thereby restoring the adhesive activity 
of the peptide.  
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1.2 SPECIFIC AIM 1 
Examine the role of temporal activation of caged-RGD presenting hydrogels in an in vivo 
subcutaneous inflammation and vasculogenesis model.  We have succeeded in 
producing caged-RGD poly(ethylene glycol)-acrylate conjugates that can be tethered to 
poly(ethylene glycol) di-acrylate based hydrogels.  Using this non-degradable, hydrogel-
surface presentation system, we can study the effects of adhesive control on cell types 
both in vitro and in vivo. Using a murine subcutaneous implantation model, we evaluated 
the effects of caged-RGD activation on inflammatory response and vasculogenesis.  We 
hypothesized that the delayed activation of adhesive ligands would attenuate the effects 
of the acute phase inflammatory response on implant fibrous capsule formation and 
macrophage activity.  Also, we hypothesized that transdermal caged-RGD activation in a 
PEG-hydrogel would be able to modulate blood vessel infiltration into the implant. 
1.3 SPECIFIC AIM 2 
Analyze the effects of spatiotemporal presentation of RGD on a multiple post array 
deflection substrates on cell traction force and focal adhesion assembly.  We have 
demonstrated the utility of using multiple post array deflection substrates (mPADs) in a 
variety of applications. The optical clarity of the PDMS device allows for high resolution, 
real-time, live cell microscopy studies.  When used in the conjunction with cells 
containing fluorescently labeled proteins of interest, we can perform real-time studies to 
decipher the relationships between adhesive ligand presentation and cell traction force.  
We hypothesized that by tethering caged-RGD ligands to the surface of mPAD 
substrates and using stable cells lines expressing eGFP-vinculin, we would be able to 
study the real-time formation of focal adhesion components after confocal microscopy-
based UV irradiation of the device. 
 3 
1.4 SIGNIFICANCE 
 This thesis presents a significant contribution to field of biomaterials research by 
demonstrating the utility of dynamic, triggerable biomaterials using novel caged-
compounds.  By having unparalleled spatiotemporal control of RGD ligand presentation, 
we demonstrated two novel tools for discovery: 1) in vivo ligand presentation to probe 
downstream tissue behavior and cell infiltration to biomaterial implants, and 2) in vitro 
ligand presentation in situ using confocal-based live cell microscopy to investigate real-
time vinculin recruitment and cell traction force generation.  The power of triggerable in 
vivo adhesive ligand presentation was evaluated in both a biomaterial-associated 
implant inflammation model and an in vivo vasculogenesis study.   These studies 
represented the first demonstration of triggerable adhesive ligand presentation in vivo 
and demonstrated the utility of caged-compounds at probing specific receptor-ligand 
responses on highly defined PEG-based hydrogels.  Triggerable in vitro ligand 
presentation, combined with traction force microscopy, demonstrated a new research 
tool for investigating focal adhesion formation and downstream force generation.  Taken 
in whole, these results provide previously unknown insights into the power of 
spatiotemporal control of adhesive ligand presentation and created novel new research 
platforms for future discovery.  
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CHAPTER 2  
The Biological Basics of Engineering Surfaces1 
 
2.1 The Extracellular Matrix 
2.1.1  Constituents and Functions of the ECM 
Before we can investigate how to engineer surfaces for cell adhesion, we must 
first understand the basics of extracellular matrices, its protein constituents, and the 
fundamentals of cell adhesion and spreading. This overview presents important 
knowledge to understand the composition of the ECM and engineer synthetic ECMs to 
tune cell-fate based processes. 
ECMs comprise of a complex, insoluble, three-dimensional mixture of secreted 
macromolecules, including collagens and non-collagenous proteins, such as elastin and 
fibronectin, glycosaminoglycans, and proteoglycans, which are present between cells 
[1].  Provisional fibrin-based networks constitute specialized matrices for wound healing 
and tissue repair.  The ECM’s provides structure and order in the extracellular space, 
which serves to regulate many cellular functions including the establishment, 
maintenance, and remodeling of differentiated tissues [2].  In particular, ECM 
components such as fibronectin, laminin, and vitronectin mediate adhesive interactions 
that support cell anchorage, migration, and tissue organization.  These cell-ECM 
                                                
1 1 Adapted from: Lee TT, García AJ.  “Biology lessons for engineering surfaces for controlling 
cell-material adhesion.”  In:  João F. Mano, Biomimetic Approaches for Biomaterials 
Development. Wiley-VCH, 2012, ISBN 978-3-527-32916-8 
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interaction all serve to activate signaling pathways that direct cell survival, proliferation, 
and differentiation. 
Aside from providing physical use to cells, ECM components can also interact 
with growth and differentiation factors, chemokines, and other soluble factors that 
regulate cell cycle progression and differentiation – ultimately controlling the their 
availability and activity.  By using various strategies to immobilize and order these 
complex proteins and small oligopeptide ligands, ECMs control the spatial and temporal 
profiles of many cellular-responsive signals and generate gradients necessary for 
vectorial responses.  Moreover, structural elements within ECMs, namely collagens, 
elastin, and proteoglycans, contribute to the mechanical integrity, rigidity, and 
viscoelasticity of skin, cartilage, vasculature, and other tissues.  Furthermore, cells within 
the ECM can dynamically modulate its composition and structure, leading to a high 
regulated and bi-directional communication between both cells and the ECM. 
Therefore, it is no surprise that that cell-material interaction both in vivo and in 
vitro systems are highly dependent on the ECM.  By designing simplified proteins 
sequences, we can take an engineered approach to decoding, and possible controlling, 
these complex interactions with cells. 
2.1.2 Protein Structure 
Proteins are structurally complex and functionally sophisticated biomolecules 
present in all living systems.  Their efficiency and effector actions been tuned by natural 
selection over millions of years and serve a variety of functions in all living organisms.  In 
the following section, we explore the basic chemistry and structure of proteins so that we 
can better understand protein interactions with biomaterial surfaces. 
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Proteins are polymer chains that consist of an exact sequence of amino acids [3].  
There are 20 known basic amino acids in nature and a number of amino acid derivatives 
that have slightly modified structure.  All amino acids contain conserved structural 
regions, including an alpha-carbon (α-carbon), an amino group, a carboxyl group, and a 
variable side chain (R group).  This side chain determines the chemical properties of 
each amino acid.  There are non-polar, polar, acidic, basic side chains; as a result, the 
combined action of all side chains largely dictates a proteins overall 3-dimensional 
structure, biochemical activity, electrostatic interactions, and adsorption kinetics. 
 
 
Figure 1.  Structural diagram of amino acid and peptide bond.  Cα is the alpha carbon; 
R1/R2 are functional groups.  There are 20 basic functional groups. 
 
Proteins are made of individual amino acids that are linked via a peptide bond 
(Figure 1).  This bond has a resonance-stabilized structure that keeps the peptide bond 
in a planar conformation.  A chain of many amino acids creates a polypeptide.  Most 
polypeptides, with the exception of certain cyclic peptides, have two free ends – a 
carboxy terminus (C-terminus) and an amino terminus (N-terminus).   
Protein structure can be broken into four discrete levels of organization: primary 
(1°), secondary (2°), tertiary (3°), and quaternary structure (4°).  The physical 
arrangement or sequence of amino acids in a chain is known as the primary structure.  
Hydrogen bonding interactions between the functional groups of an amino acid chain 
cause the formation of local ordered or repeating units known as the secondary 
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structure.  Examples of secondary structures include α-helices, β-sheets, and turns.  The 
tertiary structure of a protein consists of the spatial orientation of various structural units 
within a single protein chain.  These interactions are largely dictated by weaker 
interactions such as van der Waals, ionic, and hydrophobic interactions.  The complex of 
various individual polypeptide chains forms a protein’s quaternary structure.  Ultimately, 
variations in protein structure modulate both its function and activity in biological 
systems. 
2.1.3 The Basics of Protein Adsorption 
The first event in the cell adhesion cascade to material surfaces is protein 
adsorption to a surface, and it is one of the major mechanisms regulating cell-material 
interactions [4].  Therefore, it becomes no surprise that when engineering biomaterials 
surfaces control of protein adsorption becomes critical.  Protein adsorption is a 
phenomenon driven by entropy that is influenced by the chemical and physical 
properties of both the protein and the receiving surface.    In general, protein adsorption 
to surfaces is controlled by non-covalent interactions that are mediated by the amino 
acid side chains present in different parts of the protein.  These interactions include 
hydrophobic interactions, van der Waals, hydrogen bonding, and electrostatic forces. 
While examining the structure of any protein, we can make a couple 
generalizations about its interactions with surfaces and surrounding fluids.  Under 
physiological conditions, protein folding is highly dictated by hydrophobic interactions to 
exclude water from highly hydrophilic regions.  There are two main types of proteins, 
those that are membrane bound, and those that largely exist as soluble globular 
proteins.  Soluble proteins often have hydrophobic domains, areas rich in non-polar 
amino acids, which are buried in the protein core to minimize the entropy of the protein-
solution system.  The domains of membrane bound or transmembrane proteins often 
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have outward facing hydrophobic domains that interact with the lipid bilayer.  These 
hydrophobic interactions are all driven by the minimization of free energy of the system 
and are the primary mediators of protein tertiary structure. 
Biomaterial engineers are usually most interested in surface hydrophobicity and 
surface charge.  Hydrophobicity is the manner in which a material responds in the 
presence of water and it is generally quantified by a contact angle measurement (Figure 
2).   
 
 
Figure 2.  Contact Angle.  A) Measurement of contact angle on a surface.  Θ denotes 
contact angle; ϒ denotes respective surface tensions.  B) Basic schematic of water 
droplets on hydrophobic and hydrophilic surfaces. 
 
Generally, with increasing hydrophobicity on the surface, there will be greater 
protein adsorption; however, this does not mean the protein activity is maintained.  The 
strength of the protein-surface hydrophobic interaction can destabilize a protein’s tertiary 
structure.  Protein charge may also influence the conformation of a protein when it 
adsorbs to a surface.   A negatively charged domain interacting with a negatively 
charged surface will not be energetically favorable; therefore, one would expect counter 
ions from solution to shield the protein from these entropically unfavorable events. 
Other surface properties that can influence protein adsorption to a surface 
include topography, composition, heterogeneity and electrical potential (Figure 5).  The 
topography of a surface can influence the available surface area for protein adsorption.  
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The surface composition of a material, or its chemical moieties present will influence 
interactions with amino acid side chains and determine the intermolecular forces that will 
be exerted on a protein.  The heterogeneity of a material will increase the types of 
protein “domains” that can interact with a surface.  Electrical potential will also affect the 
conformation of a protein on a surface and perhaps affect the distribution of ions within a 
protein.  Therefore, in engineering surfaces, one must take these factors all into 
consideration in order to maintain the activity of the protein of interest. 
 
 
Figure 3.  Protein on a heterogeneous surface.  + denote positive charged region; - 
denote negatively charged region; grey areas denote hydrophobic regions; arrows 
indicate polar regions with dipole. 
 
2.1.4 The Kinetics of Protein Adsorption 
Before protein adsorption to a material can occur, proteins must first be 
transported from the bulk solution phase to a surface.  Transport occurs through two 
main modes:  diffusion and convection.  The area of transport that is most relevant to 
cell-material interactions occurs at the boundary layer between the surface and protein 
solution, where the protein adsorption rate is primarily dictated by diffusion alone.  
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However, in certain microfluidic systems and blood-contacting surfaces, where active 
flow occurs, convection mediated adsorption may also be important. 
In the adsorption process, proteins are constantly in motion, actively rearranging 
in the most entropically favorable orientation and packing density.  After a protein has 
begun adsorbing to a surface, as protein density increases, the protein will begin to 
adopt different conformations for more efficient packing (Figure 4).  Interactions between 
the protein and the surface, as well as other proteins, will influence protein conformation 
and its interactions with surfaces.  Usually, this is accompanied by limited protein 
unfolding and spreading.  After a period of time, protein adsorption is thought to be 
irreversible since it is unlikely that all of the modalities for interaction between the protein 
and the surface would fail simultaneously.  After adsorption, the final conformation of a 
protein with respect to the surface ultimately dictates its activity and function.  Depending 
on the orientation of the protein, its activity can be severely hindered (Figure 5). 
 
 
Figure 4.  Packing density affects protein adsorption.  As packing density of a protein 




Figure 5.  Protein orientation vs. activity.  Proteins with active domains oriented upwards 
towards cells will exhibit higher overall activity compared to proteins with active domains 
facing towards the substrate surface. 
 
Even though protein adsorption is classically thought to be irreversible, in the 
context of heterogeneous protein solution, a protein can be displaced from a surface by 
a protein of higher surface affinity.  As mentioned before, proteins on a surface are 
highly dynamic.  In a two protein system, the instant one protein (protein A) changes its 
orientation or breaks a series of non-covalent interactions with the surface, it is possible 
for a second protein (protein B) to compete for that physical space on the surface.  As a 
consequence, if this second protein has higher affinity for the surface, it could displace 
the original protein from the surface.  Therefore, the final concentration of proteins on a 
surface is influenced by the concentration and protein affinity of individual proteins.  In a 
mixed population of proteins, those with higher concentration will be adsorbed first; 
however, eventually they will be displaced by proteins with higher surface affinity.  This is 




Figure 6.  Vroman Effect.  A) Protein adsorption isotherm; single protein species.  B) 
Vroman effect with two proteins of different initial concentration and affinities for surface. 
 
2.2 Integrin-Mediated Cell Adhesion 
2.2.1 The Importance of Cell Adhesion  
Most mammalian cells adhere to ECMs via specific cellular receptor-ligand 
interactions.  In the previous section, we covered how the ECM functions as a scaffold 
facilitating the transfer of signals to adhering cells via specific proteins such as those 
containing adhesive domains such as fibrinogen, vitronectin, collagen, and fibronectin.  
Cells bind these adhesive ligands through a special class of receptors known as 
integrins [6, 7].  These integrin-ligand interactions regulate a myriad of specific cellular 
processes ranging from adhesion, migration, proliferation, secretion, gene expression, 
and apoptosis.  In the following section, we highlight the importance of integrin-mediated 
cell adhesion before we begin our discussion of controlling cell-matrix interactions. 
Integrin-mediated cell adhesion to the ECM is central to the organization 
maintenance, and repair of tissues by providing both mechanical anchorage and signals 
that direct cell survival, migration, cell cycle progression, and expression of differentiated 
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phenotypes [8, 9].  In fact, integrin-mediated adhesion is required for mammalian 
development.  Animal models containing deletions for integrin receptors, integrin ligands, 
or focal adhesion components result in absolute lethality at early embryonic stages [10-
13].  Abnormalities in adhesive interactions are often involved in pathological states, 
including blood clotting and wound healing defects, as well as malignant tumor formation 
[14, 15].  Furthermore, adhesive interactions are responsible for regulating cellular and 
host responses to implanted biomedical devices, tissue-engineered, constructs, and 
biotechnological systems [7].   
Whereas significant progress has been achieved in identifying key adhesion 
components and how these participate in cell spreading, migration, and signaling, the 
mechanical interactions between a cell and its microenvironment remain poorly 
understood.  It is increasingly evident that mechanotransduction, or signaling triggered 
by mechanical stimulation, between cells and their environment, regulates gene 
expression, cell fate, and even malignant transformation [16].   Therefore, engineering 
and controlling specific cell-matrix interactions are essential to unraveling these complex 
interactions [17-22]. 
2.2.2 Integrins and Adhesive Force Generation 
Cell adhesion to native ECM components, such as fibronectin (FN) and laminin, 
is primarily mediated by the integrin family of heterodimeric receptors [23].  The integrin 
receptor has a large extracellular domain formed by both α and β subunits, a single 
transmembrane pass, and two short cytoplasmic tails that do not contain catalytic motifs.  
Integrin-mediated adhesion is a highly regulated process involving receptor activation 
and mechanical coupling to extracellular ligands [24-27].  Bound integrins rapidly 
associate with the actin cytoskeleton and cluster together to form focal adhesions (FAs) 




Figure 7.  Basic diagram of integrin cascade.  Inactive integrin becomes activated, 
creating a conformation change in the molecule, unfolding the cytoplasmic domains.  
This allows interactions with focal adhesion proteins, ultimately resulting the linkage with 
the cell cytoskeleton. 
 
FAs are supramolecular complexes that contain both structural proteins, such as 
vinculin, talin, and α-actinin, and signaling molecules, including FAK, SRC, and paxillin 
[28].  Focal adhesions function as structural links, allowing for strong cell adhesive 
forces and signal transduction elements between the cell and its extracellular 
environment.  These adhesive complexes are dynamic structures that are actively 
remodeled during cell migration [29, 30].  In response to external stimuli, numerous 
modalities are responsible for the assembly and disassembly of focal adhesions, 
including soluble growth factors and mechanical force [31-33].  In particular, the Rho 
GTPase effector Rho-kinase (also designated ROCK and ROKaII) plays a central role in 
serum-induced formation of focal adhesions and stress fibers.  Rho-kinase controls focal 
adhesion and stress fiber formation by regulating actomyosin contractility through direct 
phosphorylation of the myosin light chain (MLC) and inactivation of myosin phosphatase 
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[34, 35].  Actomyosin contractility then drives the formation of focal adhesions and stress 
fibers by an unknown mechanism [36, 37].   
 
 
Figure 8.  Detailed cartoon of mechanotransduction pathway.  Copyright Ingber et al. 
 
Mechanical interactions between a cell and ECM environment comprise of 
different spatiotemporal force components.  For example, migrating cells utilize complex 
spatiotemporal patterns of traction forces via focal adhesion assembly dynamics that 
ultimately generate directional cell movement [29, 38].  Also, a cell attached to a surface 
exhibits an equilibrium balance between its own internal contractile forces and the 
anchorage forces to the underlying surface.  This equilibrium is dictated by the size and 
distribution of cell-material adhesive structures, cytoskeletal architecture, and 
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actomyosin contractile forces.  What further confounds the analysis is that all these 
adhesive interactions are inter-related and exhibit complex, often non-linear 
relationships.  For example, migration speed exhibits a biphasic dependence on 
adhesive strength and ligand density [39], while epithelial cell scattering correlates with 
adhesion strength and actomyosin contractility but not with migration speed [40]. 
The accepted model for focal complex-generated adhesive forces, proposed by 
McClay and Erickson postulates a two-step process consisting of initial integrin-ligand 
binding followed by a rapid strengthening [41].  The strengthening response is a 
consequence of (i) increases in cell-substrate contact area (spreading), (ii) receptor 
recruitment to anchoring sites (recruitments and clustering), and (iii) interactions with 
cytoskeletal elements that lead to enhanced force distribution among bound receptors 
via local membrane stiffening (focal adhesion assembly). 
 
 
Figure 9.  Schematic of cell adhesion cascade to a surface. Initial attachment leads to 
integrin recruitment, spreading, and integrin clustering; ultimately resulting in the 
generation of contractile forces by the cell on the surface. 
 
Integrin clustering was one of the first observed and most intensively studied 
events in the adhesive process.  Using chimeric receptors, LaFlamme et al, showed that 
ligand binding targets integrin receptors to sites of integrin-FN adhesion [42].  Integrin 
clustering is a critical step in the adhesive process by promoting the recruitment of 
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cytoskeletal components and initiating activation of signaling molecules.  Based on 
immunostaining analyses, Yamada and colleagues demonstrated that integrin binding 
and clustering have synergistic effects in integrin function [43, 44].  Integrin occupancy 
by a single monovalent ligand induced receptor redistribution but no recruitment of 
cytoskeletal or signaling elements.  In contrast, antibody-mediated integrin aggregation 
induced recruitment of FAK and tensin but no other focal adhesion components.  Both 
integrin occupancy and aggregation are required for the robust assembly of focal 
adhesions and activation of signaling pathways. 
2.2.3 Adhesive Interactions in Cell and Host Response to Biomaterials 
Integrins are critically involved in host and cellular responses to biomaterials due 
to their essential roles in cell adhesion to ECM components.  In platelet aggregation, the 
platelet integrin αIIbβ3 (GPIIb/IIa) binds to several ligands such as fibrinogen, von 
Willebrand factor, and fibronectin [6].  This receptor is the essential mediator of initial 
events in the blood-activation cascade after blood as come into contact with a synthetic 
material [45, 46].  Leukocyte-specific β2 integrins, such as αMβ2 (Mac-1), mediate 
monocyte and macrophage adhesion to various ligands, including fibrinogen, fibronectin, 
IgG, and complement fragment iC3b.  These receptors all play central roles in 
inflammatory responses in vivo [47, 48].  Binding of αMβ2 integrin to fibrinogen P1 and 
P2 domains exposed upon adsorption to biomaterial surfaces controls the recruitment 
and accumulation of inflammatory cells on implanted devices [49]. This integrin also 
plays a critical role in macrophage adhesion and fusion into giant foreign-body cells [48, 
49].  For many types of tissue such as connective, muscular, neural, and epithelial, the 
β1-family of integrins is largely responsible for adhesion to extracellular matrix ligands 
[7]. 
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Integrins mediate cell-materials interactions by binding to adhesive extracellular 
ligands.  These can be adsorbed from solution blood, plasma, or serum; secreted and 
deposited onto the biomaterial surface by cells; or specifically engineered onto a 
biomaterial interface.  All of these interactions are highly dynamic, and the dominant 
adhesive mechanism could vary over time and is often different among cell types.  For 
example, in blood plasma, the primary adhesive ligand is fibrinogen; while in serum, 
vitronectin plays a dominant role [50, 51].  As mentioned in previous sections, adhesive 
ligands can be displaced and replaced by other proteins in the surrounding medium via 
the Vroman effect.  Therefore, a common surface engineering strategy is to coat a 
surface with fibronectin to promote cell adhesion and survival, and then allow cells to 
secrete their own adhesive proteins and extracellular matrix onto the material surface.  It 
is important to note that integrin expression and activity profiles on a particular cell 
change over time.  Most cells exhibit several integrins specific for the same ligand, and 
the binding activity of these receptions can be rapidly regulated via changes in integrin 
conformation.  However, integrin expression profiles do not necessarily correlate with 
integrin function on a particular substrate.  In most cellular responses, multiple integrins 
are typically involved.  
 
2.3  Model Systems for Controlling Integrin-Mediated Cell Adhesion 
A key to studying and controlling cell-material interactions is starting with a 
material that provides a “clean-slate” background – one that prevents non-specific 
protein adsorption and cell adhesion and signaling.  Surfaces that are able to resist non-
specific adsorption of biomolecules are known as “bio-inert” or “non-fouling”.  These 
types of non-fouling surfaces are required for the detailed study of singular bioactive 
 19 
peptide sequences or molecules.  By tethering a single or multiple bioactive species in a 
highly characterized manner, detailed investigations of specific cell-material interactions 
can be completed. 
Poly(ethylene glycol) (PEG) groups are highly resistant to protein adsorption and 
remain the benchmark for non-fouling surfaces [52].  The mechanism of resistance to 
protein adsorption is thought to be the combination of the polymer chain’s ability to retain 
interfacial water (osmotic repulsion) and the resistance of the polymer chain to 
compression (entropic repulsion) [53].  Well-packed, self-assembled monolayers (SAMs) 
of ethylene glycol (EG)n repeats as short as n=3, have excellent non-fouling properties 
[54, 55].  The non-fouling characteristics of these surfaces are highly dependent on the 
conformation of the (EG)n chain.  Chains in either a helical or amorphous conformation 
have significantly higher resistance to protein adsorption than the all trans conformation, 
probably due to interactions between the EG chains and interfacial water.  While PEG 
groups are excellent at preventing protein adsorption, surfaces that completely abrogate 
protein adsorption have not been attained. 
2.3.1 Self-Assembled Monolayers (SAMs) 
Self-assembled monolayers (SAMs) are an organized layer of amphiphilic 
molecules that contain a head, alkane core, and functional group.  In the context of cell 
adhesion, alkane-thiol based SAMs assembly on gold surfaces have been a extensively 
used model system to impart both specificity and non-fouling nature to surfaces.  In this 
alkane-thiol based SAM, the head-group contains a –SH, or thiol group, that has a 
specific, yet reversible affinity for Au (gold).   In the assembly of the monolayer, first the 
head-groups are attached the gold surface via a near-covalent interaction (~100kJ/mol) 
either in the liquid or gas phase.  Then, the tail groups, which consist of long chain 
alkanes, or single bonded carbon chains, begin to orient and form semi-crystalline to 
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crystalline structures.  These tail group interactions stabilize the close packing of SAM 
molecules via hydrophobic interactions and van der Waals interactions (VDW). 
 
 
Figure 10.  Basic self-assembling monolayer structure for controlling cell adhesion. 
 
In vitro, SAMs present a method to generate and study model substrates 
presenting specific ligands to which cells can adhere.  An advantage of SAMs over other 
model substrates is the level of control over the composition of the substrate as well as 
the ability to characterize these biological interactions by surface plasmon resonance 
[56]. 
Self-assembling molecules terminated with oligo- or poly(ethylene glycol) units 
are used to render surfaces non-fouling to cell adhesion.   Non-fouling SAMs are an 
effective way to prevent non-specific protein adsorption to model surfaces.  When used 
in conjunction with bioactive or other functional groups that support protein adsorption, 
non-fouling SAMs can be used to create a mixed monolayer.  Mixed SAMs for the 
immobilization and attachment of cells only require 0.01-1% of the cell supporting 
species [57].  Cells can then adhere to these surfaces via non-specific interactions.  
Nevertheless, cells will continually remodel their microenvironment over time; therefore it 
might be difficult to control exactly which and what ratio of ECM proteins the cell will 
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secrete.  In order to rigorously study the effects of a single ligand, the ligand can be 
tethered to a mixed SAM surface, to present integrin binding peptide sequences [58]. 
Whereas self-assembled monolayers have been used extensively for in vitro 
applications, they suffer several limitations when applied to in vivo medical applications.  
It is difficult to create robust Nobel-metal coatings on biomedical implants, SAM layers 
are limited to gold and silver substrates, and SAMs still suffer from long-term instability 
and loss of bioresistance [59-62].  As a consequence, in the last decade there has been 
a concerted effort developing medical grade polymer-brush systems and hydrogels. 
2.3.2 Polymer-Brush Systems 
Polymer-brush systems offer a more robust method of tethering biomolecules to 
biomedical device surfaces.  These tethering chemistries utilize the –OH groups on 
oxidized titanium and silicon substrates for silane immobilization.  There are two main 
methodologies for functionalizing these surfaces, “grafting-to” and “grafting-from” 
approaches.  Grafting-to involves tethering a polymer-brush to the metal surface directly; 
however, this method suffers from low packing density due to steric hindrances from 
grafted groups.  Grafting-from involves first immobilizing a silane layer on top of the 
metal to provide a high density of functional groups for direct chain-growth 
polymerization.  Previously, adsorption of end-functionalized PEG onto titanium metal 
allowed the surface to be non-fouling [63].  Using surface-initiated atom-transfer radical 
polymerization (SI-ATRP) oligo(ethylene glycol)methacrylate (OEGMA) has been grafted 
to gold surface modified with a thiol monolayer of α-bromo ester.  Furthermore, 
poly(OEGMA) coatings have been successfully grafted to titanium substrates and have 




Figure 11.  Grafting-to and Grafting-From.  A) Grafting-to method; initially tethered 
polymer impedes further deposition, resulting in low-density of brushes B) Grafting-from 




Hydrogel technology has the ability to mimic the 3D architecture of the native 
ECM to control the function of cells and guide the spatially and temporally complex 
multicellular process of tissue repair and regeneration.  There are two classes of 
hydrogels, natural and synthetic – each with their own advantages and disadvantages.  
Natural hydrogels such as collagen and alginate are derived from nature; therefore, they 
already present receptor-binding ligands and are subject to cell-based enzymatic 
degradation and modeling.  However, there are issues with purification, immunogenicity, 
and pathogen transmission.  Synthetic hydrogels on the other hand are engineered to 
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have specific structure-function relationships and can be fine-tuned to suit various 
biological applications via conjugation to bioactive molecules, adhesive moieties, and 
enzymatically degradable links.  In terms of basic science research, synthetic hydrogels 
have been favored because of the ability to study single and multiple cell receptor-ligand 
interaction events in a highly empirical and step-wise fashion.  For an excellent review 
regarding the use of ECM mimetic synthetic hydrogels, refer to [66]. 
2.5  Bio-inspired, Adhesive Materials:  New Routes to Promote Tissue 
Repair and Regeneration 
The ECM is naturally complex and presents to cells a myriad of signals that 
convolute analysis of various cell processes.  Using simplified synthetic ECM-mimetic 
peptides, model surfaces can be constructed that present only a particular signal or 
adhesive motif.  Some of the most prevalent adhesion motifs consist of arginine-glycine-
aspartic acid (RGD) tri-peptide for fibronectin [67] and the tyrosine-isoleucine-glycine-
serine-arginine (YIGSR) oligopeptide for laminin [68].  These short bioadhesive peptides 
have been tethered to both synthetic and natural surfaces, as well as three-dimensional 
scaffolds, to promote adhesion and migration in various cell types (as reviewed in [69-
72]).  In conjunction with these adhesive peptides, non-fouling, or protein “resistant” 
supports, such as poly(ethylene glycol), poly(acrylamide) and alginate, are often used to 
reduce non-specific protein adhesion and background adhesion.  The density of tethered 
peptide is an important design parameter.   Cell adhesion, focal adhesion assembly, 
spreading and migration [73-76], neurite extension and neural differentiation [77, 78], 
smooth muscle cell activities [79], osteoblast and myoblast differentiation [80-82], all 
exhibit peptide density-dependent effects.  Also, tethering of bioadhesive ligands onto 
biomaterial surfaces and scaffolds also enhances in vivo responses, such as bone 
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Figure 12.  Schematic of RGD and YIGSR sites.  A) Schematic diagram of RGD and 
synergy site PHSRN on the fibronectin III domain.  B) Schematic diagram of YIGSR and 
RGD binding sites on laminin.  Adapted from [87] and [88]. 
 
These results indicate that functionalization of biomaterials with short adhesive 
oligopeptides significantly enhances certain cellular activities.  In addition, conveying 
biospecificity while avoiding unwanted interactions with other regions of the native 
ligand, short bioadhesive peptides allow facile incorporation into synthetic backbones 
and enhanced stability of the tethered motif.  However, these strategies still have their 
limitations; namely, 1) low activity of oligopeptides compared to native ligand due to the 
absence of modulatory domains, 2) limited specificity for adhesion receptors and cell 
types, and 3) inability to bind certain receptors due to conformation differences 
compared to the native ligand [7].  Strategies to improve ligand activity include 
conformationally constrained peptides (e.g. cyclic), oligopeptide mixtures, and 
recombinant protein fragments spanning binding domains of native ligands [64, 89-93].  
Also, self-assembling peptides reconstituting the triple helical structure of type I collagen 
 25 
have been used to target collagen integrin receptors and promote enhanced osteoblastic 
differentiation and mineralization on biomaterial supports [94, 95].  The improved activity 
and selectivity of these materials result in enhanced cellular activities and in vivo 
responses [64, 96].  
 
 
Figure 13.  Dose-dependent Spreading on Linear vs. Cyclic RGD.  Area of spread 
HUVEC to supported mixed monolayers of A) (C16)2GRGDSP and PEG and B) looped 
GRGDSP and PEG, after 60 min incubation at 37 1C in basal medium supplemented 
with 0.1% BSA (error bars represent S.E.M.). Adapted from [91]. 
 
2.6 Triggerable, Dynamic Biomaterials 
The previous sections highlighted the importance of bioadhesive ligand 
presentation in terms of density and specificity.  However, current approaches to ligand 
presentation often comprise of static, constant densities of ligands.  In contrast, natural 
cell adhesive interactions with ECMs exhibit spatiotemporal patterns of binding and 
activation.  Therefore, a key to future research in controlling cell-material interactions will 
be the development of materials that can respond to external stimuli.  The following 
section presents both the model systems currently being employed and emerging 
technologies in this field. 
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There are many modalities to control the presentation of ligands on a biomaterial.  
Some of these methods include, electrochemical desorption, oxidative release, light 
controlled desorption, and enzyme controlled activation. 
2.6.1 Non-Specific “On” Switches 
Electrochemical desorption 
Whitesides and co-workers, created a surface that could be used to screen drug 
candidates via controlling cell migration.  Using microcontact printed (μCP) 
HS(CH2)17CH3 and HS(CH2)11(OCH2OCH2)3OH(C11EG3) as a non-fouling barrier to 
protein adsorption, bovine capillary endothelial (BCE) cells were seeded and spread on 
the non-patterned regions.  By applying a <-1.2V potential for 30 seconds, the complete 
desorption of these non-fouling SAMs occurred, and the BCE cells were allowed to 





Figure 14.  BCE Cells Spread on Patterned Surface with Non-Fouling Barrier C11EG3 
and C18.  Images show time-lapse after application of cathodic voltage pulse (-1.2V for 
30s). The numbers indicate the time elapsed (in minutes) after the voltage pulse.  
Adapted from [97]. 
 
Oxidative Release 
Wittstock and co-workers developed an oxidative release mechanism for 
oligoethylene glycol (OEG)-terminated thiol SAMs using ultra microelectrodes [98].  By 
generating Br2 in situ using electrochemical processes, an OEG-terminated SAM was 
oxidized to a cell-adhesive state.  This process still had shortcomings in patterning 
fidelity due to limiting factors of electrode size and diffusion of bromine away from the 
electrode.  The newer method that has been employed by Wittstock and co-workers 
involves the use of scanning electrochemical microscopy (SECM) to generate bromine in 
situ [99]. 
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Nishizawa and co-workers created a pretreated surface with cell-adhesion 
resistant bovine serum albumin (BSA) [100].  By the electrochemical generation of 
hydrobromic acid in situ, the BSA was removed, and other serum proteins from media 
were allowed to attach to the desorbed regions.  Nevertheless, these methods also have 
the same problems as electrochemical desorption methods since they allow ECM 
proteins to adsorb, with little overall control of composition. 
Photo-based Desorption 
Light-based control schemes allow for the high resolution patterning of cells in 
culture in a highly spatially repeatable and specific manner.  Strategies by Nakanishi et 
al were based on silane grafted SAMs containing a 2-nitrobenzyl group.  A glass 
coverslip was modified with 1-(2-nitrophenyl)ethyl-5-trichloro silylpentanoate (NPE-
TCSP) that contained nitrobenzyl ester group that could support the hydrophobic 
adsorption of non-adhesive BSA.  Selective areas were irradiated with λ=365nm light, 
which converted exposed nitrobenzyl ester groups to carboxylic acid groups that could 
support fibronectin adsorption [101].  Using a photomask, this technology was able to 
form subcellular adhesive islands to study focal adhesion formation and cell migration 
[102]. While these surfaces have the added benefit of spatiotemporal control via UV 
irradiation, it still suffers from the same problems as the previous surfaces in that non-




Figure 15.  Selective Initiation of Two Different Characteristic Protrusions of NIH3T3s.  A) 
Example of lamellipodia (red) and filopodium (green) on unpatterned fibronectin surface.  
B, C) Schematic of photopatterned desorption along with time-lapsed protrusion.  D) Cell 
adhesion onto substrate with patterns illuminated simultaneously. Adapted from [102]. 
 
2.6.2 Integrin Specific “On” Switches 
Photoactivation 
Mrksich and colleagues have generated substrates that used a Diels-Alders 
reaction for the immobilization of peptide-diene conjugates on quinine-terminated SAMs 
[103].  The base substrate was a nitroveratryloxy-carbonyl (NVOC)-protected 
hydroquinone-terminated SAM (1%) with a tri(ethyleneglycol)-terminated alkanethiol 
background (99%).  When selectively irradiated with λ=365nm for 2 minutes, the NVOC 
protecting group is cleaved, leaving a reactive hydroquinone that can be 
electrochemically oxidized to yield a benzo-quinone, which then reacts with a peptide-




Figure 16.  Strategy for Patterning Immobilized Ligands to a Self-Assembled Monolayer 
via NVOC-Protected Hydroquinone.  Upon irradiation with UV-light (365nm), NVOC is 
cleaved leaving hydroquinone, which is reversibly oxidized to quinine.  Quinone 
undergoes Diels-Alder reaction with cyclopentadiene conjugated ligand, immobilizing 




Figure 17.  Photodeprotection/Diels-Alder Immobilization Strategy.  A) Schematic of 
overall process flow. B,C) Swiss 3T3 fibroblasts attached to regions of substrate 
illuminated with UV-light, oxidized (+400mV, 15 sec), and then treated with RGD-Cp 
(5mM, 4hr).  Adapted from [103]. 
 
Del Campo and co-workers have demonstrated photo-controlled cell adhesion to 
self-assembled monolayers via a caged-cyclic RGD containing peptide [104].  A 
photolabile caging group consisting of a 3-(4,5,dimethoxy-2-nitrophenyl)-2-butyl ester 
(DMNPB) is tethered to the carboxylic acid side chain of the aspartic acid residue. Upon 
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UV-irradiation at 361nm, the DMNPB group is cleaved effectively removing the cage, 
and leaving behind standard cyclic RGDfK.  The caging groups mechanism of action has 
not been fully characterized, but it is possible that additional steric hindrance, 
conformation restriction or changes in the charge distribution of the peptide are 
responsible for blocking integrin-recognition.   
 
 
Figure 18.  Caged-RGD Compound Immobilized to Surface.  Chemical structure of 
cyclo[RGD(DMNPBfK)] (DMNPB in red) with TEG-based silane immobilization strategy 
(TEG in green).  Upon UV-irradiation @ 365nm, DMNPB group is cleaved from aspartic 
acid residue, restoring bioactive cyclo(RGD).  Adapted from [104].  
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2.6.3 Adhesion “Off” Switches 
Electrochemical Off-switching 
An improvement of Mrksich’s NVOC system resulted in the generation of an 
electroactive quinone ester SAM that has a tethered RGD [105].  Upon electrochemical 
reduction (5min at 550 mV), the quinone forms a hydroquinone, which then performs a 
rapid cyclization, ultimately cleaving the RGD peptide.  A further improvement allowed 
Mrksich to generate two different redox-active tethers based on the quinone ester and O-
silyl hydroquinone which respond to -650mV and 650mV, respectively [106] .  This 




Figure 19.  Molecular Strategies to Prepare Dynamic Substrates.  A) Monolayer 
presenting maleimide tethered to electroactive quinine ester reacts with cysteine-
terminated RGD peptides to immobilize the ligand, electrochemical reduction of 
quinine releases RGD ligand.  B) Monolayer presenting a maleimide group 
tethered to an electroactive O-silyl hydroquinone is used to immobilize cysteine-
terminated RGD, electrochemical oxidation releases RGD ligand.  Adapted from 
[106]. 
 
Del Campo and colleagues have recently developed an intercalated 4,5-dialkoxy 
1-(2-nitrophenyl)ethyl photolabile group that can be attached to free amine groups at the 
surface of a substrate via a carbamate bond [107]. A tetraethyleneglycol (TEG) spacer is 
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included in the structure in order to provide a protein- and cell-repellent surface before 
attaching bioactive ligands. A bioactive ligand, such as biotin or RGD oligopeptide, can 
be attached to the surface by reacting with the free amine at the end of the TEG spacer.  
When used in conjunction with amine-terminated SAMs, this methodology allowed for 
the removal of human umbilical vein endothelial cells from model surfaces using 
irradiation at λ=350.  After 8 minutes of irradiation, 70% cleavage of RGD was attained.  
This system allows for the selective immobilization of a peptide containing a free 
carboxylic acid and its subsequent cleavage by UV irradiation. 
 
 
Figure 20.  Schematic and Microscopy Images of Intercalated 4,5-dialkoxy 1-(2- 
nitrophenyl)ethyl Photolabile Linker.  A, C) HUVECs attached to RGD immobilized onto 
photolabile linker and non-cleavable linker control, respectively.  B, D) Resulting HUVEC 
detachment post UV-irradiation.  E) HUVECs seeded 2hrs on amine-terminated SAM.  
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F) HUVECs incubated for 2hr on cyclo(RADfk) non-adhesive control coupled to amine-
terminated SAM with linker.  Adapted from [107]. 
 
2.6.4 Reversible Adhesion Switches 
Reversible Photoactive Switching 
Liu et al has demonstrated a switchable SAM system that can reversibly 
modulate RGD presentation [108].  This design employed an azobenzene unit that upon 
UV irradiation (λ=340-380nm) can be switched from a thermally stable E-isomer to the 
thermally unstable Z-isomer.  Additional irradiation at λ=450-490nm reverts this SAM to 
its original E-state.  When an RGD group is tethered to the end of this molecule, in the E-
isomer form, the substrate supports cell adhesion, while in the Z-isomer form, cell 
binding is significantly attenuated.  Using a similar method Kessler et al, used the 
switching from the E to Z-isomers directly to modulate the percentage of cells on the 
surface [109].  These methods, however, are potentially limited by damaging pre-




Figure 21.  Cyclic RGD Peptide Presented on Photoswitchable 4-[(4-
aminophenyl)azo]benzocarbonyl unit].  c-(RDfK) denotes cyclic(RGD) peptide.  Adapted 
from [110].  
 38 
Reversible Temperature-Based Switching 
One of the most promising technologies to control the adhesion of cells and 
tissues to a substrate has been the temperature responsive polymer poly(N-
isopropylacrylamide) (NIPAAm).  This polymer that can be covalently tethered to cell 
culture surface, has the unique characteristic of being able to control protein adsorption 
based on temperature alone.  At temperatures above the lower critical solution 
temperature (LCST) of 32°C, poly(NIPAMM) surfaces are hydrophobic and support the 
adsorption of proteins from serum and media, allowing cells to attach and proliferate.  
Upon, lowering the temperature below the LCST, the surface is rendered hydrophilic and 
causes a hydrated layer to form between the cell sheet and the culture surface [111].  
This causes all cells and ECM components to detach from the polymer surface in a 
sheet, allowing for “cell-sheet” based tissue engineering.  This technology has 
experienced great success in recent years and is currently being utilized in early phase 




Figure 22.  Cell Harvest Mechanism by Using Temperature-Responsive Culture 
Surfaces.  A) Cells attach to hydrophobic surfaces via cell membrane proteins and 
adsorbed ECM proteins from serum.  B) Enzymatic digestion of membrane and ECM 
components result in cell detachment.  C) On poly(NIPAAm) surfaces interconnection 
between ECM and cells remained intact post-release.  Adapted from [113]. 
 
2.7 The Multiple Post Array Deflection Substrate (mPADs) 
Mechanotransduction has been implicated in many cell processes, from 
proliferation, differentiation, and cell fate [114].  Early studies attempted to modulate 
substrate rigidity by growing cells on collagen gels and polyacrylamide (PAA) gels.  The 
first cell traction forces were reported by cells on silicone substrates [115].  Cells spread 
on these substrates, wrinkle the silicone membrane, and these wrinkles were 
deconvoluted into strain fields.  Later, investigators tried to improve on these approaches 
by embedding aligned arrays of fluorescent markers to monitor the deformation of 
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membranes, or used cantilever systems to monitor cell traction forces [116, 117].  All 
these systems are not amenable to measuring discrete cell traction forces on a surface.  
The multiple post array deflection substrate allows for the highly defined monitoring of 
cell traction forces in live-cell applications with the added ability to decouple surface 
rigidity from cell traction force [118].  The general schematic of mPAD behavior is shown 
below in Figure 23. 
 
 
Figure 23.  Characterization of mPAD Masters and Substrates.  A) SEM images of 
silicon masters.  B) FEM simulation of von Mises stresses on posts of different heights.  
C) Nominal spring constant of posts of different height.  Adapted from [119]. 
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2.8 Summary of Background 
In summary, controlling cell-adhesive interactions is paramount to the study of 
cell mechanical signaling.  Cell-matrix interactions rely on specific interactions with either 
the native or synthetic ECM.   This ECM is comprised of various biomolecules including 
proteins.  Proteins are biomolecules with complex structure and can modulate function 
and activity of biological systems.  Engineering surfaces with simplified protein 
sequences allows for an empirical approach to decoding these complex cell-material 
interactions. Through the rational design of material surfaces, protein adsorption and 
receptor-ligand interaction can be tightly controlled both spatially and temporally.  
Because of this level of control, researchers have begun unraveling the complex 
symphony of signals for cellular events such as adhesion and cell spreading.   
Cell-material interactions are primarily mediated by receptor-ligand interactions 
between adsorbed or covalently bound ligands to a surface and cell receptors called 
integrins.  Integrin mediated signaling has been implicated in many cellular processes 
ranging from adhesion, migration, growth, secretion, gene expression, and apoptosis.  
These adhesive interactions also regulate cellular and host responses to implanted 
biomedical devices, tissue-engineered constructs, and biotechnological systems.  It is 
increasingly evident that mechanotransduction between cells and their environment 
regulates gene expression, cell fate, and even malignant transformation.   
The cell adhesion cascade involves initial attachment, integrin recruitment and 
spreading, integrin clustering and focal adhesion formation, and contractile force 
generation via cytoskeletal interactions.  Cell adhesion to native ECM components, such 
as fibronectin and laminin, is mediated by the activation and mechanical coupling to 
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integrins.  Bound integrins rapidly associate with the actin cytoskeleton and cluster to 
form focal adhesion complexes.   
Model surfaces have been created to explore in-depth specific mechanisms for 
cell adhesion and spreading to various peptide sequences and adhesive proteins.  
Simplified protein sequences such as RGD and YIGSR tethered to both synthetic and 
natural surfaces in order to study the effects of a single protein motif.  Dynamic 
biomaterials can modulate the spatiotemporal presentation of these motifs through 
electrochemical, enzyme and light controlled modalities.   The development of additional 
dynamic biomaterials is critical to unraveling the complex adhesive interactions between 
cells and surfaces.  Applications of adhesive control in three-dimensions and in in vivo 
applications will undoubtedly provide key insights into cellular behavior in more complex 




AIM 1: IN VIVO TRIGGERABLE LIGAND PRESENTATION 
USING CAGED-RGD PRESENTING HYDROGELS 
 
3.1 ABSTRACT 
 PEG-based hydrogels provide a novel platform to elucidate cell-ECM interactions 
through a highly defined, non-fouling surface.  Through the use of simplified ECM-
peptides such as RGD, specific integrin-ECM interactions can be studied.  We have 
demonstrated the uses of a novel caged-RGD molecule that can be activated by UV 
irradiation in the context of PEG-based hydrogels.  Delayed activation of caged-RGD 
presenting hydrogels, via transdermal irradiation was able to modulate macrophage 
recruitment and downstream fibrous capsule formation in subcutaneously implanted 
PEGDA-based hydrogels.  When applied to PEG-maleimide based hydrogels, caged-
RGD was effective at controlling in vitro cell outgrowth into a degradable hydrogel with 
protease sensitive crosslinks.  In an in situ polymerized subcutaneous model, caged-
RGD was effective at controlling vasculogenesis through the modulation of RGD 
presentation via transdermal UV irradiation.  Therefore, we demonstrate that caged-RGD 
in conjunction with PEG-based hydrogels is a versatile platform that offers unparalleled 
spatiotemporal control of RGD ligand presentation.  Through UV-activation we 
demonstrated that ex vivo control of RGD-mediated cell adhesion is a critical regulator of 
many events including inflammation and vasculogenesis.  We show that that caged-
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compounds provide a versatile and effective means of controlling the presentation of 
signals and ligands in both in vitro and in vivo systems. 
3.2 INTRODUCTION 
Fibrous capsule formation has long been an undesirable inflammatory response 
to implantable medical devices.  Immediately following implantation, proteins and other 
biomolecules quickly adsorb to the surface of an implant, creating a surface rich for 
inflammatory cell adhesion and activation [120].  The inflammatory cascade that begins 
with neutrophil and macrophage recruitment and activation, followed by foreign body 
giant cell response and fibroblast-based fibrosis, results in the formation of a dense 
collagen matrix around the implant [120].  This natural barrier, between the host tissue 
and the implant surface, is a critical limiter of device performance and engraftment in a 
variety of applications ranging from implantable sensors to cosmetic applications [121, 
122].  Although studies have attempted to elucidate methods of abrogating fibrous 
capsule formation through the use of specialized materials, surface coatings, and drug 
eluting polymers, until now there have been few ways to study the effects of time-
dependent regulation of integrin-ligand based cell adhesion on downstream inflammatory 
pathways. 
Integrin-mediated cell adhesion to the ECM is essential for the maintenance and 
repair of tissues by providing both mechanical anchorage, and biochemical cues that 
direct cell survival, migration, cell cycle progression, and the expression of differentiated 
phenotypes [8, 9].   Abnormalities in adhesive interactions have also been implicated in 
pathological states, including blood clotting, wound healing defects, and malignant tumor 
formation [14, 15].  Inflammatory cell adhesion to ECM components, specifically integrin 
mediated binding to adhesive extracellular ligands, are responsible for regulating cellular 
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and host responses to implanted biomedical devices, tissue-engineered constructs, and 
biotechnological systems [7].  These ligands can be adsorbed from solution blood, 
plasma, or serum; secreted and deposited onto the biomaterial surface by cells; or 
specifically engineered onto a biomaterial interface.  All of these interactions are highly 
dynamic, and the dominant adhesive mechanism could vary over time and is often 
different among cell types.  In platelet aggregation, the platelet integrin αIIbβ3 (GPIIb/IIa) 
binds to several ligands such as fibrinogen, von Willebrand factor, and fibronectin [6].  
This receptor is the essential mediator of initial events in the blood-activation cascade 
after blood as come into contact with a synthetic material [45, 46].  Leukocyte-specific β2 
integrins, such as αMβ2 (Mac-1), mediate monocyte and macrophage adhesion to 
various ligands, including fibrinogen, fibronectin, IgG, and complement fragment iC3b.  
These receptors all play central roles in inflammatory responses in vivo [47, 48].  Binding 
of αMβ2 integrin to fibrinogen P1 and P2 domains exposed upon adsorption to 
biomaterial surfaces controls the recruitment and accumulation of inflammatory cells on 
implanted devices [49]. This integrin also plays a critical role in macrophage adhesion 
and fusion into giant foreign-body cells [48, 49].   
Clearly, cell-material interactions are governed by a complex symphony of 
integrin-ligand binding and downstream signaling events that that act in a coordinated 
time-dependent manner.  Thus, controlling specific cell-matrix interactions is essential to 
unraveling these complex interactions [17-22].  Synthetic hydrogels can be engineered 
to elicit specific structure-function relationships and can be fine-tuned to suit various 
biological applications via conjugation to bioactive molecules, adhesive moieties, and 
enzymatically degradable links [66].  These ECM-mimetic matrices have been popular 
because of the ability to study single and multiple cell receptor-ligand interaction events 
in a highly empirical and step-wise fashion.  In this study, poly(ethylene glycol)-based 
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hydrogels are used as a “clean-slate” model surface that is highly resistant to non-
specific protein adsorption, cell adhesion, and signaling [52, 53].     
Using simplified synthetic ECM-mimetic peptides, model surfaces can be 
engineered to present only a particular signal or adhesive motif, such as arginine-
glycine-aspartic acid (RGD) tri-peptide for fibronectin [67].  These short bioadhesive 
peptides have been tethered to both synthetic and natural surfaces, as well as three-
dimensional scaffolds, to promote adhesion and migration in various cell [69-72]. These 
ligands also enhance in vivo responses, such as bone formation and integration [64, 83], 
nerve regeneration [84, 85], and corneal tissue repair [86]. 
Traditional investigations of cell-matrix interactions, however, have often relied on 
static ligand presentation; in contrast, natural cell adhesive interactions with ECMs 
exhibit spatiotemporal patterns of binding and activation.  Nevertheless, recent advances 
have resulted in a new class of “dynamic” biomaterials that provide triggerable, real-time 
control of mechanical and biomolecular cues in response to external stimuli.  These 
materials can be triggered by changes in temperature, pH, chemical concentration, light, 
and electrical field [104, 123-125].   
Previously, it has been shown the adhesive sequence RGD (arginine-glycine-
aspartic acid) has the ability to modulate inflammatory response as measured by 
cytokine production and downstream fibrous capsule formation [126].  Also it has been 
shown that the RGD ligand is required for in vivo vasculogenesis into VEGF-presenting 
degradable hydrogels.  In this study, we used a novel UV-labile DMNPB-“caged”-
cRGD(fk) [104] to demonstrate in vivo control of biomaterial implant associated 
inflammation, as measured by fibrous capsule formation, immunohistochemistry, and 
quantitative in vivo reactive oxygen species imaging, and also cell infiltration into 
implants via whole-mount fluorescence imaging.  
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3.3 RESULTS AND DISCUSSION 
3.3.1 Synthesis of PEG-Conjugates and Fabrication of PEGDA Hydrogels 
We have engineered poly(ethylene glycol) di-acrylate (PEGDA) based hydrogels 
that have covalently tethered adhesive ligands on the surface.  The first step in the 
generation of adhesive PEGDA hydrogels is the synthesis of “adhesive ligand”-
poly(ethylene glycol)-acrylate derivatives (Figure 24, B).  Acrylate-PEG-SVA contains a 
NHS ester that is readily displaced by the free amine in any peptide in 50mM sodium 
bicarbonate solution (pH 8.2).  RGD and caged-RGD derivatives were synthesized.  
These PEG-conjugates were then dialyzed and lyophilized to obtain a stable solid.  
Successful functionalization of the Acrylate-PEG-caged-RGD and Acrylate-PEG-
cyclic(RGD) were confirmed using MALDI mass spectrometry; and, the overall increase 
in molecular weight of the product is consistent with the tethering of the adhesive ligands 
(Figure 24, C).  
The detailed fabrication protocol can be found in Figure 25.  The final hydrogels 
are cast in sterilized silicon grommets affixed to glass surfaces treated with Sigmacote 
(to facilitate mold release).  In the interest of using the minimal amount of caged-RGD, 
we first create the bottom bulk 10% (w/v) PEDGA hydrogel, using a combination of 
PEGDA and UV-activated BASF (Ciba) Irgacure 2959 crosslinker. A Sigmacote treated 
coverslip was then placed on top of the mold to generate a flat disk.   After UV-based 
free radical crosslinking, coverslip was removed from the bulk PEGDA gel.  At this point 
the bulk gels were ready for a separate layer of functionalized PEGDA hydrogel (Figure 
24, D-E).  We cast a thin layer of functionalized gel (8% PEGDA (w/v) and 2% (w/v) 
PEG-conjugate) on top of the PEGDA bulk gel because we are only interested in 
studying the tissue/implant interface at the top functionalized surface.  The bulk portion 
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of the gel primarily serves to increase ease of handing during surgical implantation.  
However, this caged-RGD was UV labile at the wavelength required for 
photopolymerization; therefore, the functional layer crosslinked via TEMED/APS 
chemistry to preserve the intact caging group.   
 
 
Figure 24.  PEGDA-based Caged-RGD Hydrogels.  A) Acryl-PEG-Caged-RGD tethered 
to Acryl-PEG-Acryl Hydrogels; red hydrogel denotes “caged” RGD molecule, green 
hydrogel denotes “uncaged” RGD molecule on surface.  B) Reaction Scheme for 
tethering Caged-RGD molecule to Acryl-PEG-SVA (NHS ester terminated).  C) MALDI-
MS curves showing successful tethering of Caged-RGD to PEG-Acryl, forming Caged-





Figure 25. Fabrication Schematic for Caged-RGD Presenting PEGDA Hydrogels. 
 
3.3.2 Caged-RGD Presenting Hydrogels Modulate Cell Adhesion and Spreading 
In vitro characterization of functionalized hydrogels was completed using NIH3T3 
fibroblasts in a 24hr cell adhesion and spreading assay (Figure 26). PEGDA, RDG 
(scrambled, inactive peptide), and linear(RGD) controls were compared to unexposed 
and exposed caged-RGD gels.  NIH3T3s cells were seeded at 20k/cm2 density, and 
allowed to spread overnight, washed to remove minimally attached and dead cells, and 
then treated with Calcein-AM/ethidium homodimer I  (live/dead) stain.  Calcein signal 
indicates that even on the non-adhesive controls the cells were still alive.  The lack of 
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ethidium homodimer II positive staining is not surprising because all the dead and 
minimally adherent cells would have been removed during washing.  
 
 
Figure 26.  Caged-RGD Modulates Cell Adhesion and Spreading to PEGDA-based 
hydrogels.  A) NIH3T3 24hrs post seeding on various conditions.  Not exposed caged-
RGD presenting hydrogels show similar cell adhesion and spreading as the PEGDA and 
RDG non-adhesive controls.  Exposed caged-RGD and RGD positive control support cell 
adhesion and spreading.  Live/dead stain; Calcein AM (green) and ethidium homodimer 
II (red).  B) Quantification of cell attachment to functionalized PEGDA hydrogels.  
 
Low levels of NIH3T3 fibroblast spreading were observed in the PEGDA, RDG, 
and “No UV” caged-RGD conditions.  The cells that attached to these surfaces were 
largely rounded or bipolar in morphology indicating poor adhesion to surface by lack of 
adhesive ligands. High levels of adhesion and spreading were observed in the RGD and 
“UV Exposed” caged-RGD conditions (Figure 26, A). These cells exhibited normal 
spreading morphology and were well spread.  There was no statistical difference in cell 
density in controls PEGDA and scrambled peptide RDG (Figure 26, B), which is 
expected due to the lack of adhesive ligands.  Also, this validates the non-fouling nature 
 51 
of PEG surfaces, where adhesive proteins from serum are unable to adsorb and 
facilitate cell attachment.  There was a statistical difference between the “No UV” and 
“UV Exposed” condition, showing that caged-RGD was effective in controlling cell 
adhesion/spreading through controlling RGD ligand presentation in the 
presence/absence of UV irradiation.  Another important conclusion was that poor 
adhesion and spreading on the “No UV” caged-RGD conditions confirm that the DMNPB 
caging group was not compromised while incorporating the Acrylate-PEG-caged-RGD 
conjugate into the PEGDA gel via free radical crosslinking.   
3.3.3 In vivo Subcutaneous Model for Caged-RGD/fluorescein Hydrogels 
The subcutaneous implantation of hydrogels in Balb/c mice was performed via 
the schematic described in Figure 27.  All procedures were approved by the Georgia 
Tech Institutional Animal Care and Use Committee. First, incisions were made left and 
right proximal of the dorsum.  Hemostats were used to create a subcutaneous pocket, 
ensuring the subcutaneous space was large enough to accept the hydrogel implant.  The 
hydrogel was implanted, and wound clips were used close the wound.  Wound clips 
were taken off at Day 10.  Mice were single housed to prevent biting and reopening of 
wound.   At designated time points, UV lamp-based 361nm UV irradiation was 
performed on each implant while mice under anesthesia. For the Day 0 condition, mice 




Figure 27.  Subcutaneous Implantation of Pre-cast PEDGA Hydrogels.  Incisions are 
made on dorsum of mouse, just proximal to spine.  Hemostats are used to create 
subcutaneous pocket.  Functionalized hydrogels are implanted.  Wound clips are used to 
close incisions. UV lamp-based 361 nm irradiation at designated timepoints is used to 
transdermally activate hydrogels. 
 
3.3.4 In vivo Uncaging Efficiency Validated Using Caged-fluorescein 
In order to validate the efficacy of transdermal uncaging, Caged-fluorescein 
functionalized hydrogels were used to characterize the transdermal in vivo un-caging 
efficiency of the DMNPB group.  The tethering scheme and mechanism of action is 




Figure 28. Schematic of Caged-fluorescein-Acrylate Synthesis and Mechanism of Action.  
A) Caged–fluorescein is reacted with a PEG-Acrylate in DMF and DIPEA overnight to 
yield caged-fluorescein-acrylate.  B) Schematic representation of caged-fluorescein 
conjugated to PEGDA hydrogels.  Upon 361 nm irradiation the caging groups (red) are 
cleaved. 
 
Caged-fluorescein hydrogels and blank PEDGA controls were fabricated (Figure 
29, A) and implanted subcutaneously in Balb/c mice.  All implants were irradiated using 
a UV-lamp with bandpass filter at 361nm.  After designated takedown points of one 
week and two weeks, explants were whole-mount imaged using an epifluorescent 
microscope.  For the 7-day explant condition, PEGDA, and caged-fluorescein gels were 
implanted, and half of the caged-fluorescein gels were irradiated immediately following 
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implantation.  For the 14-day takedown condition, PEGDA, caged-fluorescein, and pre-
exposed caged-fluorescein hydrogels were implanted in Balb/C mice.   
 
 
Figure 29.  In vivo Characterization of Caged-fluorescein.  A) Schematic of PEGDA 
hydrogel functionalization for caged-fluorescein characterization.  B) Schematic of 
subcutaneous implantation of caged-fluorescein presenting hydrogels and subsequence 
361nm UV irradiation.  C) Whole-mount explants of caged-fluorescein implants at 
designated takedown points.  Blank PEGDA control has minimal fluorescence signal 
similar to the 7-day takedown and 14-day takedown “No UV” conditions.  7-day 
takedown “Day 0 Transdermal UV”, 14-day takedown “pre-exposed UV” and “Day 14 
Transdermal UV” conditions all exhibit strong fluorescein signal. Scale bar 1mm. D) 
Quantification of fluorescein signal of hydrogel explants at designated takedown points.  
Uncaged conditions exhibit strong fluorescein signal when compared to unexposed 
conditions and PEGDA control.  Differences are statistically significant (p<0.0001).   
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At both time points, the “No UV,” non-exposed, caged-fluorescein hydrogels 
exhibited minimal fluorescence signal, similar to the PEGDA non-functionalized control.  
This indicates that even after hydrogel preparation, surgical implantation, and exposure 
to animal facility lighting, the caging group was still intact and exhibited no measureable 
uncaging.  In the 7-day explants, transdermally irradiated caged-fluorescein hydrogels 
exhibited markedly increased fluorescein intensity compared to the non-irradiated Day 0 
control (Figure 29, C, top row, middle and right panel).  In order to confirm the long-term 
un-caging efficiency at two weeks, explants of pre-exposed caged-fluorescein controls 
(irradiated before implantation) were compared to Day 14 transdermally irradiated 
conditions and exhibited similar fluorescence intensity (Figure 29, C, bottom row, middle 
and right panel). Both the transdermal activation at both Day 0 and Day 14, and the pre-
exposed caged-fluorescein conditions have significantly higher fluorescein intensity than 
the PEGDA, Day 0 non-exposed, and Day 14 non-exposed conditions (Figure 29).  This 
data shows that DMNPB caging group after 10 minutes of 361 nm irradiation is UV labile 
at similar efficiency regardless of whether it is pre-exposed, transdermally exposed at 
Day 0, or transdermally exposed at Day 14.  These results are important because they 
show the stability of the caging group through out the whole experiment and how caging 
efficiency remains unchanged regardless of fibrous capsule formation or inflammation 
around the implant in the weeks after surgery. 
3.3.5 GMA Based Histology Preserves Tissue/Implant Interface 
Histology is especially difficult at tissue/hydrogel interfaces.  A traditional 
cryosectioning medium is a mixture of poly(ethylene glycol) [PEG] and poly(vinyl alcohol) 
[PVA], commonly known as OCT.  Cryosectioning, due to freezing fracturing, caused by 
the different freezing rates of tissue vs. hydrogels, often leads to the destruction of the 
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hydrogel and damage to the interface.  We have developed a new method of embedding 
tissue/hydrogel explants that preserves the hydrogel interface using Polymer Science 
Immunobed, a resin-based embedding system based on poly(gylcidyl methacrylate) 
[GMA].   
 
 
Figure 30.  GMA Histology Preserves Implant/Tissue Interface.  A) OCT-based 
cryosection (10μm thickness) of caged-RGD functionalized hydrogel explant; gel is no 
longer present after cutting, implant interface is badly damaged with infiltrate front 
completely missing.  B) Polymer Sciences Immunobed plastic section (2μm thickness) of 
caged-RGD functionalized hydrogel explant; implant interface is perfectly preserved with 
hydrogel intact, staining/antigen retrieval is adequate. 
 
After optimization of the Immunobed system, we were able to take 2 μm thick 
sections, compared to the minimum thickness of 10 μm in OCT-based cryosections.  It is 
clear that the GMA embedding method (Figure 30, B) leads to a preserved 
tissue/hydrogel interface, whereas in the traditional cryosectioning method (Figure 30, A) 
the interface is destroyed.  These resin-embedded sections can be de-plasticized using 
solvents and antigen retrieval methods can be used in downstream immunostaining.  We 
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demonstrate in future sections that Hematoxylin and Eosin, Mason’s Trichrome, and 
fluorescent-based immunohistochemistry is still possible. 
3.3.6 In vivo Subcutaneous Implantation of Caged-RGD Presenting Hydrogels 
 After demonstrating the caged system allowed for efficient triggerable ligand 
presentation in vivo, we investigated the effects of delayed activation of caged-RGD 
surfaces on the localized inflammatory response.  PEGDA, RGD, and caged-RGD 
hydrogels are implanted subcutaneously in mice.  All conditions are exposed to UV (n=6) 
at different time points (Day 0, 7, 14) yielding 72 total implants.  A brief outline of 
experimental setup is outlined in Figure 31.  Hydrogels were prepared using a PEGDA 
bulk base layer, and functionalized with caged-RGD, and cyclic(RGD) ligand using the 
PEGDA-conjugates discussed in earlier sections (Figure 31, A).  Two implants of the 
same condition are implanted in left/right proximal to dorsum in Balb/c mice.  The reason 
mice were implanted with the same implants was to minimize the chance of unwanted 
UV-irradiation from other timepoints.  From the caged-fluorescein study we have 
confidence that caging group is not labile from standard fluorescent bulbs present in 
mouse housing areas.  Mice are irradiated at designated timepoints outlined in Figure 




Figure 31.  Outline of In vivo Subcutaneous Implantation of Caged-RGD Presenting 
Hydrogels.  A) Functionalization of bulk PEGDA hydrogels with RGD, caged-RGD, or 
blank PEGDA.  B) Schematic of implantation sites on dorsum of Balb/c mice, two 
implants per mouse, transdermal UV irradiation.  C) Timeline representation of 
implantation conditions and designated irradiation timepoints.  Each condition has n=6 
implants.  Red bars indicate no adhesive ligand presentation; green bars indicate when 
RGD is presented. 
 
3.3.7 In vivo Activation of Caged-RGD Presenting Hydrogels Modulates 
Macrophage Localization 
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 Using a CD68 antibody, macrophage localization to the implant was visualized 
through immunohistochemistry; results for the 28 day (4 week) takedown are 
summarized in Figure 32, A.  Using the GMA-based embedding technique, the 
implant/tissue interface is well preserved.  CD68+ staining is shown in green, and DAPI 
nuclear stain is in red.  The nominal infiltrate thickness for all conditions was measured 
by taking the average thickness of the dark purple infiltrate band in Mason’s Trichrome 
images or the CD68+ band in immunofluorescence images (data not shown).  These 
infiltrate thickness measurements were consistent regardless of measurement method.  
PEGDA non-adhesive control exhibits a nominal CD68+ band thickness of 21.57 ± 0.57 
μm, and the cyclic(RGD) adhesive control exhibits a nominal thickness of 26.71 ± 0.65 
μm, these results are statistically significant (p<0.01).  Results for the “No UV” caged-
RGD condition (20.95 ± 0.44μm) are consistent with the PEGDA non-adhesive control 
and the differences are not statistically significant.   The “Day 0” transdermal irradiation 
of caged-RGD (24.56 ± 0.96 μm) exhibits a similar CD68+ band thickness as the RGD 
control, and the differences are not statistically significant.  These results indicate that 
transdermal irradiation of caged-RGD is able to modulate macrophage recruitment to the 
implant (Figure 32, B).   
 Interestingly, in “Day 7 UV” caged-RGD, the macrophage band thickness (20.44 
± 0.87 μm) is significantly lower than the “Day 0 UV”, “Day 14 UV”, and cyclic(RGD) 
control (Figure 32, B).  This indicates that activation of caged-RGD, and subsequent 
presentation of cyclic(RGD) ligand, delayed after 7 days, perhaps after the end of acute 
phase inflammation, can elicit a lower inflammatory response.  When a biomaterial is 
implanted with adhesive ligands present, it is known that the first cells that arrive at the 
implantation site are neutrophils and macrophages.  RGD ligation to integrins has been 
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known the play a critical role in macrophage adhesion and activation, all which serve 
initiated a FBGC response [48, 49].  By delaying the activation of RGD ligand to day 7, 
we would be able to delay integrin-mediated macrophage adhesion and activation until 
acute phase inflammation subsided [120], this would result in a lower infiltrate band 
thickness when compared to conditions were RGD ligand we present since Day 0.   
This does not explain, however, why the “Day 14 UV” caged-RGD condition 
exhibits infiltrate band thickness similar to “Day 0 UV” caged-RGD and static 
cyclic(RGD) conditions (25.65 ± 1.03 μm).  This result is statistically significant when 
compared to “Day 7 UV” caged-RGD and PEGDA conditions (p<0.01).  It is possible that 
after two weeks, over a week after the remission of acute phase inflammation, the 
delayed activation of RGD ligand starts a new inflammatory cascade.  It is known that 
active remodeling of the infiltrate front occurs during chronic inflammation, with many 
macrophages fusing in to FBGC cells [120].  Day 0 activated caged-RGD hydrogels 
would have had 4 weeks to remodel, Day 7 with only three weeks to remodel.  
Therefore, if Day 14 activation of caged-RGD ligand began a new inflammatory 
response, it is possible that its infiltrate band thickness would be thicker than Day 7 
conditions by virtue of recruiting macrophages to the implant without as much time to 




Figure 32.  Triggerable Ligand Presentation of Caged-RGD Modulates Macrophage 
Localization.  A) GMA-based immunohistochemistry showing CD68 localization to 
implant surface; CD68 (green), DAPI (red).  Scale bar 30μm. B) CD68+ band thickness 
for all implant conditions.  PEGDA (non-adhesive control) has a band thickness, similar 
to the caged-RGD “No UV” and “Day 7 UV” condition.  RGD (static cyclic(RGD) control) 
has a band thickness, similar to the caged-RGD “Day 0 UV” condition and “Day 14 UV” 
condition.  ** denotes statistical significance (p<0.01)  C) Quantification of CD68+ cell 
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density as measured by co-localization of CD68+ and DAPI staining.  No statistical 
differences between conditions.  D) CD68+ intensity profiles of PEGDA, RGD, and 
Caged-RGD (No UV and UV exposed).   
  
There are no differences in density of macrophages as measured by 
CD68+/DAPI co-localization (Figure 32, C).  Unfortunately, due to higher background of 
GMA-based embedding, it is impossible to see cell outlines to quantify FBGC formation.  
We next assessed the spatial distribution of CD68+ staining across the infiltrate band by 
measuring the CD68+ staining vs. distance from the implant, normalizing each trace, 
and then finding the average normalized CD68+ thickness over the band (Figure 32, D 
and E).  The PEGDA and No UV caged-RGD conditions exhibit a similar profile of 
CD68+ intensity, both with peak intensity at 3.41μm and 2.48 μm, respectively, from the 
implant surface.  The static RGD control and Day 0 caged-RGD condition have also 
have a profile of CD68+ intensity, with peak occurring further from implant surface 
(17.4μm and 12.12 μm).  This shows that transdermal irradiation of caged-RGD, and 
subsequent RGD presentation is effective at modulating macrophage CD68+ density (as 
measured by CD68+ intensity) to the implant surface (Figure 32, D). 
The CD68+ intensity profiles were also generated for the delayed activation of 
caged-RGD conditions (Figure 32, E).  Interestingly, for all conditions where RGD was 
not activated immediately, “No UV”, “Day 7 UV” and Day 14 UV (black, green, blue), the 
peak CD68+ localization occurs relatively close to the implant surface (2.48 μm, 5.28 
μm, 3.41 μm, respectively), similar to the PEGDA control (3.41 μm).  This is consistent 
with the fact that “Day 7 UV”, “Day 14 UV”, and “No UV” conditions did not present any 
adhesive ligands for over a week (during acute phase inflammation), resulting in similar 
profiles of macrophage recruitment and localization in the infiltrate band.  It seems that 
 63 
delayed presentation did have an effect on the tissue side CD68+ density; however, by 
that point the FBGC response on the implant surface had already resulted in high CD68+ 
density and localization.  
When RGD is presented immediately, in both static cyclic(RGD) and “Day 0 UV” 
caged-RGD conditions, macrophage density is concentrated towards the tissue side, 
perhaps suggesting, a active recruitment of additional macrophages to the infiltrate band 
via RGD presentation. This taken in conjunction with the increased infiltrate band 
thickness in RGD and Day 0 UV conditions suggest that these conditions elicit the 
strongest macrophage recruitment.  However, because the peak occurs at the tissue 
side in RGD and “Day 0 UV”, conditions it is not possible to say that the FBGC response 
on the implant side is lower than in PEGDA, “Day 7 UV” and “Day 14 UV” conditions.  
The fact that “Day 14 UV” condition exhibits a flatter CD68+ intensity plot as well as a 
thicker band thickness could suggest that after the FBGC response was already 
established by day 14, and that subsequent activation of RGD ligand served to recruit 
more macrophages, changing the profile from a implant side CD68+ bias, to more of a 
flat profile.  It is important to note that because these curves are normalized, quantitative 
generalizations of the relative CD68+ densities cannot be made.  Nevertheless, this data 
shows that transdermal activation of RGD-ligand at delayed timepoints is effective at 
modulating macrophage response to implant associated inflammation. 
3.3.8 Delayed Activation of Caged-RGD Attenuates Fibrous Capsule Formation 
The fibrous capsule thickness was determined by Mason’s Trichrome staining of 
2μm GMA sections (Figure 33A).  The fibrous capsule is determined as the fibrotic, 
aligned tissue (alanine blue collagen stain) that extends from the left edge of the dark 




Figure 33.  Delayed activation of caged-RGD modulates downstream fibrous capsule 
thickness.  A) GMA-based Mason’s Trichrome 4wk explants.  The dark purple band 
denotes the infiltrate rich cell band.  The dark blue, aligned tissue, in between the 
smooth muscle layer and the infiltrate band is the fibrous capsule. Tissue/implant 
interface is perfectly preserved.  Scale bar 150μm. B) Quantification of fibrous capsule 
thickness of all PEGDA conditions.  No statistical difference, regardless of UV irradiation.  
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C) Quantification of fibrous capsule thickness of all static cyclic(RGD) conditions.  No 
statistical difference, regardless of UV irradiation.  D) Comparison of controls (PEGDA, 
RGD) to analogous caged-RGD conditions.  PEGDA and No UV caged-RGD condition 
(red) exhibit fibrous capsule thickness around 120μm, which is consistent with non-
specific FBCG response. RGD and UV exposed caged-RGD condition (green) exhibit 
statistically significant increases in fibrous capsule thickness (p<0.05). E) Delayed 
activation of caged-RGD attenuates fibrous capsule thickness.   
 
Fibrous capsule thickness was quantified for all conditions, results summarized in 
Figure 33.  For all PEGDA and RGD controls, regardless of UV irradiation, the difference 
in fibrous capsule thickness is not statistically significant.  This is the expected result, as 
UV irradiation should not affect implants presenting either no ligands (PEGDA) or static 
cyclic(RGD) (Figure 33, B and C).  In Figure 33 D and C, the PEGDA and RGD controls 
have been pooled for all irradiation conditions.  PEGDA and caged-RGD No UV 
conditions have similar fibrous capsule thickness, which is expected since they both 
present no RGD ligands.  Static cyclic(RGD) conditions (denoted by RGD) and caged-
RGD Day 0 UV conditions exhibit similar fibrous capsule thickness due to presenting 
RGD ligand for exactly the same amount of time (4 weeks).  These results are consistent 
with previous studies that have compared PEGDA hydrogels to RGD presenting PEGDA 
hydrogels [90, 126].  These results demonstrate it is possible to directly modulate fibrous 
capsule formation via triggerable presentation of RGD ligand. 
We have already established that the DMNPB caging group uncaged with the 
same efficiency even after 14 days (Figure 29).  Interestingly, delayed activation of 
caged-RGD ligand (Day 7 and Day 14) both exhibit statistically significant lower fibrous 
capsule thickness, even though these conditions should still be presenting equal 
amounts of RGD ligand, only at different time points after implantation (Figure 33, E).  
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This is not particularly surprising because the Day 7 UV and Day 14 UV conditions 
presented RGD ligand for a shorter amount of time than the Day 0 condition by 7 days 
and 14 days, respectively.  It should be noted that the caged-RGD Day 0 exposure 
condition has a slightly lower, but not statistically significant fibrous capsule thickness 
when compared to the RGD control.  Therefore, we have shown that delayed activation 
of adhesive ligands is effective at modulating a second order inflammatory response, the 
downstream fibrous capsule formation. 
 
3.3.9 In vitro Cell Sprouting Modulated by Caged-RGD Presenting Hydrogels 
 The previous sections described the ability of caged-RGD to modulate cell and 
inflammatory processes on a two-dimensional surface.  To further demonstrate the 
applications of caged-RGD we have applied the use of triggerable ligand presentation in 
a three-dimensional environment.  While it is known that caged-RGD ligand can effect 
macrophage recruitment and fibrous capsule formation at the implant site, these studies 
only demonstrate second order effects of caged-RGD in an in vivo system.  In order to 
demonstrate a directly functional link between ligand presentation and cell or tissue level 
behavior, we decided to perform two functional assays, in vitro cell outgrowth model and 
an in vivo vasculogenesis assay.  In both cases, there should be stark differences in cell 
and tissue behavior between irradiated and non-irradiated caged-RGD conditions. 
Caged-RGD presenting PEG-maleimide (PEG-MAL) gels were used to 
demonstrate the ability of triggerable RGD ligand presentation to modulate IMR90 cell 
migration and sprouting in the 3-dimensional hydrogel system.  It has been previously 
shown that PEGDA-based hydrogels are not effective at promoting cell infiltration, even 
when crosslinked with protease-sensitive crosslinks; therefore, we ported the caged-
RGD technology to a PEG-MAL-based hydrogel system [127].  Caged-RGD analogs 
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were created with a cysteine termination (Figure 34, A) for compatibility with PEG-MAL 
chemistry (Figure 34, B).  These caged-RGD analogs still have exactly the same 
DMNPB caging group and UV labile linker, therefore the uncaging efficiency and peptide 
behavior should be exactly the same as in the PEGDA-based gels. 
 
Figure 34.  PEG-Maleimide Caged-RGD Presenting Hydrogels.  A) Chemical formula of 
cysteine contained caged-RGD.  B) Schematic representation of PEG-Maleimide based 
peptide tethering and crosslinkers.  The maleimide group in combination with a free thiol 
under in TEA buffer at pH 7.4 leads to the formation of a covalent thioester bond.  C) 
Schematic representation of sandwiched PEG-MAL hydrogel with embedded cell pellet.  
 
 4% PEG-MAL hydrogels were created with 10 mM VPM (protease-sensitive 
crosslinker), 10 μg/mL VEGF, and 2 mM ligand (RDG, RGD and caged-RGD).  VEGF 
was used not to promote IMR90 cell outgrowth, but to maintain the same gel formulation 
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in all PEG-MAL studies.  The gels were directly crosslinked in a #1 coverslip bottomed 8-
chamber slide.  The bottom of each well was coated with a small amount of PEG-MAL 
hydrogel so that cells seeding into wells would not be able to spread on the bottom 
glass.  This gel was allowed to crosslink.  A cell pellet of IMR90 cells (~1 mm in 
diameter) was pipetted into the center of the bottom gel.  Immediately after, a top layer of 
PEG-MAL gel was pipetted on top, with great care not to disturb the cell pellet.  After 
allowing the gel to fully crosslink at 37°C for 20 minutes, growth media was added to 
each well.  This method is summarized in Figure 34, C. Gels were UV irradiated using a 
UV-lamp based setup already described in previous sections.  Dosage optimization of 
UV irradiation time was performed, as too much UV irradiation directly to cells resulted in 
cell death (data not shown), too little irradiation resulting in not enough uncaging of 






Figure 35.  Quantification of Outgrowth in Caged-RGD containing PEG-MAL Hydrogels.   
A) In vitro characterization of caged-RGD containing PEG-MAL gels using IMR90 cells in 
a cell outgrowth assay.  Outgrowth was observed in RGD and caged-RGD “UV Exposed” 
conditions.  No outgrowth was observed in RDG negative control and caged-RGD “No 
UV” conditions.  Red arrows denote outgrowths.  Scale bar 100 μm.  B) Degree of 
outgrowth of RGD vs. “UV Exposed” caged-RGD.  Both hydrogels that presented RGD 
ligand exhibited cell outgrowth between 100-150μm.  There is no significant difference 
between degrees of outgrowth in RGD control vs. UV exposed caged-RGD conditions. 
 
The results of this study are summarized in Figure 35, A.  In the static RDG 
controls and in the “No UV” caged-RGD condition, there was no cell sprouting after three 
days.  After three days in culture, the static RGD and “UV Exposed” caged-RGD 
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condition both exhibited IMR90 cell outgrowths of 134.33 ± 13.96 μm and 100.95 ± 
12.08 μm, respectively.  “UV exposed” caged-RGD conditions exhibited slightly less 
sprouting presumably due to poorer cell health due to UV damage from irradiation, 
however, these differences were not statistically significant.  Taken in whole, these 
results show that caged-RGD presenting PEG-MAL hydrogels can control IMR90 cell 
outgrowth through the modulation of cyclic(RGD) presentation via UV irradiation. 
3.3.10  In vivo Vasculogenesis Modulated by Caged-RGD Presenting 
Hydrogels 
 To show in vivo efficacy of caged-RGD presenting PEG-MAL hydrogels, an in 
vivo vasculogenesis assay was performed.  Hydrogels were prepared with the same 
formulation described in the previous section:  4% PEG-MAL hydrogels were created 
with 10 mM VPM (protease-sensitive crosslinker), 10 μg/mL VEGF, and 2 mM ligand 
(RDG, RGD and caged-RGD).  Instead of pre-casting hydrogels as in caged-RGD 
presenting PEGDA gels, caged-RGD PEG-MAL gels were crosslinked in situ for better 
vasculogenesis (data not reported, Garcia Lab).  A subcutaneous implantation study 
using Balb/c mice was performed in the manner outlined in Figure 36. The same UV-
lamp source described in previous sections was used to irradiate mice at designated 
time points (Day 0 and Day 7).  RDG negative controls were also irradiated to show that 




Figure 36.  In situ Crosslinking of PEG-MAL Hydrogels in Subcutaneous Implant.  A 
subcutaneous space is created using an incision along right of mouse back, hemostats 
are used to create subcutaneous pocket, PEG-MAL hydrogel containing degradable 
crosslinkers and ligands are polymerized in situ, wound is closed.  After designated time 
point of 14 days, mouse is perfused with tomato lectin to label vasculature via tail vein 
injection; mouse vasculature is rinsed with saline containing papaverine.  Explants are 
then removed for whole mount fluorescent microscopy. 
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 After the designated 2-week time-point, all mice were perfused with tomato lectin-
DyLight488 through the tail vein to label the vasculature.  The tomato lectin was allowed 
to circulate for 20 minutes to ensure that there was good staining of small vessels.  
Afterwards, the mice were perfused with papaverine containing saline and are bled from 
the inferior vena cava.  This was to ensure that all of the blood was removed from the 
vasculature for better fluorescent imaging.  Afterwards, all of the implants were 
explanted from the mice and placed in 4% formalin for preservation.  After overnight 
incubation in formalin, implants were washed three times in DPBS and imaged on the 




Figure 37. Tomato Lectin Dylight488 Staining of Vasculogenesis in PEG-MAL Caged-
RGD Hydrogels.  Three-dimensional reconstructions using alpha blending of z-stacks.  
Stack height approx. 22μm.  Squares indicate 100μm2.   
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 Upon analysis, all hydrogels were still visible in the microscope as visualized by 
air bubbles trapped in the hydrogel.  Z-stacks were taken in and around these regions to 
ensure that imaged vasculature was in hydrogel.  These image stacks were then 
converted to three-dimensional reconstructions for cursory visualization of results (Figure 
37).  The RDG negative control exhibited no vasculogenesis, with no structures 
resembling blood vessels labeled above background level.  The RGD positive control 
exhibited robust vasculogenesis with a dense blood vessel network with both large and 
small diameter blood vessels throughout the implant site.  In accordance with the control 
groups, the “No UV” caged-RGD condition extremely low levels of vasculogenesis 
comparable to the RDG negative control.  The “Day 0 UV” and “Day 7 UV” caged-RGD 
conditions exhibited vasculogenesis, but not the same extent as the RGD positive 
control.  The UV exposed caged-RGD conditions only had large blood vessels 
throughout the gel at much lower density.  These differences will be investigated in more 
detail and quantified in the following section. 
Using ImageJ we created the maximum intensity projections of each field so that 
we could quantify the number of blood vessels and determine the average diameter of 
each blood vessel.  We ensured that vessel counts and diameters were accurate by 
ensuring that we were imaging the area with the hydrogel.  During in situ polymerization 
the gels were mixed with a pipet tip and this introduces some small air bubbles into the 
hydrogel.  Therefore, these air bubbles were an excellent guide to ensure that the 
vasculogenesis regions that were imaged indeed within the hydrogel (Figure 38, A).   
From the images it is clear that there is some tissue autofluorescence from collagen and 
in some images you can see the smooth muscle layer behind some of the blood vessels.  
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However, the vasculature signal via tomato lectin is significantly higher, and in 
conjunction with the morphology of the blood vessels it is easy to discriminate between 
vasculature in the gel and bulk tissue. 
 
Figure 38. Quantification of Vasculogenesis.  A) Maximum intensity projections of 
representative images.  White arrow denotes air bubble in hydrogel, used to confirm 
hydrogel location.  Scale bar 80 μm.  B) Quantification of number of blood vessels per 
field. RGD Day 0 UV, and Day 7 UV exhibit higher numbers of blood vessels per field 
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when compared to No UV and RDG control, differences are statistically significant 
(p<0.02).  C) Quantification of average diameter of blood vessels.  RDG control has 
significantly lower diameter of blood vessels when compared to all other conditions, 
results are statically significant (p<0.01). 
 In the RDG and “No UV” caged-RGD condition, there is minimal vasculature 
within the gel, which is consistent with previous studies that demonstrated that RGD is 
required for vascular infiltration of the hydrogel [127].  In the RGD condition there is 
robust formation of vasculature with a significant amount of blood vessel formation.  In 
“Day 0 UV” and “Day 7 UV” conditions, there was also blood vessel formation, however, 
not as much as in the RGD condition.  There are several possibilities for this result.  
There could be reduced uncaging efficiency stemming from larger irradiation distances 
of three-dimensional PEG-MAL gels, when compared to previous uncaging studies that 
occurred directly below the surface of the skin.  Furthermore, inefficient uncaging could 
lead to lower RGD presentation leading to fewer blood vessel sprouting events into the 
hydrogel bulk.  Also, there could be side effects from the solvents used to solubilize the 
cys-containing caged-RGD in DPBS that may have had an effect on vasculogenesis.  
Compared to the “No UV” caged-RGD condition, both the “Day 0 UV” and “Day 7 UV” 
caged-RGD conditions, exhibited significantly higher amounts of blood vessels per frame 
(p<0.02).  These results are consistent with previous studies that have shown that RGD 
tethered to PEG-based hydrogels is required for in vivo vasculogenesis in PEG-based 
hydrogels [127, 128].  Taken in whole, transdermal UV irradiation of caged-RGD 
containing PEG-MAL gels was effective at providing ex vivo control of in vivo 
vasculogenesis in a simple reproducible manner without requiring additional surgeries or 
invasive procedures.  This shows the promise of caged-compounds, in vivo, to study 
various tissue level processes in a robust and non-invasive fashion.  
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3.4 CONCLUSION 
 PEG-based hydrogels provide a novel platform to elucidate cell-ECM interactions 
through a highly defined, non-fouling surface.  Through the use of simplified ECM-
peptides such as RGD, specific integrin-ECM interactions can be studied.  We have 
demonstrated the uses of a novel caged-RGD molecule in the context of PEG-based 
hydrogels.   
Caged-RGD conjugated PEGDA based hydrogels were able to effectively 
modulate cell attachment and spreading in vitro.  We were able to demonstrate that 
DMNPB-based caged compounds were effectively controlled ex vivo using UV 
irradiation, after a subcutaneous implantation and the uncaging efficiency was 
unchanged even after 14 days.  Furthermore, delayed activation of caged-RGD 
presenting hydrogels was able to modulate macrophage recruitment and downstream 
fibrous capsule formation in subcutaneously implanted PEGDA-based hydrogels.   
When applied to PEG-maleimide based hydrogels, caged-RGD was effective at 
controlling in vitro cell outgrowth into a degradable hydrogel with protease sensitive 
crosslinks through the control of RGD presentation via wide-field UV irradiation.  When 
this PEG-maleimide system was combined with protease sensitive crosslinks and VEGF 
in an in situ polymerized subcutaneous model, caged-RGD was effective at controlling 
vasculogenesis through the modulation of RGD presentation via transdermal UV 
irradiation.  Therefore, we have demonstrated that caged-RGD in conjunction with PEG-
based hydrogels is a versatile platform that offers unparalleled spatiotemporal control of 
RGD ligand presentation.  Through UV-activation we have demonstrated that ex vivo 
control of RGD-mediated cell adhesion is a critical regulator of many events including 
inflammation and vasculogenesis.  This study has shown that caged-compounds provide 
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a versatile and effective means of controlling the presentation of signals and ligands in 
both in vitro and in vivo systems and have demonstrated the potential of this class of 
compounds in future biomaterials research.  
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3.5 METHODS 
Cell Culture and Reagents 
 NIH3T3 fibroblasts cell and IMR90 cells were purchase from the ATCC 
(Manassas, VA).  Growth media was DMEM (Gibco), 10% fetal bovine serum (Gibco), 
100 U/mL penicillin G sodium (Gibco), 100 μg/mL streptomycin sulfate (Gibco), 1% non-
essential amino acids (Gibco).  Live dead staining completed via Calcein AM and 
ethidium homodimer II (Invitrogen). 
Generation and characterization of PEG-conjugates and hydrogels 
Caged-RGD is synthesized in the manner described previously and generously 
provided by Arancha del Campo’s Lab at Max-Planck-Institut für Polymerforschung, 
Mainz, Germany [104].  Poly(ethylene glycol)-based caged-RGD conjugates were 
generated by reacting Acryl-PEG-SVA (Laysan Bio, AL) with the primary amine of the 
caged-RGD molecule for 4hrs in sodium bicarbonate (Sigma-Aldrich) buffer, pH 8.2.  
Pegylated-RGD was generated in the same fashion using A-PEG-SVA and cyclo(RGDfk) 
(Peptides International; AL).  The pegylated derivatives were dialyzed using a Slide-A-
Lyzer dialysis cassette with a 3400MW cutoff (Pierce; IL) for 2 days in ultra-pure diH2O 
and lyophilized using a freeze-dying system (Labconco; MO).  These PEG-conjugates 
were stable at -20°C for long-term storage.  The tethering of caged-RGD to the acryl-
PEG-SVA was confirmed using MALDI-MS.  
Hydrogel casting and functionalization 
Bulk PEGDA hydrogels were created using a mixture of 10% PEGDA (Laysan 
Bio, AL) and 0.05% Irgacure 2959 (BASF, Germany) in DPBS.  These precursor 
solutions were sterile filtered using a 0.22 μm filter.  These precursors were cross-linked 
in a sterilized silicon isolator mold (GraceBio, OR) mounted to a glass slide sealed by a 
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Sigmacote (Sigma-Aldrich) coated microscope slide.   A 15mm Sigmacote coated 
coverslip was used to squeeze out excess precursors and generate a flat top surface of 
the hydrogel.  Hydrogels were crosslinked using a UV light table for 10 minutes.  The top 
coverslip was removed and these bulk gels were then functionalized with a thin top gel 
consisting of 8% PEGDA, 2% adhesive PEG-conjugate crosslinked via TEMED (IBI 
Scientific, IA) and APS (Fluka) in the same mold.  Another Sigmacote coated coverslip 
was placed on top of the crosslinking gel to ensure that the top surface was also flat. 
In vitro characterization of cell adhesion 
Caged-RGD, RGD, RDG, and blank PEGDA hydrogels were generated and 
NIH3T3 were seeded on top at 20k/cm2 density overnight.  Live-dead assay was 
performed (Invitrogen), epifluorescent images captured at 20x using a Nikon TE-300 
(Nikon; Japan) and quantified via ImageJ. 
Subcutaneous implantation of caged-RGD presenting hydrogels 
Hydrogels precursors are sterile filtered and verified to be endotoxin-free.  Cast 
hydrogels are further sterilized in 0.2% sodium azide (Sigma-Aldrich) for overnight, and 
washed with DPBS -/- (Gibco) over the course of 3 days to remove remaining azide.  
Caged-RGD samples are protected from light.   
Sterile, endotoxin-free PEGDA-based hydrogels, (8 mm) diameter, were 
implanted subcutaneously following IACUC-approved procedures in 6-8wk old male 
Balb/c mice (Jackson Laboratories, ME) that have been anesthetized by isofluorane.  
Two 1 cm incisions were made on the dorsum proximal to the spine, on both left and 
right sides, and a subcutaneous pocket was created that laterally spanned the dorsum.  
Two hydrogels were implanted in each animal, and the incision was closed using sterile 
wound clips.  A X-Cite 120 Arc Lamp (Exfo; Canada) with an attached collimator (Nikon, 
Japan), bandpass filter (Edmund Optics, NJ), a VS14/25 shutter and VMM-T1 Shutter 
 81 
Driver Controller (Uniblitz; NY) is used to transdermally expose UV-liable implants and 
controls at Day 0, 7, and 14.  When needed, any hair over implant site was removed with 
Nair™. 
In vivo characterization of DMNPB-group via Caged-fluorescein  
Caged-Fluorescein-Acrylate was generously provided by Arancha del Campo’s 
Lab at Max-Planck-Institut für Polymerforschung, Mainz, Germany.  fluorescein is 
modified with an acrylate group and a DMNPB-caging group.  Preliminary 
characterization is performed via NMR.  Caged-fluorescein hydrogels are generated in 
the same manner as described as Caged-RGD hydrogels.  Pre-exposed, unexposed 
caged-fluorescein, and control blank hydrogels were implanted subcutaneously in mice, 
one per animal.  A X-Cite 120 Arc Lamp (Exfo; Canada) with an attached collimator 
(Nikon, Japan), bandpass filter (Edmund Optics, NJ), a VS14/25 shutter and VMM-T1 
Shutter Driver Controller (Uniblitz; NY) is used to transdermally expose UV-liable 
implants and controls at Day 0 and 7.  Implants were imaged by Nikon TE-300 using 
epifluorescence microscopy using a 4x objective.  Fluorescence intensity over several 
fields was quantified using ImageJ (NIH). 
GMA-based implant analysis 
Mice were sacrificed at 4 weeks with implants explanted without disturbing the 
implant-tissue interface.  Explants were fixed in 4% formalin for 24hrs, washed with 
DPBS three times, incubated in 70% denatured alcohol reagent in H2O, and dehydrated 
in a tissue processor (Thermo, MA).  Processed explants were incubated in 50% 
Immunobed infiltration solution (Polysciences; PA)/50% ethanol (Decon Labs; PA) for 24 
hours, then two times in 100% Immunobed infiltration solution for two more 24 hours 
incubations.  Explants were embedded using the Immunobed Kit in plastic molds.  
Embedded tissues were removed from molds after 48 hours of curing at 4°C, and 
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allowed to air dry at room temperature. Molds are sliced into 2μm tissue sections using a 
microtome (Thermo; CA) with a tungsten-carbide blade (DDK; DE).  Tissue sections 
were stained in an autostainer (Lecia; Germany) for Mason’s Trichrome stain.  Masons’s 
Trichrome stain contained:  Alanine Blue (Sigma), Phosphomolybdic-phosphotungstic 
acid (ACS Chem), Biebrich's Scarlet-Acid fuchsin (ACS Chem), Hematoxylin (ACS 
Chem).  Other processing reagents included xylene (check), xylene sub (ACS Chem), 
reagents alcohol (ACS Chem).  Macrophage and neutrophil recruitment is monitored by 
immunofluorescence analysis of CD68 and NIMP-14 (Abcam, MA), respectively.  Nuclei 
are monitored using DAPI (Invitrogen).  Image analysis is completed in ImageJ (NIH). 
PEG-maleimide based fibroblast outgrowth assay 
PEG-maleimide (Laysan Bio) was incubated with Caged-RGD, RGD, RDG in 
separate vials to conjugate the thiol-terminated peptides to one arm of the PEG-
maleimide molecule.  The final gel formulation called for a 100uL per well, 4% PEG-MAL 
gels, 2mM peptide concentration, 5ug/mL VPM, and 10ug/mL VEGF.  These 50uL of 
these gels were then formed in LAB-TEK 8 chamber #1 coverslip glass bottomed wells.  
The gels were then allowed to crosslink for 2 minutes.  A cell pellet was seeded into the 
middle of the hydrogel, and another 50uL of functionalized hydrogel was placed on top.  
Gels were allowed to fully crosslink for 30 minutes in an incubator.  Media was then 
added to wells after gels were fully crosslinked. 
Vasculogenesis in PEG-MAL hydrogels presenting caged-RGD 
4-arm PEG-MAL polymer precursors were sterilized using ethanol and then 
rotary evaporated to remove all ethanol.  4% (w/v) PEG-MAL (Laysan Bio) hydrogels 
were prepared with 2mM peptide, 5ug/mL VPM (Apptec), and 10ug/mL VEGF 
(Invitrogen).  First PEG-MAL hydrogels were allowed to incubate with 2mM peptide 
(RGD (Peptides International), RDG, and caged-RGD (del Campo Lab; M) in a 3:1 molar 
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ratio for 30 minutes in 10-20mM TEA (Sigma-Aldrich), in order to pre-conjugate, on 
average, one peptide per maleimide arm. During this incubation step, one 1 cm incision 
was made on the dorsum proximal to the spine, on the right side, and a subcutaneous 
pocket was created that laterally spanned the dorsum.  PEG-MAL-peptide precursors 
were then combined with VPM and VEGF (total volume 80μL) and were pipetted into the 
subcutaneous space and allowed to crosslink in situ. After crosslinking for one minute, 
the incision was closed using sterile wound clips.  A X-Cite 120 Arc Lamp (Exfo; 
Canada) with an attached collimator (Nikon, Japan), bandpass filter (Edmund Optics, 
NJ), a VS14/25 shutter and VMM-T1 Shutter Driver Controller (Uniblitz; NY) is used to 
transdermally expose UV-liable implants and controls at Day 0 and 7.   
Whole-mount explant analysis 
 At the Day 14 takedown point, 1 mg/mL tomato lectin was injected through the 
tail vein of the anesthetized mice and allowed to circulate for 20-30 minutes.  Following 
this incubation time, the mice were terminally perfused with 0.4% papaverine in saline 
through the left ventricle and allowed to bleed through the inferior vena cava.  This 
procedure was completed by opening up the chest cavity and performing a Y-cut to the 
sternum in order to expose the heart.  Then a butterfly needle with tubing was connected 
to a 50mL syringe filled with papaverine containing saline.  First, the inferior vena cava 
was cut using scissors, and the blood was allowed to bleed into the abdominal cavity.  
Immediately following this step, the butterfly needle was inserted into the left ventricle 
and the whole circulatory system was perfused with 50mL of papaverine containing 
saline for 5 minutes.  Following this, the implants were explanted from the back of the 
mice, and placed into 4% formalin overnight.  These implants were than rinsed with 
successive washes of DPBS, and then where placed on microscope slides for whole-
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mount confocal imaging.  Tomato lectin was imaged using the 488nm laser on a Nikon 




AIM 2: IN SITU TRIGGERABLE LIGAND PRESENTATION 
FOR THE REAL-TIME TRACKING OF FOCAL ADHESION 
FORMATION AND FORCE GENERATION 
 
4.1 ABSTRACT 
We demonstrate the use triggerable ligand presentation using a caged-RGD 
molecule covalently tethered to the surface of the multiple post array deflection substrate 
(mPADs). Using a silane-PEG-NHS ester we developed a novel method of tethering 
small ligands and peptides to PDMS surfaces. The ability to microcontact print silane 
onto surfaces furthers its utility in complicated microfabricated softlithography tethering 
schemes. Caged-RGD tethering to mPADs in conjunction with WT-eGFP-MEF cells was 
able to support normal cell adhesion, spreading, and vinculin localization to focal 
adhesions.  The efficiency of uncaging using the 403nm confocal laser was validated 
using caged-fluorescein tethered to mPADs surfaces and a full titration of stimulation 
conditions was performed.  Using a mixture of 50% static RGD and 50% caged-RGD, we 
have demonstrated the first real-time tracking of vinculin localization and cell traction 
force generation on multiple post array deflection substrates following triggered RGD 
presentation via in situ laser-based uncaging.  These studies have shown that vinculin 
recruitment to increased RGD ligand presentation occurs independently of force 
generation.  Additional RGD presentation to established, mature focal adhesions 
resulted in immediate increase in traction force generation, while vinculin localization is 
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delayed by over 200 seconds.  Taken in whole, this study demonstrates the power of in 
situ triggerable ligand presentation and the real-time tracking of focal adhesion formation 
and force generation, and it has shown two possible pathways for vinculin localization to 
focal adhesions depending on the amount of contractile force across a single focal 
adhesion. 
4.2 INTRODUCTION 
Integrin-mediated cell adhesion to ECM provides both mechanical anchorage 
and signals that mediate cell migration, proliferation, and differentiation [23, 129], 
processes that are central organization, maintenance, and repair of tissues.  Adhesion to 
ECM components, such as fibronectin (FN), and laminin, is primarily mediated by the 
integrin receptor family [23].  After ligand binging and activation, integrins form focal 
adhesion (FA) complexes that transmit adhesive and traction forces [118, 130-132].  
Focal adhesions consist of integrins and actins separated by a ~40nm core that includes 
cytoskeleton (CSK) elements such as vinculin and talin, and signaling molecules such as 
focal adhesion kinase and paxillin [133]. 
Focal adhesions are dynamic structures whose size and composition are actively 
remodeled during cell migration [29, 30].  Assembly of focal adhesions is regulated by 
numerous pathways in response to external stimuli – including signaling by growth 
factors and stimulation by mechanical force [31-33].  Focal adhesions mediate 
responses to internal and external stresses by modulating force transfer between 
integrins and the actin cytoskeleton [33, 132, 134].  This function is analogous to a 
“mechanical clutch” between and engine and a transmission [135]. 
Vinculin (116 kDa, 1066 amino acids) is an actin binding protein consisting of a 
globular head linked to a tail domain by a proline-rich strap and its interaction with 
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binding partners has been well mapped for all three domains [136].  Vinculin contains a 
talin binding site in its globular head (VH) and an actin binding site in its tail domain (VT).  
Interactions between VH and VT are regulated by an auto-inhibited conformation arising 
from strong head-tail binding [137].  VH contains talin, α-actinin, and α- and β-catenin 
binding sites.  VT contains actin, paxillin, and phosphatidylinositol 4,5 biphosphate (PIP2) 
binding sites.  The proline rich region contains binding sites for vasodilator stimulated 
phosphoprotein (VASP), actin-related protein 2/3 (Arp2/3), and vinexin.  One case of 
vinculin activation includes the simultaneous binding of to talin and actin.  When vinculin 
localizes to focal adhesions, vinculin forms a complex with β1 integrin and talin [138].  
FRET studies in live cells indicate that vinculin exhibits a spatial gradient of activation 
that correlates with FA dynamics [139].  While vinculin is not required for FA assembly, 
vinculin deletion is embryonically lethal and leads to aberrant cell spreading and 
migration, cardiomyopathies, and defects in hematopoietic stem cell repopulation [13, 
140-143].  It has recently been shown that vinculin a critical mediator of force generation 
between adhesive clusters and the cytoskeleton that stabilizes focal adhesions [144, 
145].   
Dumbauld et. al., performed through characterization of vinculin-null mouse 
embryonic fibroblasts (MEFs) that re-expressed WT, T12, and VH eGFP-vinculin mutants 
[145].  These studies on FN-coated mPADs showed that vinculin regulates the 
transmission of adhesive forces by modulating ECM-integrin complexes through its head 
(VH) domain and acted as a link to the actin cytoskeleton via the tail domain (VT).  
Furthermore, vinculin regulated the cell area-traction force coupling and myosin 
contractility-dependent traction force.  They also showed that in WT MEF cells, vinculin 
residence time at a focal adhesion correlates linearly with the force applied to the focal 
adhesion.  The data supported a model for vinculin stabilization in which forces applied 
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across vinculin maintain the molecule in its active conformation and to increase 
residence times at focal adhesions to promote force transfer.  
Despite extensive characterization of vinculin and its role in force generation on 
native full-length ECM proteins, these systems still rely on static presentation of ECM 
molecules.  There have been no studies that utilize the dynamic materials that can 
modulate adhesive ligand presentation in real-time to study the correlation between 
vinculin recruitment and force generation.  In this study, we demonstrate the use of 
caged-RGD presenting mPADs, that can through confocal-based laser irradiation can 
effectively trigger additional RGD ligand presentation and track downstream vinculin 
recruitment and force generation.  
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4.3 RESULTS AND DISCUSSION 
A significant limitation of the traditional mPADs system is that it relies on the 
passive adsorption of ECM proteins (e.g., fibronectin) onto the PDMS posts.  Surfaces 
based on synthetic simplified ECM peptides have shown promise as a model system to 
study integrin specific interactions with materials.  However, due to the small size of 
these oligopeptides (typically <500 Da), they cannot be adsorbed stably to a surface.  
Herein, we will describe two strategies to tether these peptides to a PDMS surface: 
“protein μCP” and “direct tether”. 
4.3.1 Streptavidin-based Protein μCP for Small Molecule Immobilization 
The streptavidin-biotin interaction has long been used as a coupling chemistry in 
affinity purification and surface immobilization strategies.  Since streptavidin is a 52kDa 
protein, it can be readily adsorbed to the PDMS surface.  With the use of biotinylated-
peptides, we can exploit the biotin-streptavidin interaction to tether small peptides to the 
PDMS surface.  By using microcontact printing (μCP), we are able to pattern streptavidin 





Figure 39.  Schematic of Small Biomolecule Immobilization via μCP of Streptavidin.  
Schematic of fabrication flow for small molecule tethering to PDMS via streptavidin-
biotin. Stamps are inked with streptavidin and microcontact printed onto UV ozone 
treated PDMS, the stamp is removed, and the PDMS surface is incubated with 
biotinylated peptide, the surface is then backfilled with Pluronics F127 to passivated the 
surface against non-specific protein absorption. 
 
In order to perform characterization on the efficiency of this tethering 
methodology, we employed the use of fluorescently tagged streptavidin and biotin 
proteins.  We demonstrate the successful patterning of labeled-streptavidin on a flat 
PDMS surface with high efficiency (Figure 40, A).  Using a labeled-biotin conjugate, we 
are also able to show specific tethering of biotin to the streptavidin islands  (Figure 40, 
B).  The co-localization of the tagged-biotin (red) to tagged-streptavidin islands (blue), 




Figure 40.  Immunofluorescence Characterization of μCP Surface and Cell Attachment. 
A) Alexaflour488-labeled streptavidin (blue) patterned in 100um islands. Scale bar 50μm 
B) Atto-655 conjugated biotin (red) tethered to streptavidin islands. Scale bar 50μm C) 
Overlay of Atto655-biotin (red) colocalized to streptavidin islands (blue).  Scale bar 50μm 
D) Low magnification view of HT1080 cell attachment to array of patterned streptavidin 
with bound biotinylated-RGD.  Images taken at 60x:  transmission (brightfield), 
streptavidin (green), cell nuclei (DAPI, orange).  Scale bar 50μm.  E) High magnification 
view of a single patterned streptavidin island with bound biotinylated-RGD, and HT1080 
attachment.  Streptavidin (green), cell nuclei (DAPI, orange). Scale bar 15μm. 
 
In order to test the viability of this method for controlling cell attachment to 
PDMS, streptavidin islands were patterned and tethered with biotinylated-cyclic(RGD) 
peptide.  HT1080 cells were seeded overnight and allowed to spread.  There was 
generally poor cell attachment to these surfaces indicating inadequate density of RGD 
ligand (Figure 40, D).  When looking at a single island, it is clear that cells have higher 
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cell-cell contacts, are not spread, and are mostly bipolar in morphology, even though 
HT1080s should be able to anchor to a single island and become fully spread (Figure 40, 
E).  This low RGD density was either caused by poor streptavidin transfer efficiency 
during μCP, due to its relatively low weight, or denaturing of the streptavidin during the 
μCP process from ethanol washes.  Therefore, while in principle this streptavidin μCP 
immobilization method does immobilize RGD ligand; its tethering efficiency is inadequate 
for the purpose of our study.  If cell spreading and attachment was inadequate on a flat 
PDMS surface, it would be woefully inadequate on mPADs surfaces that have less the 
25% of the available surface area for cell attachment in the same cell spread area. 
4.3.2 Silane-PEG-NHS-based Direct Covalent Tethering of Small Biomolecules 
Clearly, a new approach was needed to address the limited RGD tethering 
efficiency.  Using a “direct tether” approach, we have developed a simple way to tether 
any small peptide/biomolecule to –OH presenting surfaces, such as silicon, glass and 
PDMS.  The silane-PEG-NHS ester molecule was ideal for our application.  It contains a 
silane group that readily reacts with –OH moieties in organic phase at extremely high 
efficiency. Its long PEG chains will allow for high density packing on a suitable surface 
and at the same time prevent non-specific cell adhesion in tethered regions.  The NHS-
ester is ideal for tethering to the amino-terminus of linear peptides or primary amines on 
cyclic peptides and larger biomolecules.  A simple two-step, two-phase tethering scheme 
was developed in order to react each side of the silane-PEG-NHS ester at maximum 
efficiency (Figure 41, A).  The silane group was tethered to the PDMS in organic phase, 
dissolved in DMSO.  This prevented premature hydrolysis of the NHS ester.  Then the 
surfaces were rinsed in ethanol for sterilization, and then transferred to peptides that 
were dissolved in sodium bicarbonate (aqueous phase).  This allowed for the direct 
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tethering of peptides to the surface via displacement of the NHS ester.  These surfaces 
were rinsed to remove excess silane and unconjugated peptides. 
Using this method, cyclic(RGD) was immobilized onto a flat PDMS surface, and 
HT1080 cells seeded overnight.  Cells were fixed and stained with V284 antibody 
(vinculin localization) and phalloidin (actin cytoskeleton).  Cells exhibited normal cell 
attachment, spreading, and formation of robust focal adhesions (Figure 41, B).  These 
results indicate that for direct incubation of silane onto surfaces, followed by tethering of 
cyclic(RGD), there was adequate adhesive ligand density to support normal cell 




Figure 41.  Silane-PEG-NHS Ester In vitro Characterization.  A) Tethering Chemical 
Schematic.  Silane-PEG-NHS Ester reacts with –OH groups on PDMS surface in organic 
phase, NHS-ester is displaced by primary amine containing peptide in aqueous phase.  
B) Direct Incubation vs. Microcontact printing silane; HT1080s seeded overnight. FA 
staining shown; DAPI (blue), vinculin (green), phalloidin (red).  Scale bar 5μm. 
 
On mPADs surfaces, however, direct incubation with silane was not possible.  
Tethered peptides had to be localized only to the tips of the posts, and any direct 
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incubation in silane solution would results in unwanted peptide tethering to the regions 
between posts.  Therefore we had to assess the possibility of microcontact printing 
(μCP) silane, instead of direct silane incubation.  By applying silane-PEG-NHS ester 
dissolved in DMSO to an untreated PDMS stamp, there should be minimal silane 
coupling.  After blow-drying under a stream of nitrogen, there should still be silane 
adsorbed on the surface on the stamp.  By inverting the stamps onto an oxygen-plasma 
treated PDMS surface, the silane should then covalently tethered to the receiving 
surface.  Following incubation with cyclic(RGD) and the subsequent immobilization of the 
adhesive peptide, HT1080 cells seeded and allowed to spread overnight.  Cells were 
fixed and stained with V284 antibody (vinculin localization) and phalloidin (actin 
cytoskeleton).  When compared to the direct incubation approach (Figure 41, C), the 
μCP method appears to support normal cell attachment, spreading, morphology, and 
focal adhesion formation (Figure 41, C).  Therefore, we validated μCP-based approach 
to peptide tethering. 
 
4.3.3 Silane-PEG-NHS Ester-based Tethering of Cyclic(RGD) Supports Cell 
Adhesion and Focal Adhesion Formation 
μCP of silane-PEG-NHS ester appeared to be the ideal candidate for 
immobilizing small biomolecules and peptides to mPADs surfaces.  This method was 
validated for the mPADs system through cell attachment and focal adhesion formation 
assay.   A flat PDMS stamp was inked in 4% (w/v) silane-PEG-NHS ester dissolved in 
DMSO to prevent the premature cell hydrolysis of the NHS ester.  The stamp was then 
dried under a stream of nitrogen, inverted, and brought into contact with an oxygen 
plasma-treated mPADs device.  This plasma treatment increases the density of –OH 
presenting groups on the surface and is critical for high efficiency silane tethering.  The 
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samples were then washed in ethanol and then three serial washes of sodium 
bicarbonate buffer (NaHCO3, pH 8.2), and incubated with peptide dissolved in NaHCO3.  
Efficient NHS ester-mediated tethering must be done at near pH 8.2, under aqueous 
conditions.  Following tethering, samples are labeled with Δ9DiI and passivated with 
Pluronics F127.   
 
 
Figure 42.  Silane-PEG-NHS on mPADs Characterization.  A) (-)silane (+)RGD control.  
B) (+)silane (-)RGD control. C)  (+)Silane (+)RGD condition.  [A-C:  Images taken 20x 
Ph1, 24 hours post seeding on mPADs, scale bar 50μm].   D) Microcontact printed 
(+)silane (+)RGD flat control on mPAD device.  E) Microcontact printed (+)silane 
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(+)RGD, cell spread on mPADs.  [D-E:  Images are >60x on Laser Scanning Confocal; 
DAPI (blue), phalloidin (green), vinculin (yellow), posts (red), scale bar 20μm]. 
 
HT1080 cells were seeded overnight in order to determine the viability of this 
direct tether approach for mPADs traction force studies (Figure 42).  Cells were fixed 
and stained with V284 antibody (vinculin localization) and phalloidin (actin cytoskeleton).  
In the controls that either contained (-)silane or (-)cyclic(RGD) peptide, there was 
minimal cell spreading and attachment (Figure 42, A and B).  The (-)silane result is 
consistent with the fact that cyclic(RGD) peptide is too small to passively adsorb to 
PDMS surfaces.  The (-)cyclic(RGD) condition was used to demonstrate the efficacy of 
silane tether to effectively resist non-specific protein adsorption. Standard tethering with 
(+)silane and (+)cyclic(RGD) show normal cell spreading and proliferation on a mPADs 
surface (Figure 42, C).  Both on a flat region on the mPAD device and the normal pillar 
array cells exhibit standard cell spreading, normal morphology, and focal adhesion 
formation (Figure 42, D and E). Therefore, the mPADs system in conjunction with the 
silane-PEG-NHS ester tether was shown to be a promising platform for detailed 
investigation of mechanotransduction and cell traction force events on highly defined 
engineered small biomolecule surfaces. 
4.3.4 Tethered RGD vs. FN on mPAD Surfaces 
 Traditional studies of cell traction force on mPADs have been performed with 
passively adsorbed fibronectin (FN).  The RGD peptide is known to be the minimal 
adhesive sequence of the FN molecule.  Fibronectin has multiple RGD binding sites and 
synergy sites (i.e. PHRSN) that all serve to stabilize and reinforce focal adhesions.  In 
order to perform detailed investigations of single mechanotransduction and cell traction 
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force events, we must use simplified engineered surfaces that present only single 
ligands.  The RGD peptide is specific a small family of integrins, including α1β1 and αvβ3.   
Traction force vs. cell area measurements were performed on RGD and FN 
coated mPADs.  The cells used in these mPADs studies were a stable line of vinculin-
null MEFs with retroviral expressed WT-eGFP-vinculin, and from this point will be 
referred to as WT MEFs.   WT MEFs were seeded on mPADs (FN and RGD surfaces) 
and allowed to spread overnight to reach steady state.  WT MEF cells on RGD surfaces 
exhibited markedly lower traction forces and cell spreading when compared to FN 
surfaces (Figure 43, A).  On FN surfaces, there was a linear relationship between cell 
traction force and cell area, which is consistent with previous findings [118].  
Interestingly, on RGD surfaces there was also a linear relationship between cell traction 
force and cell area.  Linear regressions were performed on both data sets, and they 
exhibited similar slopes (Figure 43, B).  It appears that RGD is a critical regulator of cell 
spreading the cell area in MEF cells, and when in combination with the PHSRN or other 





Figure 43.  Traction forces of MEFs on Tethered Cyclic(RGD) vs. Passively Adsorbed 
Fibronectin mPADs .  A) WT eGFP-vinculin expressing MEF cells on mPADs.  Left 
column, RGD condition. Right column, FN condition.  Top row, vinculin localization 
(green), and posts (red).  Bottom row, traction forces (red arrows), and cell outline 
(yellow). Scale bar 10μm. FN conditions exhibit better cell spreading and traction force 
generation.  B) Total traction Force vs. Cell Area of WT eGFP-vinculin expressing MEF 
cells for cyclic(RGD) conditions vs. FN.  Note: regression lines are similar in slope, MEF 
cells on RGD surfaces have proportionally lower cell traction force and cell spreading.  
 
4.3.5 Cell Adhesion to Silane-PEG-RGD Surfaces Is Mediated by β1 and β3 
Integrins 
In order to confirm that the mechanism of RGD adhesion via silane-PEG-NHS 
ester tethering was indeed due to integrin-receptor interactions, an antibody blocking 
experiment was performed.  Flat PDMS surfaces were prepared with tethered 
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cyclic(RGD) and passivated with Pluronics F127.  WT MEF cells were incubated with 
blocking antibodies for β1, β3, or both β1 and β3.  These cells were then seeded on 
cyclic(RGD) surfaces.  WT MEF cells without antibodies were seeded on cyclic(RGD) 
and RDG surfaces to serve as positive and negative controls.   
 
 
Figure 44.  Antibody Blocking of β1 and β3 on Silane-PEG-Peptide Surfaces.  RGD 
control exhibits normal cell spreading and adhesion.  RDG control has no cell 
attachment.  RGD surface with β1 antibody and RGD surface with β3 antibody have 
minimal cell attachment and poor cell spreading.  RGD surface with both β1 and β3 
antibodies exhibit no cell attachment or spreading.  Results are quantified in graph, all 
conditions except RGD have low cell adhesion fraction (p<0.0001).  Scale Bar 100μm. 
 
WT MEFs attached and spread normally to the RGD control and no cells 
attached to the RDG surfaces.  Both β1 and β3 blocking conditions exhibited low levels 
of cell attachment and had poor spreading, characterized by the bipolar morphology of 
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cells.  Under the combined β1 and β3 blocking condition, there was almost no cell 
attachment or spreading.  Therefore, we can conclude that β1 and β3 integrins are 
responsible for RGD dependent adhesion and spreading in WT MEFs. 
4.3.6 WT MEF Cells on Silane-PEG-caged-RGD Surface Exhibit Cell Spreading 
and Focal Adhesion Formation  
We then validated the efficacy of tethering the caged-RGD ligand using the 
silane-PEG-NHS ester direct tether approach using WT MEF cells.  Static RGD and 
caged-RGD was tethered to mPADs using the chemistry outlined Figure 41, A.  Samples 
were irradiated at 361nm wavelength, using a wide-field UV lamp with a bandpass filter, 
before cell seeding.  WT MEF cells were seeding onto mPADs substrates after 
preparation and were allowed to spread overnight (Figure 45, A).  The controls either 
without silane or without caged-RGD exhibited no cell attachment and spreading, which 
is consistent with the absence of adhesive ligands on the mPADs surface.  With the 
tethering of static RGD ligand, in both the presence and absence of UV irradiation, WT 
MEF cells exhibited normal cell attachment and spreading.  In contrast, in the caged-
RGD conditions, in the absence of UV irradiation, there was minimal cell attachment and 
spreading, consistent with the assertion that the caging group remains intact, and no 
RGD was presented.  With UV irradiation, the caged-RGD presenting mPADs exhibit 
normal cell attachment and spreading, validating the ability of caged-RGD to modulate 
cell attachment and spreading on mPADs.  Therefore, the efficacy of the UV labile 
DMNPB caging group, using the wide-field UV irradiation, was validated on the mPADs 
system. It is clear that WT MEF cells can exhibit measureable traction forces and eGFP 
vinculin localization—sample confocal images of posts (red) and vinculin localization 




Figure 45.  Validation of Caged-RGD tethering to mPADs Surface.  A) In vitro 
Characterization of caged-RGD surfaces.  (+)silane (–)RGD and (–)silane (+)RGD 
controls exhibit no cell attachment.  Both unirradiated and irradiated static cyclic(RGD) 
surfaces exhibit normal cell attached and adhesion.  Unirradiated caged-RGD exhibits 
no cell attachment.  Irradiated caged-RGD condition exhibits normal cell spreading and 
attachment similar to static cyclic(RGD) controls.  Scale bar 50μm. B) Multiple WT 
eGFP-vinculin MEF cells on mPADs exhibiting normal cell spreading, vinculin 
localization and force generation.  Scale bar 20μm.  C) Zoomed view of WT eGFP-
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vinculin MEF cells on mPADs showing vinculin localization and force generation.  Scale 
bar 10μm.   
 
4.3.7 Validation of Uncaging Efficiency on mPADs Surface Using Tethered 
Caged-fluorescein 
The previous section demonstrated the ability of the silane tethering system to 
immobilize small peptides to PDMS surfaces, specifically caged-RGD and the 
preservation of function of the UV labile caging group via wide-field UV irradiation.  We 
demonstrated in the previous section that the silane tethering chemistry did not impact 
the stability and integrity of the DMNPB caging group of caged-RGD on mPADs 
surfaces.  While the UV labile moiety on caged-RGD is optimized for maximum efficiency 
at 361 nm, our confocal microscope only has a UV laser at 403 nm.  Thus, the efficiency 
of the UV labile caging group at 403 nm was investigated using a fluorescent analog of 
the caged-RGD molecule, caged-fluorescein.  Caged-fluorescein contains a similar 
caging group and utilizes the same linker chemistry as the caged-RGD. In its caged 
form, caged-fluorescein is not fluorescent.  Through 361 nm UV irradiation, the caged-
fluorescein molecule becomes “uncaged,” thereby restoring its fluorescence emission.  
The uncaging efficiency of caged-fluorescein was determined when tethered to surface 




Figure 46.  Covalent Tethering of Caged-fluorescein to mPADs.  Caged-fluorescein is 
immobilized to PDMS surface via reaction with silane-PEG-NHS ester.  Caging groups 
are highlighted in RED.  Caging groups are cleaved via 403 nm laser scanning confocal-
based irradiation. 
 
Using the stimulation function of the Nikon Elements software, a 2 μm diameter 
circular ROI was defined and centered on a single post.  Using 1.96% laser power of the 
403 nm laser and a 1 frame per second (fps) stimulation speed, the caged-fluorescein 
molecule was successfully uncaged at maximum efficiency.  The 403 nm ROI-based 
laser stimulation offers unparalleled spatial control of fluorescein presentation using 
sequential stimulations (Figure 47).  Although the mPADs device is excellent at 
scattering and diffracting light, we can see that using laser-based 403 nm irradiation, 
there is minimal activation of adjacent posts (Figure 47, C).  This specific activation is 
already far superior than a photolithography based approach because a photomask 
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cannot be brought into conformal contact with the mPADs and cell substrate. A titration 
of laser power and scan speed was performed to demonstrate the ability of the 403 laser 
to modulate exactly the degree of uncaging on a single post (Figure 47).  These 
stimulation events were performed sequentially using the Nikon Elements software.  
 
 
Figure 47.  Caged-fluorescein Characterization on mPADs. Georgia Tech logo patterned 
on mPADs using 403 nm laser on individual posts. A) Transmission and fluorescein B) 
fluorescein only, scale bar 25 μm   C) Stimulation laser power and scan speed titration; 




In the previous section, we demonstrated real-time in situ confocal-based 
uncaging was a promising platform for the spatiotemporal presentation a single molecule 
on a single post.  Applied to the caged-RGD molecule, it is clear that in conjunction with 
WT MEF cells, we would be able to track in real-time the effects of RGD-ligand 
presentation of a single post or focal adhesion on vinculin recruitment and force 
reinforcement.  This type of spatiotemporal control is currently unprecedented in the cell 
mechanotransduction world. 
 
4.3.8 Real-time Tracking of Vinculin and Force Generation in WT MEFs 
Following successful characterization of the kinetics of the UV-labile DMNPB 
caging group during confocal-based 403 nm irradiation, mPADs experiments using 
caged-RGD could now be performed.  Caged-RGD and static RGD was tethered to the 
mPADs in equal molar ratios so that cells were allowed to minimally attach and spread, 
but still have enough caged-RGD on the surface to later irradiate.  These molar ratios 
can be modified; however, this ratio was determined to be a good balance between 
steady-state cell contractile force, while still having adequate amounts of caged-RGD to 
uncage at later timepoints.  A limitation of this system however is that there is no good 
way to characterize this actual concentration of RGD ligand on the surface without using 
radiometric methods.  Using this setup, 403 nm laser stimulation of a single post can 
dynamically increase the ligand presentation on a single post within the 951 ms, which is 
the same time it takes for the laser scanning confocal to raster across the post.  
Therefore, using this caged-RGD, mPADs, and WT MEF cells system, we can modulate 
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ligand density almost instantaneously and begin tracking force generation and vinculin 
localization concurrently.   
Using time-lapse live-cell confocal microscopy, we dynamically tracked the 
recruitment of vinculin (WT eGFP-vinculin (488 nm) and subsequent force generation 
through the deflection of posts (DiI, 561 nm).  Using position list-based time-lapse 
microscope utilizing many stimulation regions of interest (ROI), we could track as many 
as three different cells, with stimulation of three separate posts.  This speed and number 
of stimulation ROIs was limited by the acquisition speed of the Nikon C2+ confocal 
system and limitations of the software.  Theoretically, using spinning disc confocal 
microscopy, this system should be able image at least 10 cells, concurrently, and track 
force and vinculin recruitment with sub-second resolution. 
Live cell microscopy using the Nikon C2+ system had to be optimized as to not 
kill the cells from phototoxicity.  It was determined (data not shown) that 0.16% 488 nm 
laser power, using a 4.3 μsec dwell time, at 512x512 resolution, one frame captured 
every 10 seconds was a good balance of signal/noise ratio and cell survival.   488 nm 
laser power higher than 2% was shown to be the upper limit before acute cell 
phototoxicity (data not shown).  403 nm laser power higher than 5% was shown to 




Figure 48. Stimulation of Individual Focal Adhesions of a Single WT MEF on mPAD#5.  
Panel A (top) shows transmission image of cell, (bottom) shows vinculin localization 
(green), post deflections (red), stimulation ROI 1 (pink), and cell outline (dotted yellow). 
Panel B (top) shows transmission image of cell, (bottom) shows vinculin localization 
(green), post deflections (red), stimulation ROI 2 (pink), and cell outline (dotted yellow).  
Stimulation ROI 1 and stimulation ROI 2 were performed sequentially, 20 minutes per 
time-lapse movie. Scale bar 6μm. 
 
For our pilot study, WT MEF cells were seeded on 50% caged-RGD/50 static 
cyclic(RGD) mPADs #5 (stiffness 18.19nN/um).  Cells were allowed to spread overnight 
to reach a quazi-steady state.  Cells were minimally adhesive mostly in rounded or 
bipolar morphologies, with small focal adhesions being formed on posts.  In Figure 48, 
above, depicts the ROI based irradiation of two separate posts in the same cell (outlined 
in yellow).  These two adhesions (Figure 48, A and B) differ in their original amount of 
contractile force and vinculin localization.  In the ROI outlined in pink, there is already 
significant force on the post and strong vinculin localization.  In contrast, in the ROI 
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outlined in orange, there is no force on the post, and minimal vinculin localization.  In the 
proceeding section we will investigate this cell in detail.  
Using particle-tracking software developed by Mosaic in ImageJ, we are table to 
track the deflection of every post using the DiI fluorescently labeled posts.  This 
fluorescent labeling of posts is critical because the transmission image of the cells on 
posts is marred with many artifacts and refraction patterns Figure 48, A.  As seen in 
Figure 48, B, the fluorescent channel image of posts (red) is far clearer and leads to 
simple and accurate tracking of post deflection.  By binarizing the image in ImageJ and 
setting the search parameters for the particle-tracking algorithm, it is able to 
automatically detect all of the posts in each from of a time-lapse study (Figure 49, A, 
left).  Once the software has found the posts it can automatically track the displacement 




Figure 49.  Particle Tracking to Quantify Force and Vinculin Localization.  A) ImageJ 
based analysis of post images using binarization and 2D particle tracking algorithm.  B) 
Output of particle tracking algorithm of a single post, binarized image and path shown in 
time-lapse form at 0, 840, and 1550 seconds.  C) Tracking of vinculin intensity on single 
post after irradiation in time-lapse faction.  Note: there is increased vinculin localization 
after 1550 seconds. 
 
By selecting an individual post, the software automatically plots the displacement 
of the post, providing both a path and X-Y coordinates (Figure 49, C).  These 
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coordinates can be exported for graphing purposes. Using this displacement data, 
combined with the stiffness of the mPADs substrate, we quantified the force that the cell 
exerted on the post in response to the triggered ligand presentation of RGD.  Using the 
488 nm eGFP-vinculin images, we tracked the real-time trafficking of vinculin to the 
irradiated post (Figure 49, C) and exported this data using ImageJ’s [stack->”plot z-
intensity”] functionality.  Using these two data sets, the correlation between force 
generation and vinculin localization in response to changes in RGD ligand presentation 
was quantified (Figure 50). 
 
 
Figure 50.  Quantifying the Difference in Force Generation and Vinculin Recruitment in 
Mature vs. Nascent Focal Adhesions.  A) Summary data of stimulation ROI 1 (mature 
focal adhesion with preexisting deflection) time lapse videos of displacement, force, and 
intensity vs. time.  B) Summary data of stimulation ROI 2 time lapse videos of 
displacement, force, and intensity vs. time.  Green denotes stimulated post, red denotes 
unstimulated post with cell attached, blue denotes free post with no cell.    Note: vinculin 
recruitment occurs independently of force generation. 
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 In the first ROI, the post is already moderately deflected, and contains a small 
amount of vinculin localization; this type of adhesion we will classify as a mature 
adhesion.  This adhesion was selected because it was already bearing the most force in 
the cell; therefore, should be strongly coupled to the cytoskeletal machinery for maximal 
response to uncaging.  In control conditions, a post where the cell was attached 
(attached post) and a free post with no cell (free post), there was no appreciable 
increase in force generation or vinculin localization over the course of the time-lapse 
study. Also, it is important to note that there is no photobleaching in the vinculin channel 
during acquisition as evidenced by no change in vinculin signal in the control attached 
post; therefore, no post processing of vinculin signal is required.  After the first ROI 
stimulation, both vinculin and force generation increase in response to increased RGD 
presentation. In this case, increase in force generation precedes an increase in vinculin 
localization by almost 250 seconds (Figure 50, A, middle and right).  The implications of 
this will be discussed in the following sections. 
A second adhesion was selected in the same cell to demonstrate the versatility of 
this system to perform independent measurements of force generation and vinculin 
recruitment in a single cell.  This adhesion was selected because there was a very small 
amount of vinculin localization and no force generation, this type of adhesion we will 
classify as a nascent adhesion.  After the second ROI stimulation of a post in the same 
cell, it appears that there is no force generation, however there is still appreciable 
vinculin recruitment to the post (Figure 50, B, middle and right).   
This dichotomy in behavior of these adhesions can be explained in several ways.  
In a mature adhesion, the focal adhesion complex is already stabilized through the 
formation of a robust adhesive plaque, and vinculin is likely stabilized in a active 
conformation, linking the focal adhesion complex to the actomyosin-cytoskeletal 
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machinery.  Therefore, when an increase RGD-dependent ligand is detected, the main 
constituents of the focal adhesion such as talin, paxillin, and FAK are already localized in 
the area and therefore the stimulated FA can immediately generate more contractile 
force.  Interestingly however, in the mature adhesion, increases in vinculin recruitment 
over baseline is delayed ~250-500 seconds from the onset of force generation.  These 
results are consistent with recent findings on cell spreading experiments on flat 
nanopatterned RGD membranes that there is a delayed recruitment of vinculin to RGD 
clusters while talin, paxillin, and FAK are all recruited almost instantaneously [146].  
Furthermore, studies on tension-mediated FA maturation have suggested that FA 
recruitment of vinculin and FAK are myosin II dependent and that phosphorylation of 
paxillin is responsible for vinculin recruitment to reinforce the ECM to cytoskeletal linkage 
and drive FA maturation [147].  Therefore, if myosin II dependent FAK phosphorylation 
of paxillin were required for vinculin recruitment, then logically vinculin recruitment to 
contractile FAs would be delayed. 
In the case of the nascent adhesion, increases in vinculin recruitment occur 
immediately after post stimulation, even in the absence of force generation. This is 
consistent with previous studies have shown that both talin and paxillin is recruited to 
adhesions even in the absence of myosin II contractility [147].  Additionally, it is known 
that vinculin can be recruited to focal adhesions in the absence of paxillin [148].  
Therefore, these results suggest, vinculin localization to new focal adhesions could be 
mediated by association with talin-integrin complexes, before the onset of downstream 
paxillin/FAK mediated myosin II contractility.   However, these assertions are beyond the 
scope of this study. 
This novel platform of triggerable RGD-presentation on mPADs has many 
applications for studying integrin clustering, kinetics and properties of FA formation, and 
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force generation.  Through the generation of new stable cell lines containing both 
vinculin and other fluorescently labeled FA constituents, such as paxillin and talin, we 
could elucidate which mechanism is responsible for contractility and force mediated 
vinculin recruitment. Furthermore, with the use of either FAK (focal adhesion kinase) or 
SRC FRET based biosensors we could obtain an in-depth understanding of the kinetics 
of these critical mediators of mechanotransduction in both mature and nascent focal 
adhesions.   
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4.4 CONCLUSION 
 We have demonstrated a novel method of tethering small ligands and peptides to 
PDMS surfaces using a silane-PEG-NHS ester.  This scheme opens up new avenues of 
research in small molecule presentation on PDMS, glass, and silicon surfaces.  The 
ability to microcontact print silane onto surfaces furthers its utility in complicated 
microfabricated softlithography tethering schemes.  RGD tethering to microcontact 
printed silane was shown to support normal cell adhesion and focal adhesion formation 
comparable to the RGD tethered direct incubated approach.  Caged-RGD tethering to 
mPADs in conjunction with WT-eGFP-MEF cells was able to support normal cell 
adhesion, spreading, and vinculin localization to focal adhesions.   
The efficiency of uncaging the DMNPB group using the 403nm confocal laser 
was validated using caged-fluorescein tethered to mPADs surfaces and a full titration of 
stimulation conditions was performed.  Using a mixture of 50% static RGD and 50% 
caged-RGD, we have demonstrated the first real-time tracking of vinculin localization 
and cell traction force generation on multiple post array deflection substrates following 
triggered RGD presentation via in situ laser-based uncaging.  These studies have shown 
that vinculin recruitment to increased RGD ligand presentation occurs independently of 
force generation.  Additional RGD presentation to established, mature focal adhesions, 
results in immediate increase in traction force generation, while vinculin localization is 
delayed by over 200 seconds, suggesting that vinculin localization in these adhesions is 
regulated by signals downstream of myosin II-mediated increases in cytoskeletal 
tension.  In nascent adhesions, however, vinculin localization occurs immediately even in 
the absence of force generation.  This suggests that local focal adhesion adaptor 
proteins such as talin could be responsible for vinculin localization under low force 
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regimes.  Taken in whole, this study suggests that that there are two pathways for 
vinculin localization to focal adhesions depending on the amount of contractile force 




Cells and reagents 
Mouse embryonic fibroblasts (MEF) vinculin mutants (null, WT, T12, Vh) were 
provided by David Dumbauld.  Growth media was DMEM (Gibco), 10% fetal bovine 
serum (Gibco), 100 U/mL penicillin G sodium (Gibco), 100 μg/mL streptomycin sulfate 
(Gibco), 1% non-essential amino acids (Gibco), 1% sodium pyruvate (Gibco).  Vinculin 
antibody (V284; Sigma-Aldrich), actin stain (Phallodin-Alexafluor555; Invitrogen), and 
nuclear stain (DAPI; Sigma-Aldrich) were used for immunostaining. Human plasma 
fibronectin was purchased from Invitrogen (Carlsbad, CA).  Cyclic(RGD) peptide and 
RDG peptides were purchased from Peptides International (Louisville, KY).  Caged-RGD 
and caged-fluorescein were generously provided by Arancha del Campo’s lab from Max-
Planck-Institut für Polymerforschung, Mainz, Germany.  
mPADs fabrication 
mPADs silicon masters were prepared as previously described [149] and were 
provided by Jianping Fu’s lab from the University of Michigan.  The elastomeric 
micropost arrays were fabricated using Sylgard 184 PDMS (Dow-Corning) via replica 
molding.  To make a microfabricated post array template, PDMS prepolymer was cast on 
top of mPAD silicon masters, cured at 110˚C for 1 hr, peeled off, oxidized with oxygen 
plasma (Plasma-Preen; Terra Universal), and silanized with (tridecafluoro-1,1,2,2,-
tetrahydrooctyl)-1-trichlorosilane (Sigma-Aldrich) vapor overnight under vacuum.  To 
make the final PDMS mPAD device, PDMS prepolymer was cast on the template, 
degassed under vacuum, and cured at 110˚C for 20 hrs and peeled off the template.  
Peeling induces collapse of the mPADs was rectified by sonication in 100% ethanol 
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(Decon Labs), followed by super-critical drying in liquid CO2 using a critical point dryer 
(Samdri-PVT-3D; Tousimis). 
Peptide tethering and cell seeding 
Flat PDMS stamps were generated by casting PDMS prepolymer on silanized 
silicon wafers.  Stamps were coated in saturating concentration of fibronectin (50 μg/mL 
in DPBS) for 1 hr.  These stamps were washed in distilled water and dried under a 
stream of N2.  4% Silane-PEG-NHS ester (Nanocs) dissolved in DMSO was then 
incubated on the stamp surfaces for 5-10 minutes.  During this time, mPAD substrates 
were oxygen plasma treated at 100 mW/cm2 for 5 seconds (Plasma-Preen; Terra 
Universal).  Immediately following, the silane-PEG-NHS ester stamps were dried under a 
stream of N2.  These stamps were then inverted onto the plasma treated mPADs surface 
for around 10 seconds.  These substrates with stamp were then sequentially washed in 
100% ethanol, and three times in 50mM sodium bicarbonate buffer, and then directly into 
100 μL of peptide reconstituted in sodium bicarbonate buffer (1 mg/mL).  Peptides used 
in study were caged-RGD and cyclic(RGD).   mPAD substrates were labeled with 5 
μg/mL of Δ9-DiI (Invitrogen) in distilled water for 1 hr.  mPAD substrates were then 
transferred to a solution of 0.1% Pluronics F127 (Sigma-Aldrich) to prevent non-specific 
protein absorption.  WT, Null eGFP-vinculin MEF cells were seeded in growth medium 
and then allowed to spread overnight. 
Characterization of confocal-based uncaging efficiency of DMNPB group 
Caged-fluorescein was tethered to mPADs in the described in the previous 
section.  mPAD substrates were labeled with 5 μg/mL of Δ9-DiI (Invitrogen) in distilled 
water for 1 hr.  Substrates were washed three times in DPBS and allowed to sit at RT.  
Samples were stable for over two days. 
Time-lapse microscopy and laser confocal based stimulation of caged-RGD 
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mPAD substrates were transferred to an aluminum coverslip holder (Attoflour 
Cell Chamber; Invitrogen)  for live cell microscopy and placed in an stage top incubator 
that regulated temperature, humidity, and CO2 (Live Cell; Pathology Devices).  Confocal 
images were taken with a Nikon-C2+ Laser Scanning Confocal connected to a Nikon Ti-
Eclipse Inverted Microscope using a high magnification objective (CFI Plan Apochromat 
TIRF 60x oil, N.A. 1.45; Nikon).  Uncaging of the caged-RGD was completed by single-
post ROI stimulation using the Nikon Elements software to control the 403 nm laser at 
1.96% power, 1fps.  Post images were captured using a 561 nm channel, and vinculin 
images were captured using a 488 nm channel.  Capture settings were the following: 
0.16% 488 nm laser power, 0% 561 nm laser power, 4.18 μs pixel dwell time, 7.1 AU 
pinhole, 512x512 resolution, scan area gated on single cell. 
Image analysis to quantify force generation and vinculin recruitment 
 Time-lapse movies were saved in .nd2 format and imported into Fiji (ImageJ, 
NIH) using the “BioFormats Importer” plugin.  These time-lapse series were split into 
their transmission, 488, and 561nm channels.  The 488nm channel was used to 
visualize vinculin localization.  By placing a ROI box around the expected displacement 
area of a stimulated, attached, and free post, using the [stack->plot z intensity], the 
488nm vinculin signal vs. time was automatically extracted and exported to Excel.  
561nm post time-lapses were smoothed to remove noise artifacts, and then binarized 
using the [Image->Adjust->Threshold] tool.  Using the “2D/3D Particle Analyzer” (Mosaic, 
Germany) plugin, and setting the search parameters to 6um-10um, all of the posts, in 
each field, were automatically detected.  Then the particle analysis and path-tracking 
algorithm was run, the output contained an image of all of the posts with superimposed 
displacements.  Upon clicking on a single post its time-lapse displacement path could be 
visualized and data exported to Excel.  Displacement was converted to force by 
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multiplying values with the stiffness of the mPADs device.  Final data output was 
graphed in GraphPad Prism 6 (Graphpad Software, CA).  
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CHAPTER 5 
CONCLUSION AND FUTURE DIRECTIONS 
This thesis presents a significant contribution to field of biomaterials research by 
demonstrating the utility of dynamic, triggerable biomaterials using novel caged-
compounds.  By having unparalleled spatiotemporal control of RGD ligand presentation, 
we demonstrated two novel tools for discovery: 1) in vivo ligand presentation to probe 
downstream tissue behavior and cell infiltration to biomaterial implants, and 2) in vitro 
ligand presentation in situ using confocal-based live cell microscopy to investigate real-
time vinculin recruitment and cell traction force generation.   
In Aim 1, PEG-based hydrogels provided a novel platform to elucidate cell-ECM 
interactions through a highly defined, non-fouling surface.  Through the use of simplified 
ECM-peptides such as RGD, specific integrin-ECM interactions can be studied.  We 
have demonstrated the uses of the novel caged-RGD molecule in the context of PEG-
based hydrogels.  Caged-RGD conjugated PEGDA based hydrogels were able to 
effectively modulate cell attachment and spreading in vitro.  We were able to 
demonstrate that DMNPB-based caged compounds were effectively controlled ex vivo 
using UV irradiation, after a subcutaneous implantation and the uncaging efficiency was 
unchanged even after 14 days.  Furthermore, delayed activation of caged-RGD 
presenting hydrogels was able to modulate macrophage recruitment and downstream 
fibrous capsule formation in subcutaneously implanted PEGDA-based hydrogels.   
When applied to PEG-maleimide based hydrogels, caged-RGD was effective at 
controlling in vitro cell outgrowth into a degradable hydrogel with protease sensitive 
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crosslinks through the control of RGD presentation via wide-field UV irradiation.  When 
this PEG-maleimide system was combined with protease sensitive crosslinks and VEGF 
in an in situ polymerized subcutaneous model, caged-RGD was effective at controlling 
vasculogenesis through the modulation of RGD presentation via transdermal UV 
irradiation.  Therefore, we have demonstrated that caged-RGD in conjunction with PEG-
based hydrogels is a versatile platform that offers unparalleled spatiotemporal control of 
RGD ligand presentation.  Through UV-activation we have demonstrated that ex vivo 
control of RGD-mediated cell adhesion is a critical regulator of many events including 
inflammation and vasculogenesis.  This study has shown that caged-compounds provide 
a versatile and effective means of controlling the presentation of signals and ligands in 
both in vitro and in vivo systems and have demonstrated the potential of this class of 
compounds in future biomaterials research. 
With the ability to modulate presentation of ligands/compound after implantation, 
the caged-system has wide ranging applications in vivo.  First, it can be used to 
dynamically control the presentation of chemical moieties immobilized on biomaterial 
surfaces.  This will have wide ranging effects in the field of immunomodulation. With the 
rise of personalized medicines and cell-based biopharmaceuticals, there is a need to 
study spatiotemporal presentation of antigens in immunological synapses.  Current 
methods of inducing antigenicity in t-cell populations only rely on the mixing antigen in a 
solution of white blood cells, which utilizes only the static presentation of antigens.  Also, 
in the study of CD8+ T-cells, that are already antigen specific, researchers could use a 
substrate presenting caged-antigen to visualize the formation of an immunological 
synapse in real-time and uncover antigen density dependent patterns of activation.   
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Wound healing and cell migration studies would also be greatly aided by the use 
of caged compounds.  Restenosis of vascular stents has long been a problem in the 
treatment of atherosclerosis due to wounding of the epithelial layer of blood vessels.  
This causes the a wound healing response in which smooth muscle cells migrate over 
the stent, eventually causing blockage.  Perhaps using a caged-adhesive ligand system, 
we can control the migration of specific cell types over the stent in order to stabilize the 
stent inner diameter. 
In Aim 2, we have demonstrated a novel method of tethering small ligands and 
peptides to PDMS surfaces using a silane-PEG-NHS ester.  This scheme opens up new 
avenues of research in small molecule presentation on PDMS, glass, and silicon 
surfaces.  The ability to microcontact print silane onto surfaces furthers its utility in 
complicated microfabricated softlithography tethering schemes.  RGD tethering to 
microcontact printed silane was shown to support normal cell adhesion and focal 
adhesion formation comparable to the RGD tethered direct incubated approach.  Caged-
RGD tethering to mPADs in conjunction with WT-eGFP-MEF cells was able to support 
normal cell adhesion, spreading, and vinculin localization to focal adhesions.   
The efficiency of uncaging the DMNPB group using the 403nm confocal laser 
was validated using caged-fluorescein tethered to mPADs surfaces and a full titration of 
stimulation conditions was performed.  Using a mixture of 50% static RGD and 50% 
caged-RGD, we have demonstrated the first real-time tracking of vinculin localization 
and cell traction force generation on multiple post array deflection substrates following 
triggered RGD presentation via in situ laser-based uncaging.  These studies have shown 
that vinculin recruitment to increased RGD ligand presentation occurs independently of 
force generation.  Additional RGD presentation to established, mature focal adhesions, 
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results in immediate increase in traction force generation, while vinculin localization is 
delayed by over 200 seconds, suggesting that vinculin localization in these adhesions is 
regulated by signals downstream of myosin II-mediated increases in cytoskeletal 
tension.  In nascent adhesions, however, vinculin localization occurs immediately even in 
the absence of force generation.  This suggests that local focal adhesion adaptor 
proteins such as talin could be responsible for vinculin localization under low force 
regimes.  Taken in whole, this study suggests that that there are two pathways for 
vinculin localization to focal adhesions depending on the amount of contractile force 
across a single focal adhesion. 
Spatiotemporal control of RGD ligand presentation on spread cells has many 
applications when used in conjunction with other sensing modalities, such as FRET 
biosensors.  Using either sensors of FA proteins (vinculin tension sensor) or essential 
signaling molecules (FAK and SRC biosensors), in conjunction with caged-RGD 
presenting mPADs, researchers would be able to track signaling cascades in addition to 
FA localization and force generation.  Furthermore, because this system allows 
researchers to perform the same studies on new vs. established focal adhesions, 
important insights into the dichotomy of these types of adhesions can be uncovered. 
Designing new caging chemistries, based on maleimide chemistry, will extend 
the use of caged compounds from only short peptides to medium or large sized globular 
proteins.  Most proteins have free cysteine sites, and if it is determined that the active 
site of a protein is near one of these cysteines, a maleimide –based caging group may 
be able to disrupt the proteins activity.  If caging groups were shown to influence activity 
of whole proteins, this would greatly increase the use of caged compounds in the 
research world, and may even extend the use of caged compounds into the clinic. 
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Ultimately, these studies provided the biomaterials community with new tools for 
detailed investigation into the role of spatiotemporal ligand presentation in both hydrogel 
and PDMS-based systems.  Triggerable in vivo adhesive ligand presentation was 
evaluated in both a biomaterial-associated implant inflammation model and an in vivo 
vasculogenesis study. These studies demonstration the power of triggerable adhesive 
ligand presentation in vivo and demonstrated the utility of caged-compounds in probing 
specific receptor-ligand responses on highly defined PEG-based synthetic hydrogels.  
Triggerable in vitro ligand presentation, combined with traction force microscopy, 
demonstrated the first real-time tracking of vinculin recruitment and traction force 
generation in response to additional ligand presentation.  It also represented a new 
research platform for investigating the temporal control of ligand presentation and its 
effect on integrin activation, focal adhesion formation, and downstream force generation.  
Taken in whole, this thesis demonstrates the potential of UV-light mediated temporal 
control of adhesive ligand presentation in a variety of systems and created several new 
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Engineered biointerfaces covered with biomimetic motifs, including short bioadhesive ligands, are a promising
material-based strategy for tissue repair in regenerative medicine. Potentially useful coating molecules are ligands
for the integrins, major extracellular matrix receptors that require both ligand binding and nanoscale clustering for
maximal signaling efficiency. We prepared coatings consisting of well-defined multimer constructs with a precise
number of recombinant fragments of fibronectin (monomer, dimer, tetramer, and pentamer) to assess how nano-
scale ligand clustering affects integrin binding, stem cell responses, tissue healing, and biomaterial integration.
Clinical-grade titaniumwas grafted with polymer brushes that presentedmonomers, dimers, trimers, or pentamers
of thea5b1 integrin–specific fibronectin III (7 to 10) domain (FNIII7–10). Coatings consisting of trimers and pentamers
enhanced integrin-mediated adhesion in vitro, osteogenic signaling, and differentiation in human mesenchymal
stemcellsmore thandid surfaces presentingmonomers anddimers. Furthermore, ligand clustering promotedbone
formation and functional integration of the implant into bone in rat tibiae. This study establishes that a material-
based strategy in which implants are coated with clustered bioadhesive ligands can promote robust implant-tissue
integration.
INTRODUCTION
An overarching goal in materials engineering and medicine is the de-
velopment of biomaterials to control cell function in order to promote
tissue healing and regeneration (1, 2). Cell-biomaterial interactions are
primarily governed by cell adhesion, which arises from the binding of
cellular integrin receptors to biomacromolecules adsorbed, tethered, or
deposited onto a surface or the extracellular matrix (3). Engagement of
distinct integrin ab heterodimers activates specific signaling path-
ways that regulate survival, proliferation, and phenotypic cellular pro-
grams (4, 5). For instance, binding of cell surface integrin to extracellular
fibronectin promotes osteoblast survival, cell cycle progression, differen-
tiation, and matrix mineralization (6–9). Strategies to control integrin-
mediated adhesion to bioinspired materials have been developed to
regulate tissue repair and maintenance. For example, presentation of
short oligopeptides such as the Arg-Gly-Asp (RGD) sequence derived
from fibronectin on substrates allows for the selective activation of in-
tegrin signaling pathways (for example, avb3-mediated signaling by
RGD) (2, 10–12). Other approaches make use of macromolecular lig-
ands, including extracellular matrix–derived proteins such as collagen,
elastin, and fibronectin (11, 12). These strategies have typically relied on
the immobilization of the bioadhesive ligand onto a solid support in a
relatively static arrangement, without the possibility of substantial
ligand mobility or directed receptor clustering. This presentation is
in contrast to the state of cell membrane integrin receptors, which
are mobile and cluster together to attain maximal function (13, 14).
Integrin clustering drives the assembly of focal contacts that serve as
mechanotransducers and signaling nexuses for cells (5, 15, 16).
Synthetic clustering of multiple copies of the RGD sequence in
polyvalent dendritic polymers enhances cell attachment, migration,
and targeting (17–20). For optimal effect, clustered ligands should be
spaced far enough apart to avoid steric hindrance to binding (integrin
receptor diameter, ~10 nm) but close enough to promote synergistic
interactions. Integrin ligand spacings on the order of 80 to 140 nm
are required for the assembly of focal adhesion domains (21, 22). How-
ever, in rats and dogs, coating of implants with individual linear RGD-
containing peptides does not promote or enhance implant integration
or bone formation compared to the surface treatments that are used in
the clinic (23–26), including porous and hydroxyapatite-coated implants.
These findings suggest that such RGD-based approaches have limited
therapeutic application.
We hypothesized that immobilization of a flexible macromolecular
assembly that presents multiple tethered copies of bioligands could
promote cellular integrin clustering and signaling and thereby enhance
integration of an implant. We therefore tested whether recombinant
constructs displaying specified numbers of the 7 to 10 type III repeats
of fibronectin (FNIII7–10)–binding domain (27) could promote im-
plant integration into bone.
RESULTS
FNIII7–10 presents the PHSRN (Pro-His-Ser-Arg-Asn) and RGD
integrin-binding sites of fibronectin in an arrangement that results
in high binding specificity for integrin a5b1 (23, 28). In previous
studies, we have shown that the presentation of FNIII7–10 on a substrate
enhances osteoprogenitor cell differentiation and implant osseo-
integration when compared to a coating of simple immobilized RGD-
containing oligopeptides (23). By combining the FNIII7–10 fragment,
a flexible linker derived from tenascin (TNfnIII3–8), and a multiplex-
forming coiled-coil sequence at the C terminus (Fig. 1A), we assembled
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the bioadhesive domains into a supramolecular construct that presented
defined numbers of copies of the cell-adhesive domain on a flexible
linker (Fig. 1A). Constructs presenting one, two, three, or five nano-
clustered adhesive ligands were generated with different coiled-coil do-
mains. The linker within the FNIII7–10 multimeric construct provided
flexibility to allow for the rearrangement of the bioadhesive ligands
within a range of about 10 to 50 nm.
We expressed recombinant constructs in Escherichia coli and pu-
rified themwith anion-exchange chromatography. The hydrodynamic
radii of themultimers were assessed by dynamic light scattering to ver-
ify the assembly of the subunits into the expected dimers, trimers, and
pentamers. Size histograms (Fig. 1B) show the expected hydrodynamic
radius for the monomer (8.5 nm), dimer (12 nm), trimer (22 nm), and
pentamer (41 nm) constructs. Smaller peaks corresponding to partially
assembledmultimers were observed for the trimer and pentamer prep-
arations, but these constituted <15% of the total amount of material.
To precisely control the presentation of biological ligands on clini-
cally relevant materials, while preventing nonspecific adsorption of
biomacromolecules, we used a nonfouling oligo(ethylene glycol)-
substituted polymer brush system on clinical-grade titanium (Ti). This
thin polymeric coating, generated by surface-initiated atom transfer
radical polymerization of poly[oligo(ethylene glycol) methacrylate]
[poly(OEGMA)] brushes on Ti, provides a robust coating that can
be engineered to present well-defined densities of covalently tethered
biological ligands in a background that is resistant to nonspecific bio-
macromolecule adsorption and cell adhesion (29). This coating tech-
nology is compatible with in vivo applications and can be used to
rigorously evaluate biomaterial integration and function in animal
models (23). Multimeric FNIII7–10 constructs were covalently tethered
onto these materials, and the density of tethered multimers was
controlled by varying the ligand concentration in solution and mea-
sured via surface plasmon resonance (SPR) (fig. S1) (28).
The ability of a5b1 integrin to bind to our multivalent constructs
was examined by SPR in a cell-free system. In a first set of experiments,
SPR chips coated with polymer brushes were modified with the differ-
ent multimers to present the same density of the FNIII7–10 integrin-
binding sites (Fig. 2A) (that is, surfaces modified with five times as
muchmonomer as pentamer present the same density of FNIII7–10 lig-
and). Binding of soluble integrin a5b1 to these surfaces was the same for
all multimers. In a complementary set of experiments, polymer-coated
SPR chips presenting equimolar densities of constructs were used (Fig.
2B). For the same construct densities, integrin binding increased lin-
early (R2 = 0.994) with the valency. These results demonstrate that the
multivalent constructs support integrin a5b1 binding, that integrin-
binding sites within the constructs are accessible for receptor binding,
and that they are not subject to steric inhibition.
Fig. 1. Multimeric constructs with precise nanoclustered integrin-binding
domains. (A) Constructs consisting of the FNIII7–10 integrin-binding domain
at the N terminus, flexible spacer arm comprising the FNIII domains 3 to 8
from tenascin, and a distinct oligomerization sequence at the C terminus:
K6 peptide for dimer, cartilage matrix protein (CMP) for trimer, and cartilage
oligomericmatrix protein (COMP) for pentamer. Schematic of trimer tethered
to a surface and interacting with integrins via the FNIII7–10–binding domain.
(B) Histograms of construct hydrodynamic diameter (D) for purified mul-
timer fractions. A mixture of complete and incompletely assembled multi-
mers was detected; the majority (>85%) of multimers were completely
assembled as the desired dimer, trimer, and pentamer constructs.
Fig. 2. The integrin-binding sites within the multivalent ligand constructs
are accessible for receptor binding and support robust a5b1 binding.
Binding of soluble human a5b1 integrin to multimers immobilized on poly-
mer brushes (orientation uncontrolled). (A) Equimolar average densities
of FNIII7–10–binding domains. (B) Surfaces presenting equimolar densi-
ties of multimers. Integrin binding increased linearly with ligand valency
(R2 = 0.994).
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The effects of ligand clustering on cellular responses were exam-
ined by culturing human mesenchymal stem cells under osteogenic
conditions (growth medium supplemented with Osteogenic Single-
Quots kits) on biomaterials presenting multimeric constructs. These
stem cells have the potential to differentiate into various lineages and
represent a promising cell source for regenerative medicine (30). Bio-
material surfaces were engineered to present equivalent average den-
sity (150 fmol/cm2) of the FNIII7–10 domain as quantified by SPR.
Because of differences in molecular weight among constructs, the sat-
uration density of tethered constructs was different for each construct
(fig. S1). The density of FNIII7–10 used (150 fmol/cm
2) represents the
highest density of the integrin-binding domain that could be tethered
onto the polymer coating while still having equivalent average densi-
ties of the FNIII7–10 domain for all of the multimeric constructs. In-
tegrin binding in adherent cells was quantified with a biochemical
cross-linking and extraction method (31). Surfaces that presented tri-
meric and pentameric ligands exhibited twice as much integrin bind-
ing as the monomeric and dimeric ligands at equivalent ligand densities
(P < 0.05) (Fig. 3A). No differences in integrin binding were observed
between monomeric and dimeric ligands, or between trimers and
pentamers, suggesting a threshold response rather than a monotonic
increase with valency. Cells did not adhere to control surfaces that
presented no multimeric constructs or in the presence of antibodies
against the integrin subunit a5. Using Ti surfaces coated with passively
adsorbed monomeric and pentameric ligands, we also examined the
effects of ligand nanoclustering on integrin binding at higher multimer
surface densities (fig. S2). Adsorption of multimers on unmodified Ti
yielded about five times higher FNIII7–10 surface density (680 fmol/cm
2)
compared to tethered multimers on polymer brush–coated Ti. Experi-
ments to determine binding of soluble integrin to substrates modified
with adsorbed monomer and pentamer constructs confirmed equiv-
alent integrin receptor accessibility for these coated densities (fig.
S2A). Consistent with our observations with ligands tethered onto
polymer brushes, cells on surfaces that presentedpentameric constructs
exhibited greater levels of integrin binding (fig. S2B) and adhesion
strength (fig. S3C) than the monomeric ligand at equivalent FNIII7–10
densities. Together, these results demonstrate that nanoclustering en-
hances integrin binding to adhesive ligands presented on biomaterial
surfaces.
The differences in binding of soluble integrins (linear with total
FNIII7–10 density) (Fig. 2B) and cell-bound integrins (enhanced bind-
ing to trimer and pentamer over monomer and dimer at equal overall
densities of FNIII7–10) (Fig. 3A and fig. S2) demonstrate that ligand
clustering improves cell-adhesive activity. The effects of ligand cluster-
ing on cell signaling were explored further by quantification of phos-
phorylation of focal adhesion kinase (FAK) by Western blotting (Fig.
3B). FAK is a central signaling molecule that is activated by phospho-
rylation and is involved in integrin-mediated signal transduction, focal
adhesion formation, and the osteogenic differentiation pathway (32).
We used a phosphotyrosine-specific antibody to examine the phospho-
rylation of Y397, a tyrosine autophosphorylation site critical for FAK
function. We previously demonstrated that blocking the binding of
integrin a5b1 to fibronectin inhibits FAK-Y
397 phosphorylation and
osteoblastic differentiation (23, 33). Here, FAK-Y397 exhibited more
phosphorylation on pentamer-presenting surfaces than on the other
multimer-functionalized materials (P < 0.05) (Fig. 3B). This result is
consistent with the valency-dependent threshold effects observed for
integrin binding.
We next examined the effects of ligand clustering on lineage com-
mitment and osteoblastic differentiation for mesenchymal stem cells.
Cells cultured on surfaces displaying trimeric and pentameric bioadhe-
sive ligands exhibited significantly more alkaline phosphatase activity
Fig. 3. Human mesenchymal
stem cell responses to bioma-
terials presenting multivalent
adhesive ligands at equimolar
average density of FNIII7–10 do-
mains. (A) Integrin binding to
multimeric constructs in whole
cells (1 hour, 37°C), showing thresh-
old response [pentamer (P) and
trimer (T) versus monomer (M)
and dimer (D): *P < 0.05, n = 6].
(B) Phosphorylation of FAK-Y397
in whole-cell lysates (2 hours, 37°C)
is enhanced on surfaces presenting
higher-valency ligands [pentamer
(Pent) versus monomer (Mon), di-
mer (Dim), and trimer (Tri): *P <
0.05, n = 4]. (C and D) Biomaterials
presenting trimers and pentamers
enhance alkaline phosphatase (ALP)
activity (pentamer and trimer versus
monomer and dimer: *P < 0.01) and
mineralization asmeasured by ex-
tracellular Ca2+ in 14-day cultures
of mesenchymal stem cells (pen-
tamer and trimer versusmonomer
and dimer: *P < 0.04).
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than did cells on materials functionalized with monomeric or dimeric
constructs (P< 0.01) (Fig. 3C).Deposition of calciumphosphatemineral
within a collagen matrix is considered an endpoint marker of differen-
tiation.Mineralization, asmeasured byCa2+ levels, was up-regulated in
human stem cells cultured on biomaterials presenting trimers and pen-
tamers of FNIII7–10 compared to substrates functionalized withmono-
meric and dimeric constructs (P < 0.04) (Fig. 3D), in agreement with
our results on alkaline phosphatase activity. Together, these results dem-
onstrate that adhesive ligand multivalency (trimers and pentamers)
enhanced integrin binding, signaling, and osteoblastic differentiation
in human stem cells.
Enhancements of tissue repair and device integration represent the
ultimate goal for biomaterial-based therapeutic strategies. As a rele-
vant test of such behavior, we examined the effects of our multivalent
ligands on implant osseointegration. Ti rods functionalized with the
multimeric constructs (FNIII7–10 average density, 150 fmol/cm
2) were
press-fit into circular defects drilled into rat proximal tibia (Fig. 4A).
This model mimics dental and orthopedic clinical procedures, such as
endosteal dental implants and joint arthroplasties, where the mechan-
ical and biological integration of the implant and surrounding bone is
critical to function. Therefore, this in vivo model provides a platform
to rigorously evaluate the effects of implant coating in a relevant dental
and orthopedic setting (23, 34, 35). Tibiae were harvested after 4 and
12 weeks and analyzed for bone-implant contact by histomorphometry
(4 weeks) and implant-bone fixation by mechanical testing (4 and 12
weeks). Histological sections revealed more extensive and contiguous
bone in close apposition to the trimer- and pentamer-functionalized
implants than for the monomer- and dimer-coated implants (Fig. 4B).
Control implants presenting poly(OEGMA) brushes without tethered
bioadhesive ligands displayed limited bone-implant contact. No evi-
dence ofmultinucleated cells, fibrous capsule, or chronic inflammation
was observed for any of the groups.Histomorphometric analysis demon-
strated a 50% increase in bone-implant contact area for the trimer-
and pentamer-functionalized implants compared to monomer-coated
rods (P < 0.04), a 250% increase compared to the polymer brush–coated
Ti in the absence of tethered ligand (P < 0.01), and a 75% increase over
unmodified Ti (33 ± 3% bone-implant contact), the current clinical
standard (P < 0.02) (Fig. 4C).
Mechanical fixation provides a rigorous metric of functional im-
plant osseointegration. Pullout mechanical testing at 4 and 12 weeks
of implantation revealed ligand valency–dependent differences (P <
0.01; Fig. 4D). Trimer- and pentamer-functionalized implants exhibited
a 250% enhancement in fixation over monomer- and dimer-tethered
implants (P < 0.002), and ~400% improvement relative to the un-
modified polymer coating (P < 0.001). Furthermore, implants present-
ing trimers and pentamers required twice asmuch force to be pulled out
as did unmodified Ti (17 ± 4.2 N pullout force at 12 weeks, P < 0.001),
the current clinical standard.
DISCUSSION
Our results demonstrate that clinical implants coated with nano-
clustered biological ligands enhance integrin binding and signaling,
stem cell differentiation, and in vivo implant integration relative to coat-
ings displaying equivalent densities of monovalent ligand. We attribute
the effects of ligand multivalency and clustering on these biological re-
sponses to enhancements in binding of integrin a5b1. How does ligand
clustering exert its influence over binding to integrins in a cell mem-
brane? For integrins located in the cell membrane, ligand clustering
results in greater integrin binding by increasing the local density of lig-
and and increasing the effective affinity by spatially constraining the
receptors to the plane of the membrane. We observed this cooperative
binding behavior for integrin receptors in cells but not for freely diffus-
ing soluble receptors. These findings agree with simulations of integrin
binding and clustering (36, 37). Our observation of a threshold for op-
timal binding (trimer and pentamer exhibit greater in vitro and in vivo
biological responses than monomer and dimer) is consistent with pre-
vious suggestions that a trimer is the minimal matrix complex causing
integrin-cytoskeleton connections (27, 38).
Fig. 4. Nanoclustered ligand coatings enhance
functional in vivo implant osseointegration. (A)
Bone implantation model for assessment of im-
plant integration by measuring bone-implant con-
tact and mechanical fixation. Photograph shows
placement of two implants. (B) Micrographs of
bone-implant longitudinal sections showing min-
eralized bone (red/orange) and implant (black)
contact. Scale bars, 0.2 mm. (C) Quantification of
bone-implant contact at 4 weeks after implantation
demonstrating valency-dependent enhancements
(pentamer versus monomer and dimer: #P < 0.04;
pentamer versus no ligand: *P < 0.0001, n = 4; tri-
mer versus monomer, dimer, and no ligand: *P < 0.05,
n = 4; monomer versus no ligand: *P < 0.01, n = 4).
(D) Biomaterials presenting trimers and pentamers
significantly increased mechanical fixation (4 weeks:
pentamer, trimer, and monomer versus no ligand:
*P < 0.01, n = 8; 12 weeks: pentamer versus mono-
mer and dimer: #P < 0.002, n = 7; pentamer, trimer,
and monomer versus no ligand: ¥P < 0.01, n = 7).
R E S EARCH ART I C L E
































Integrin clustering is a critical step in the cell adhesion process that
promotes recruitment of cytoskeletal components and activation of
signaling molecules (13, 14). Our data show that integrin clustering
can be exploited by engineering materials that present well-defined,
multivalent adhesive ligands. This affords control over mesenchymal
stem cell lineage commitment and differentiation, as well as biomaterial
integration. Moreover, our work demonstrates that substrate manipula-
tion alone can be used to directly influence essential functions of the
entire tissue, confirming the utility of a material-based strategy in re-
generative medicine. The use of recombinant multimeric constructs
has important advantages over the stochastic presentation ofmany other
adhesive RGD-based peptides, including the ability to have precise con-
trol over valency ligand spacing and integrin-binding specificity. Spe-
cifically, this study establishes bioadhesive ligand clustering as a key
parameter for the rational engineering of bioactivematerials for regen-
erative medicine and demonstrates methods to exploit this strategy.
MATERIALS AND METHODS
Multimer preparation and characterization
Recombinant multimeric FNIII7–10 proteins presenting the central
cell-binding domain of fibronectin were expressed as described (27).
DNA constructs were transformed into E. coli BL21(DE3), and cells
were lysed with lysozyme. Protein was precipitated with ammonium
sulfate. Pellets were resuspended in buffer (0.02 M tris, 0.1 M NaCl)
and run through a Sephacryl 500 column. Peak fractions were then run
through a RESOURCEQ column (AmershamPharmacia). High-purity
proteins were eluted at 0.22 M NaCl (pentamer and trimer), 0.24 M
NaCl (dimer), and 0.27 MNaCl (monomer). Dynamic light scattering
was performed on purified protein samples dialyzed in ultrapure water
at protein concentrations of 2 mg/ml.
Biomaterial supports
Poly(OEGMA)brushes (135Å thick)were grownon commercial clinical-
grade Ti as described (29). For ligand tethering, brushes were first in-
cubated in a 4-nitrophenyl chloroformate (NPC) solution containing
triethylamine, followed by incubation in ligand solution for 1 hour, and
residual activated NPC sites were quenched in 20 mM glycine in
phosphate-buffered saline (PBS). Brush synthesis and functionalization
reactionswere verified by x-ray photoelectron spectroscopy andFourier
transform infrared spectroscopy. Ligand surface density measurements
were obtained via SPR with a Biacore X instrument.
Cells
Human mesenchymal stem cells were obtained from Lonza, cultured
in Lonza MSCM and SingleQuots, and passaged every 3 to 4 days
before 60% confluency. Osteogenic SingleQuots kits (PT-4120, Lonza)
were used in Lonza Basal Medium (replaced every 3 to 4 days) for sub-
sequent osteoblast differentiation assays.
Integrin binding, adhesion, and FAK signaling assays
SPRmeasurements were conductedwith soluble human a5b1 integrin by
means of a Biacore X instrument. Gold-coated SIA chips (Biacore) were
coated with 50 Å Ti, and brushes were deposited on the surface as de-
scribed (29). Surfaces were activatedwithNPC for 20min. Ligandswere
tethered on chips by flowing a solution containing them at 8 ml/min for
30 min. A solution (200 mg/ml) of human recombinant soluble a5b1
(R&D Systems) was passed over the multimer-functionalized chips
for 10 min in integrin-activating conditions (PBS + 1 mM Mn+2), the
surfaces were washed, and the baseline was allowed to stabilize before
the amount of bound integrin was quantified. Resonance units (RUs)
were converted to surface density values (10 RUs = 1 ng/cm2).
Integrinbinding in cellswasquantifiedwith a cross-linking–extraction–
reversal procedurewith 3,3!-dithiobis[sulfosuccinimidyl propionate] cross-
linker (31). For FAK activation assays, humanmesenchymal stem cells
were plated onmultimer-tethered substrates for 2 hours at 37°C under
serum-free conditions. Cells were lysed in radioimmunoprecipitation
assay buffer [1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS,
150 mMNaCl, 150 mM tris-HCl (pH 7.2), phenylmethylsulfonyl fluo-
ride (350 mg/ml), leupeptin (10 mg/ml), and aprotinin (10 mg/ml)], and
equal amounts of total protein were loaded on 8% SDS–polyacrylamide
gel electrophoresis (SDS-PAGE) gels, separated by SDS-PAGE, and
transferred to nitrocellulose membranes. FAK activation was assessed
by subsequentWestern blotting with antibodies specific for FAK phos-
photyrosines (Invitrogen) and normalized to total FAK levels.
Osseointegration study
Implantations into the tibiae ofmature Sprague-Dawleymale rats were
conducted in accordance with an Institutional Animal Care and Use
Committee–approved protocol (35). Ti rods andpolymer brusheswere
prepared as described (23). Multimeric constructs were tethered to
yield equimolar densities of the FNIII7–10 domain (150 fmol/cm
2).
Two 2-mm-diameter defects were drilled into the medial aspect of the
proximal tibial metaphysis of each leg, and implants were press-fit into
the defects (four implants per animal). After euthanasia, tibiae were
explanted and either fixed in neutral buffered formalin (histology)
or wrapped in PBS for immediate mechanical testing. Formalin-fixed
tibiae were embedded in poly(methyl methacrylate), dehydrated, and
stained with Sanderson’s Rapid Bone Stain (Surgipath) andVanGieson
counterstain (Surgipath). This procedure stained mineralized bone
(yellow-orange) and soft tissue and osteoid (blue-green). Bone apposi-
tionwas quantified as the percentage of the implant’s surface in contact
with the bone, and six to eight fields per implant were quantified.
Pullout testing was performed to quantify implant mechanical fixation
to surrounding bone tissue with an EnduraTEC Bose ELF 3200. The
ends of each excised tibia were secured, and the exposed head of the
implant was connected to a load cell via a customized grip apparatus.
Preloaded samples (<2N)were then subjected to a constant pull rate of
0.2 N/s. The pullout force (N), parallel to the long axis of implant, was
the maximum load achieved before implant detachment or failure.
Statistics
Results are presented as mean ± SEM. Results were analyzed by anal-
ysis of variance (ANOVA) in SYSTAT 8.0 (SPSS). If deemed signifi-
cant, pairwise comparisons were performed with Tukey post hoc test,
and a confidence level of 95%was considered significant. In vitro assays





Fig. S1. Surface density for constructs tethered onto polymeric brushes as a function of coating
concentration.
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Fig. S2. Cell-adhesive responses to surfaces presenting high density of multivalent ligands at
equimolar average density (680 fmol/cm2) of FNIII7–10 domains.
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 The ability to trigger or turn “on” or “off” material properties 
with external stimuli in order to control biological responses is 
critically important to biotechnological and biomedical appli-
cations. One such application is the use of light to trigger cell 
adhesion to synthetic materials by controlling the presenta-
tion of the bioadhesive arginine-glycine-aspartic acid (RGD) 
oligopeptide. Successful strategies for photoactivation of cell 
adhesion include direct modifi cation of the chemical struc-
ture of the RGD peptide with photoresponsive molecules, [ 1 ] 
using a light-triggered phase transition of a RGD-containing 
amphiphilic peptide, [ 2 ] and linking the RGD peptide to the 
surface using azobenzene units. [ 3 ] However, no light-based 
approaches are available to specifi cally promote cell adhesion 
to materials with the ability to precisely deactivate or detach the 
cells at later time points or spatial locations. This is a relevant 
issue in cell biology because cells need to be removed from 
the culture plate during culture and before application and in 
tissue engineering, i.e., cell sheet engineering therapies. In this 
article, we introduce a fl exible and facile strategy for controlled 
light-triggered cell release from surfaces based on the use of 
photocleavable linkers to couple the RGD ligand to the surface. 
Upon light exposure, the linker is cleaved by means of a photo-
lytic reaction, [ 4 ] thereby untethering the RGD peptide from the 
surface and releasing adhering cells. Our approach represents a 
more specifi c and controlled alternative to enzymatic digestion, 
temperature-driven changes in substrate hydrophobicity, [ 5 ] or 
electrochemical dissolution of polyelectrolyte coatings [ 6 ] or self-
assembled monolayers (SAMs) [ 7 ] onto conductive substrates 
for cell release (see ref.  [ 8 ] for a recent review on this topic). 
Our strategy is applicable to any material, provided that there 
is proper linker design, and provides direct control over the 
molecular interactions involved in cell adhesion. 
 The general strategy is presented in  Figure 1 . The photocleav-
able linker contains an intercalated 4,5-dialkoxy 1-(2-nitrophenyl)-
ethyl photolabile group and can be attached to free amine 
groups at the surface of the material via a carbamate bond. A 
tetraethyleneglycol (TEG) spacer is included in the structure 
in order to provide a protein- and cell-repellent surface before 
attaching bioactive ligands. A bioactive ligand, such as biotin 
or RGD oligopeptide, can be attached to the surface by reacting 
with the free amine at the end of the TEG spacer (I). The bio-
logical ligand then mediates specifi c binding to the surface of 
a particular target, such as streptavidin for biotin or cells for 
RGD peptides (II). Upon light exposure, the chromophore is 
photocleaved (III) and the linker, along with its target, is effec-
tively removed from the surface (IV). As with photolithographic 
techniques, full control over the spatiotemporal resolution of 
the release process is possible. By using a photomask for the 
illumination steps, patterns of active and nonactive sites can 
be previously generated, and immobilized species can be site-
selectively detached in the last step. 
 The detailed synthesis of the linker is included in the Sup-
porting Information. The linker was successfully reacted with 
amine-terminated substrates and the coupling reaction was 
monitored by UV spectroscopy on modifi ed quartz substrates 
(where the characteristic bands of the chromophore were 
visible) and by ellipsometry on modifi ed silicon wafers (an 
increase in the layer thickness of 1.4 nm was detected). The 
photocleavage of the linker from the surface was followed by 
UV spectroscopy after irradiating quartz substrates at  ! max  = 
350 nm for increasing times and washing with tetrahydrofurane 
and water. Exposure of  o -nitrobenzyl derivatives to light induces 
an intramolecular redox reaction and cleavage of the cage from 
the surface (see scheme in  Figure 2 ). Washing removed the 
photocleaved part of the molecule from the surface, and this 
was refl ected in a signifi cant decrease in absorbance in the 
UV spectrum, most visible around  ! max  (Figure  2 ). The ratio 
between the absorbance pre- and post-irradiation at  ! max rep-
resents the amount of photocleaved linker upon exposure 
(conversion). After 8 min irradiation, no signifi cant changes 
were visible in the UV spectrum with time, indicating that a 
maximum conversion of 70% was reached (inset in Figure  2 ). 
The residual absorbance indicates that part of the chromophore 
and/or photolytic by-products remained attached to the sur-
face or entrapped by the surface layer. [ 9 ] The residual attached 
chromophore could be a potential limitation in the perform-
ance of the light-induced detachment step. 
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(Figure  3 , I). The remaining linker molecules in the nonex-
posed areas were reacted with the fl uorophore (Figure B, II, 
Supporting Information) or with  N -( + )-biotin  N -hydroxysuc-
cinimide ester and then incubated with fl uorescently labelled 
streptavidin (Figure  3 , II). Figure  3 A shows the fl uorescent 
protein pattern observed through the microscope. The non-
irradiated regions appeared bright, indicating preferential and 
site-controlled attachment of the protein. In a second irradia-
tion step, the substrate was exposed through the same mask 
rotated 90 ° . After washing, fl uorescence decreased in the irradi-
ated regions (III and cross pattern in Figure  3 B and Figure A, 
Supporting Information) as a consequence of the cleavage of 
the intercalated cage and removal of the attached specie (pro-
tein or fl uorophore) from the surface. Low levels of residual 
fl uorescence were observed in the irradiated regions due to 
uncleaved chromophore (up to 30%) remaining attached to the 
surface after full exposure, as anticipated from the photolysis 
studies (see conversion plot Figure  2 ). Negative controls were 
performed in order to prove that the loss of fl uorescence was 
not due to bleaching of the fl uorophore. No cross pattern was 
visible in the photobleached control. Taken together, these 
 In order to assess the ability of the photolabile moiety to 
mediate specifi c binding and detachment, we tested the attach-
ment and controlled removal of the fl uorophore AlexaFluor 
647 succinimidyl ester and of streptavidin after functionaliza-
tion with biotin.  Figure  3 and Figure A (Supporting Informa-
tion) show schemes of the process. A substrate modifi ed with 
the photo sensitive linker was irradiated through a mask con-
taining 100  µ m wide chrome stripes separated by 200  µ m wide 
gaps. Irradiation cleaved the linker from the exposed regions 
 Figure  2 .  UV spectra of quartz substrates modifi ed with the photosensi-
tive linker after irradiation at 350 nm (0.6 mW cm  ! 2 ) for increasing expo-
sure times and washing for removal of the photolysis products. Inset 









































































 Figure  3 .  Phototriggered protein release and the possibility of site con-
trol. The scheme represents the coupling and irradiation steps. The 
fl uorescent micropatterns correspond to A) step II (site-selective immo-
bilization) and B) step III (site-selective release). The arrows indicate the 
exposed stripes (200  µ m). 
h"




 Figure  1 .  Left: Chemical structure of the photocleavable linker after reaction with the surface and the ligand before and after light exposure. Right: 
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photocleavable linker presenting RGD and surfaces modifi ed 
directly with RGD (Figure  4 C). This result demonstrates that 
the RGD peptide coupled to the photocleavable linker displays 
full bioadhesive activity. Importantly, control surfaces pre-
senting cyclo(RADfK) as inactive peptide displayed minimal cell 
adhesion, confi rming that adhesion to the surfaces is mediated 
by integrin cellular receptors (Figure  4 F). Next, substrates were 
irradiated under conditions for photocleavage of the linker. On 
surfaces modifi ed with photocleavable linker presenting RGD 
peptide, the cells rounded up and detached from the surface 
(Figure  4 C). Over 85% of the original, adherent cells were 
removed from the surface by simple washing with saline, and 
the remaining cells displayed a round morphology, indicative 
of poor adhesion to the surface. We attribute the small fraction 
of remaining cells to incomplete cleavage of the photolabile 
linker as shown in the photolysis analysis. Importantly, cells 
remained attached and spread on the positive control substrates 
where the RGD was directly immobilized (without photolinker, 
Figure  4 D), confi rming that the cell release is associated with 
the cleavage of the linker and that the irradiation dose used 
in the experiments did not affect cell adhesion and spreading. 
In fact, cell staining with the Live/Dead kit showed no differ-
ences in viability between irradiated and not irradiated cell cul-
tures under these exposure conditions (data not shown). These 
results demonstrate a fl exible and facile strategy for the specifi c 
attachment of cells with the ability of subsequent controlled 
results demonstrate the potential of this approach to selectively 
attach and release molecules from surfaces with spatiotem-
poral control, in contrast to other work that requires additional 
blocking steps to prevent non-specifi c protein adsorption onto 
the surface. [ 10 ] The inclusion of the TEG segment in the linker 
provides an effective protein-repellent surface background. 
 We next examined the ability of photolabile linker to mediate 
precise cell attachment to and subsequent light-triggered 
detachment from surfaces via the presence or absence (via 
photocleavage) of RGD. For this purpose, mixed SAMs of 
amine- and methoxy-terminated thiols with oligo(ethylene 
glycol) spacers were used to modify gold-coated surfaces and 
obtain a cell-repellent surface. A non-adhesive background is 
crucial in order to guarantee only RGD-mediated cell attach-
ment and minimize non-specifi c interactions of the cell with 
the surface. Cell experiments were performed on SAMs using 
a 2% surface concentration of the amine-terminated thiol to 
which the photolabile linker and cyclo(RGDfK) were attached. 
As a positive control, cyclo(RGDfK) was attached directly to the 
amine-terminated SAMs without the photolabile linker. Sub-
strates were seeded with human umbilical vascular endothelial 
cells (HUVECs) for 2 h. No cell adhesion was observed on sur-
faces that did not present RGD peptide ( Figure  4 E). For surfaces 
modifi ed with photocleavable linker and RGD, cells attached 
and spread, extending cellular processes (Figure  4 A). Similar 
levels of spreading were observed on surfaces modifi ed with 
 Figure  4 .  Microscopy images of HUVECs after 2 h incubation on RGD-modifi ed substrates anchored to A) an amine-terminated SAM with the photo-
sensitive linker and C) without the photosensitive linker (control experiment). In (B,D) the same substrates after irradiation are shown. E) HUVECs after 
a 2 h incubation on an amine-terminated SAM. F) HUVECs incubated for 2 h on cyclo(RADfK) non-adhesive peptide coupled to the amine-terminated 
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light-triggered release from surfaces. This strategy represents 
a more specifi c and controlled alternative to trypsination or to 
temperature-driven changes in substrate hydrophobicity, [ 5 ] or 
to the recently demonstrated cell release by addition of soluble 
RGD. [ 11 ] Reported cell release strategies relying on dissolution 
of the underlying electroactive coatings [ 6–8 ] or photodegradable 
gels [ 12 ] are material- and substrate-specifi c and less fl exible than 
these photocleavable linkers. This approach is applicable to any 
material, provided that the linker is properly designed, and pro-
vides direct control over the molecular interactions involved in 
cell adhesion. 
 In summary, we have demonstrated that phototriggered 
cleavage of the RGD peptide can lead to subsequent cell release 
from surfaces. To our knowledge this is the fi rst demonstration 
of a dynamic variation of RGD concentration at surfaces and 
its consequences in cell detachment by means of photosensitive 
molecules. 
 Experimental Section 
 The detailed synthesis and characterization of the linker, conditions for 
surface modifi cation irradiation, and coupling protocols are provided as 
Supporting Information. 
 Supporting Information 
 Supporting Information is available from the Wiley Online Library or 
from the author.  
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We demonstrate substantial differences in ‘adhesive 
signature’ between human pluripotent stem cells (hPSCs), 
partially reprogrammed cells, somatic cells and hPSC-derived 
differentiated progeny. We exploited these differential 
adhesion strengths to rapidly (over ~10 min) and efficiently 
isolate fully reprogrammed induced hPSCs (hiPSCs) as intact 
colonies from heterogeneous reprogramming cultures and from 
differentiated progeny using microfluidics. hiPSCs were isolated 
label free, enriched to 95%–99% purity with >80% survival, 
and had normal transcriptional profiles, differentiation 
potential and karyotypes. We also applied this strategy to 
isolate hPSCs (hiPSCs and human embryonic stem cells) during 
routine culture and show that it may be extended to isolate 
hPSC-derived lineage-specific stem cells or differentiated cells.
Generation of hiPSCs from somatic cells is a promising strategy 
to produce autologous cells for regenerative therapies and novel 
models of human development and disease1–3. However, the 
reprogramming process is inefficient (0.001%–2% reprogrammed 
cells)4, and hiPSC cultures are often heterogeneous because of 
the presence of undifferentiated stem cells, parental and partially 
reprogrammed cells and differentiated derivatives5, thereby intro-
ducing variability, potential immunogenicity6 and problems in 
directed differentiation7–11.
hiPSC survival and ‘stemness’ require compact colonies with 
E-cadherin–mediated cell-cell adhesion12. Current methods 
for maintenance of hiPSC cultures rely on manual isolation, 
either alone or in combination with enzymatic dissociation13–17. 
Such methods are time intensive, require skilled labor and are 
dependent on morphologic recognition of undifferentiated cells. 
Although many reagents have been developed for enzymatic pas-
saging, such methods are not selective for hPSCs, and unwanted 
cells are often transferred during passaging14,18. Furthermore, 
enzymatic methods have been reported to be associated with 
karyotypic abnormalities when compared to manual passag-
ing13–15,19 and require reaggregation of dissociated hPSCs for 
improved survival20. Although FACS21 can enrich undifferentiated 
populations, this method requires single-cell dissociation of 
hPSCs, which induces cell death12, and replated cells fail to form 
compact colonies (Supplementary Fig. 1).
There remains a need to develop unbiased, high-throughput 
technologies that can efficiently separate colonies of hiPSCs from 
nonreprogrammed and partially reprogrammed cells, feeder cells 
or differentiated cells. In this study, we demonstrate a unique 
‘adhesive signature’ for hPSCs that is a multifactorial function 
of extracellular matrix (ECM)-bound integrins, assembly of 
focal adhesions and the resulting cell-ECM adhesion strength. 
We present a platform technology that exploits differences in 
the adhesion strength among nonreprogrammed and partially 
reprogrammed cells, hiPSCs and differentiated cells to selectively 
isolate hiPSCs using microfluidics.
RESULTS
Changes in adhesive signature with reprogramming
During reprogramming to pluripotency, cells undergo changes in 
morphology resulting in an epithelial phenotype indicative of the 
pluripotent state (Fig. 1a). IMR90 and dermal fibroblasts, com-
mon somatic cell sources1,2 for reprogramming, exhibited an 
elongated (‘spread’) morphology and lack of pluripotency markers 
(Supplementary Fig. 2a–c) as compared to hiPSCs, which existed 
as tightly packed colonies (Supplementary Fig. 2d,e). Typically 
we observed that <1% of fibroblasts were converted to fully repro-
grammed hiPSCs22 positive for OCT4, SSEA4, TRA-1-60, NANOG 
and TRA-1-81 (Supplementary Fig. 2e–g). Residual nonrepro-
grammed and partially reprogrammed cells exhibited a less elongated 
morphology than that of parental fibroblasts and expressed some, but 
not all, pluripotency markers (Supplementary Fig. 2e).
The adhesive strength of a cell to its ECM is dependent on 
ECM-ligated integrins and their association to cytoskeletal ele-
ments23. Using flow cytometry and adhesion-inhibition studies 
(Supplementary Fig. 3), we determined that whereas paren-
tal fibroblasts expressed predominantly 5 1-integrin, hiPSCs 
expressed high levels of 6 1-integrin, regardless of whether 
the cells were cultured on fibronectin, laminin or Matrigel. 
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These results are consistent with those of human embryonic 
stem cell (hESC) studies24. Fibroblasts possessed actin stress 
fibers, and vinculin and talin were enriched at focal adhesions 
(Supplementary Figs. 4 and 5). In contrast, hiPSCs exhibited 
substantially fewer actin fibers, with diffuse vinculin and talin 
throughout the cytoplasm or localized to cell-cell junctions. 
Nonpluripotent cells in reprogramming cultures showed mixed 
regions of spread cells with well-defined focal adhesions and 
round cells without distinct focal adhesions (Supplementary 
Fig. 4). We therefore hypothesized that alterations in the adhesive 
signature related to integrin binding and cytoskeletal components 
accompany reprogramming to induced pluripotency and differ-
entiation of hiPSCs.
We evaluated the steady-state cell-ECM adhesion strength 
for hiPSCs and IMR90 cells using a spinning-disk device23 
(Supplementary Fig. 6a). We observed that adhesion strength to 
fibronectin for hiPSCs was one-seventh that for parental fibrob-
lasts (Fig. 1b). Analyses among fibroblastic parental and feeder 
cells, hESCs and hiPSCs revealed significantly lower adhesion 
strength to fibronectin, laminin and Matrigel for hPSCs than 
for fibroblasts (P < 0.02; Fig. 1b and Supplementary Fig. 6b), 
 indicating that the adhesive properties of cells shift during 
 reprogramming. These results were independent of passage 
number, underlying matrix, parental fibroblast source and colony 
size (Supplementary Figs. 6c and 7). The differences in adhesive 
strength correlated to more focal adhesions in parental cells than 
in hiPSCs. Nonreprogrammed and partially reprogrammed cells 
that expressed some but not all pluripotency markers (for example, 
OCT4+SSEA4!) exhibited higher adhesion strength than hiPSCs 
but lower adhesion strength than parental cells (Fig. 1c).
Distinct adhesive properties of differentiated cells
We next determined the adhesive signature of hiPSCs undergoing 
spontaneous or directed differentiation (Fig. 1d,e). We detected 
significant increases in the adhesion strength to the ECM of spon-
taneously differentiated cultures of hiPSCs (~10% TRA-1-60+) 
as compared to undifferentiated hiPSCs (Fig. 1f, P < 0.006); we 
obtained similar results in hESCs. Cells in spontaneously dif-
ferentiating cultures of hiPSCs displayed actin stress fibers and 
localized talin and vinculin to focal adhesions (Supplementary 
Figs. 5 and 8), which we did not observe in undifferentiated colo-
nies. Differences in adhesion strength between undifferentiated 
and differentiated cells were independent of the levels of sponta-
neous differentiation (Fig. 1g).
During directed differentiation, we observed early-stage 
multipotent neural stem cells (neural rosettes10) with a radial pat-
tern of epithelial morphology (Fig. 1d), which stained for nestin 
(Fig. 1e) and Musashi (Supplementary Fig. 9a), distinct from 
hiPSCs. The adhesion strength of these cells was comparable to that 
of hiPSCs (Fig. 1h) but significantly lower than that of fibroblast-
like cells (P < 0.05). We manually isolated rosettes and differentiated 
them to neural progenitors and neurons (Supplementary Fig. 9b). 
Neural progenitors exhibited adhesion strength comparable to 
that of neurons but 50% lower than that of hiPSCs (Fig. 1h,i) 
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Figure 1 | Adhesion of hiPSCs undergoing reprogramming and differentiation. (a) Schematic  
representing changes in adhesion of hiPSCs with reprogramming. (b,c) Adhesion strength of the indicated  
cell types on fibronectin (FN) and laminin (LM) (b) and of cells during reprogramming (c). MEFs, mouse embryonic  
fibroblasts; P, passage number; H1 and H7 indicate embryonic stem cell lines. (d,e) Morphology (d) and expression of pluripotency markers (e) in hiPSCs 
in spontaneously differentiating cultures of hiPSCs (SD-hiPSC; white arrowheads indicate differentiated cells), and expression of nestin in neural rosettes 
(red circles). Scale bars, 50 m. (f) Adhesion strength for undifferentiated (UD) and spontaneously differentiating (SD) cultures of hiPSCs and hESCs on 
FN or LM. (g–i) Adhesion strength for cells in hiPSC cultures with different levels of spontaneous differentiation (2% and 90% TRA-1-60+) cultured on  
LM (g), cells in hiPSC cultures differentiated into neural rosettes and neural progenitors (NPs) on LM (h) and hPSC-derived NPs on LM and Matrigel (i). 
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and about 85% lower than that of spontaneously differentiated 
fibroblastic cells (Fig. 1g), independent of hPSC type and matrix 
(Fig. 1i). These analyses demonstrate that hPSCs, progenitors and 
differentiated cells exhibit distinct adhesive signatures.
Hydrodynamic isolation of hPSCs
We exploited the unique adhesive signature of hiPSCs to isolate 
undifferentiated hPSCs from a heterogeneous cell population. 
We used adhesive force–based separation via a simple micro-
fluidic system, a label-free technique that requires minimal cell 
processing. We termed this technology SHEAR (micro–stem 
cell high-efficiency adhesion-based recovery). We fabricated 
SHEAR devices for a range of culture surface areas (Fig. 2a and 
Supplementary Fig. 10a). Cells remained viable in the device 
and retained their distinct morphologies, and hiPSCs remained 
undifferentiated (Supplementary Fig. 10b,c).
The application of laminar flow generated fluid shear stresses 
on adherent cells in the device. hiPSC colonies detached at a shear 
stress of 85–125 dynes cm!2 within 4 min of fluid-flow appli-
cation and were completely detached in 10–14 min (Fig. 2b,c) 
irrespective of the underlying ECM (Supplementary Fig. 10d,e), 
whereas fibroblasts remained attached. To quantify the effi-
ciency of hiPSC purification, we incubated recovered cells 
with StainAlive DyLight 488–conjugated TRA-1-60 antibody 
(Stemgent) to stain for live hiPSCs and with CellTracker Red 
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Fibroblasts: 4,000 cells per device

































































Fibroblasts: 20,000 cells per device
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Figure 2 | Adhesion strength–based isolation of  
pluripotent stem cells in microfluidic devices.  
(a) Schematic of SHEAR device cross-section and  
scale-up. (b,c) Selective isolation of hiPSCs at a shear  
stress of 85–125 dynes cm−2 when cocultured with  
IMR90 cells at low (b) and high (c) density. The white  
arrowheads indicate a hiPSC colony that is detached  
by flow. The red arrowheads indicate IMR90 fibroblasts.  
Scale bars, 200 m. (d) Flow cytometry plots showing  
detached hiPSCs (TRA-1-60+CMPTX+) and IMR90 cells  
(TRA-1-60−CMPTX+) at the indicated shear stresses.  
After SHEAR, residual cells in devices were trypsinized  
and analyzed. (e,f) Enrichment of hiPSCs and hESCs isolated  
at 85–125 dynes cm−2 from a coculture with IMR90 and mouse embryonic fibroblast cells, respectively. Graphs show mean  s.d. (*P < 0.05, n = 3).  
(g) Detached hiPSC colonies readhered to Matrigel and immunostained for the indicated markers. Scale bars, 50 m. (h) Karyotype analysis of hiPSCs 
isolated twice using SHEAR, with passages 7–8 d apart. (i) Embryoid bodies generated from SHEAR-isolated hiPSCs immunostained with markers for 
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the recovered cells revealed significant (P < 0.05) enrichment of 
hiPSCs when detached at 85–125 dynes cm!2 with up to 99% 
purity (Fig. 2d) as compared to the initial purity of 39% hiPSCs. 
Exposure to higher fluid forces (250–350 dynes cm!2) resulted in 
contamination with IMR90 cells (18%), whereas we observed <1% 
fibroblast contamination in cultures exposed to 85–125 dynes 
cm!2. When we increased the fluid force to 750–850 dynes cm!2, 
we observed high proportions of IMR90 cells in the detached pop-
ulations, similar to those in trypsinized samples under no-flow 
conditions (Fig. 2d). The SHEAR isolation efficiency was inde-
pendent of hiPSC purity in the initial coculture (Fig. 2e,f and 
Supplementary Fig. 11a). Less than 3% of residual cells in devices 
after fluid detachment were hiPSCs, indicating high recovery yield 
of hiPSCs by SHEAR (Fig. 2e,f). Similar results were observed 
with hESCs cultured on mouse embryonic fibroblast (MEF) 
feeders (Fig. 2e,f and Supplementary Fig. 10f). We observed 
similar enrichment with varying levels of hiPSCs in a fibroblast-
hiPSC coculture (baseline hiPSC purity, 1%–70%). Finally, we 

































































































































































































































































Figure 3 | Adhesion strength–based isolation  
of hiPSCs from a heterogeneous reprogramming  
culture. (a) Heterogeneous reprogramming culture  
seeded into a SHEAR device and subjected to  
a shear stress of 100 dynes cm!2 for 5 min.  
The red arrowhead indicates a hiPSC colony that is  
detached by flow. The white arrowheads indicate  
nonreprogrammed or partially reprogrammed cells.  
Scale bar, 200 m. (b) Center, flow cytometry  
plot showing detached hiPSCs (TRA-1-60+CMPTX+)  
and nonreprogrammed or partially reprogrammed  
cells (TRA-1-60!CMPTX+) at a shear stress of 100 dynes  
cm!2. Right, analysis of residual cells in the device  
after SHEAR. Left, analysis of an unpurified  
reprogramming culture in devices with baseline  
0.65% hiPSC purity. (c–h) SHEAR-isolated hiPSCs  
and residual cells from the devices replated on  
Matrigel and stained for the indicated markers. The white arrowheads indicate partially reprogrammed cells expressing pluripotency markers.  
Scale bars, 50 m. (i) Representative hematoxylin-and-eosin–stained sections from a formalin-fixed teratoma produced from SHEAR-isolated hiPSCs. 
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could also selectively enrich hiPSCs after the cells were allowed 
to proliferate with parental cells for 5–7 d in microfluidic devices 
(Supplementary Fig. 11b,c and Supplementary Video 1).
We used SHEAR to efficiently separate hiPSCs from other 
parental cell types: specifically, from peripheral blood mononuclear 
cells (PBMCs) in blood25. Because PBMCs are loosely adherent 
(Supplementary Fig. 12a,b), we first exposed the reprogrammed 
culture to a shear stress of 10 dynes cm!2 to remove PBMCs, which 
were removed from the devices within 1 min of exposure to flow 
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Figure 4 | Adhesion strength–based enrichment of hiPSCs from differentiating cultures. (a,b) Flow cytometry histograms (Alexa Fluor 488–TRA-1-60) 
showing purification (a) and survival efficiencies (b) of hiPSCs processed as indicated. (c) hiPSCs (TRA-1-60+CMPTX+) and spontaneously differentiated 
cells (TRA-1-60!CMPTX+) detached as indicated at passages 1 and 10. (d) Enrichment efficiency of hiPSCs upon repeated passaging with the indicated 
methods. P0 cells for all plots were from the same batch with 90% TRA-1-60+ cells; recovered cultures were propagated for 5–6 d. (e,f) Cell survival (e) 
and growth curves (f) of cells on Matrigel after passaging as indicated. D, day. (g) Immunostaining for pluripotency markers of SHEAR-isolated hiPSCs 
cultured on Matrigel across ten passages. Scale bars, 200 m. (h) Fold change in expression of stem cell–related (left) and differentiation (right) genes 
in hiPSCs at P10 relative to at P0. D1–D3 represent triplicate runs of SHEAR devices, and M1–M3 represent manual passaging triplicates. (i) Relative 
expression of stem cell–related genes in hiPSCs isolated manually or using SHEAR for ten passages. Magenta lines indicate a twofold change in gene 
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colonies with ~99% purity by increasing the flow (Supplementary 
Fig. 12d and Supplementary Video 2).
hiPSCs recovered by SHEAR initially adhered as small colo-
nies (Fig. 2g) with the ability to self-renew without any signs of 
differentiation (Supplementary Fig. 13). The isolated colonies 
retained their pluripotent phenotype (Fig. 2g and Supplementary 
Fig. 13) and exhibited no chromosomal abnormalities after 
two rounds of purification with passages 7–8 d apart (Fig. 2h). 
SHEAR-isolated hiPSC colonies readily generated embryoid 
bodies and differentiated into mesoderm, ectoderm and endo-
derm derivatives (Fig. 2i).
Isolation of hiPSCs from reprogramming cultures
We anticipated that adhesive signature differences could be 
exploited to selectively isolate hiPSCs from partially repro-
grammed cultures. Using SHEAR, we isolated hiPSC colonies 
(94%  3.6% purity) at 100 dynes cm!2 without detachment of 
nonreprogrammed and partially reprogrammed cells (Fig. 3a,b 
and Supplementary Fig. 14a,b). We observed only 0.05% resid-
ual hiPSCs, whereas non-hiPSCs constituted 99.9% of the culture 
remaining in the SHEAR device (Fig. 3b and Supplementary 
Fig. 14c). Isolated hiPSCs expressed TRA-1-60, TRA-1-81, 
DNMT3B, REX1, OCT4, SSEA4, GDF3, hTERT and NANOG, 
indicating that they were fully reprogrammed22. Residual cells 
in the device expressed OCT4, hTERT and GDF3 but not the 
other markers (Fig. 3c–h). We also analyzed the methylation 
patterns26,27 of endogenous OCT4 (POU5F1), NANOG and 
SOX2 genes. SHEAR-isolated hiPSCs displayed unmethylated 
OCT4, SOX2 and NANOG, similarly to hiPSCs under standard 
culture conditions and to unmethylated genomic DNA controls 
(Supplementary Fig. 14d). Finally, SHEAR-isolated hiPSCs 
formed teratomas when implanted into immunodeficient mice 
(Fig. 3i and Supplementary Fig. 15). These studies demonstrate 
that fully reprogrammed, bona fide hiPSCs can be selectively 
isolated from residual parental fibroblasts and from partially 
reprogrammed cells using SHEAR.
Isolation of hiPSCs from differentiated cells
We exploited the adhesive signature of undifferentiated hiP-
SCs to effectively separate them from differentiated progeny 
(Fig. 1f). Spontaneously differentiating hiPSC cultures with 
varying levels of differentiation were dissociated and cultured 
overnight in SHEAR devices with hiPSCs (Supplementary 
Fig. 16a). We could isolate hiPSCs as intact epithelial colonies 
before detaching differentiated fibroblast-like cells with >97% 
purity and yield irrespective of the levels of spontaneous differ-
entiation (6%–70% TRA-1-60!), and we observed similar results 
with hESCs (Supplementary Fig. 16b–d). We did not achieve 
selective purification with commonly used enzymatic agents 
(Supplementary Fig. 16b).
hPSC isolation with TRA-1-60 antibody–based purification 
(EasySep (Stemcell Technologies) and FACS) requires dissociation 
of colonies into single cells and labeling with molecular probes. 
Although both EasySep and SHEAR demonstrated 97% purification 
efficiency, SHEAR achieved improved purification with less vari-
ability in TRA-1-60 expression as compared to EasySep (Fig. 4a). 
When plated, EasySep- or FACS-purified cells did not form compact 
epithelial colonies (Supplementary Fig. 1) and exhibited poor sur-
vival (<40%; Fig. 4b) as compared to SHEAR (>80% survival).
We next assessed SHEAR for culture maintenance over 
the course of ten passages (5–7 d apart) starting with an ~10% 
spontaneously differentiated population. SHEAR-based iso-
lation resulted in repeated high-purity populations of hPSCs 
(>97%), whereas passage with routinely used methods failed to 
selectively enrich undifferentiated cells and resulted in continu-
ously increasing levels of spontaneous differentiation (Fig. 4c,d). 
Defined culture substrates, such as E-cadherin (StemAdhere 
(Stemcell Technologies)), which have also been used for hiPSC 
passaging28, were not selective for undifferentiated hiPSCs 
(Supplementary Fig. 17). The survival efficiency of cells passaged 
was higher using SHEAR than with TrypLE-based passaging 
(<30%; Life Technologies) and was comparable to that of cells pas-
saged manually (Fig. 4e). The doubling time of SHEAR-purified 
hiPSCs (~34 h) over ten passages was equivalent to that of hiPSCs 
passaged manually (Fig. 4f). hiPSC purification was selective at 
85–125 dynes cm!2, whereas at high shear stress, differentiated 
cells also detached (Supplementary Fig. 18a,b).
Recovered colonies retained pluripotency over ten passages 
(P1–P10) (Fig. 4g and Supplementary Fig. 18c), and the expres-
sion profiles of stem cell–related genes were similar at P10 and 
P0 for both SHEAR-isolated and manually picked hiPSCs 
(Fig. 4h). Expression of differentiation and lineage-specific 
genes was equivalent or downregulated for both SHEAR- and 
manually passaged hiPSCs as compared to starting P0 cells 
(Fig. 4h). Hierarchical clustering and scatter-plot analyses of 
gene expression at P10 indicated that SHEAR-passaged hiPSCs 
exhibited a high degree of similarity to manually passaged cells 
(Fig. 4h,i). SHEAR-passaged hiPSCs exhibited no chromosomal 
abnormalities at P10 (Fig. 4j) and showed the same methylation status 
of OCT4, SOX2 and NANOG as manually passaged hiPSCs 
(Supplementary Fig. 18d).
We applied SHEAR to isolate terminally differentiated cells. 
Because their adhesion strength is lower than that of hiPSCs, neurons 
were detached at 60 dynes cm!2, whereas hiPSCs remained adher-
ent to the substrate at this shear stress level. Isolated neurons 
exhibited excellent viability, neurite growth (Supplementary 
Fig. 19) and expression of MAP2 and -III tubulin. Similarly, 
we successfully isolated hiPSC-derived cardiomyocytes 
(Supplementary Video 3) from hiPSCs with >95% purity 
(Supplementary Fig. 20a,b). Recovered hiPSC adhered as colonies, 
whereas the residual cardiomyocytes expressed -smooth 
muscle actin and exhibited spontaneous contractile activity 
(Supplementary Fig. 20c,d and Supplementary Video 4).
DISCUSSION
High-throughput microfluidic devices are being adapted in routine 
cell culture29–31 and offer advantages over conventional hydrody-
namic sorting, including laminar flow with only a millionth of 
the buffer volume and the ability to recover detached cells32. We 
demonstrate that differences in adhesion strength can be exploited 
to purify undifferentiated hPSCs from other cell types in a facile, 
efficient and label-free manner, yielding higher hPSC survival 
than conventional methods provide. Our SHEAR methodology 
allows the application of a wide range of shear forces with small 
working volumes and precise magnitudes of shear force. We also 
tested the high-throughput potential of SHEAR across culture 
areas of 0.5–9 cm2 and found 95%–99% enrichment efficiency of 
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Cells are loaded in <30 s, and no time is spent precleaning the cul-
tures. Self-contained disposable microfluidic devices ensure steril-
ity, and cell recovery takes ~5 min, similar to the time required for 
a routine centrifugation step after enzymatic dissociation. In addi-
tion, the microfluidic strategy provides for direct visualization of 
the detachment process of stem cell colonies; a gradient of shear 
forces could thus be used to serially isolate individual colonies 
from the same chamber, which could not be achieved with any 
bulk passaging methods. SHEAR will facilitate the integration 
of cell isolation procedures, such as separating completely repro-
grammed hiPSCs from partially reprogrammed cells, with in-line 
biochemical, genomic, proteomic and metabolomic analyses.
METHODS
Methods and any associated references are available in the online 
version of the paper.
Note: Supplementary information is available in the online version of the paper.
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hiPSC reprogramming and hPSC culture. hiPSCs (IMR90) were 
derived and validated by ArunA Biomedical using the viPS Vector 
Kit (Thermo Scientific/Open Biosystems) consisting of six lenti-
viral vectors encoding OCT4, NANOG, SOX2, LIN28, KLF4 and 
c-MYC (MYC) driven by the EF1A promoter. IMR90 human fetal 
lung fibroblasts (female, ATCC) were transduced (MOI of 10 for 
each vector) for reprogramming per the manufacturer’s proto-
col. Transduced fibroblasts were seeded onto inactivated MEFs 
or Matrigel to form colonies, and emerging hiPSC colonies were 
manually passaged by mechanical dissociation on day 30. hiPSCs 
demonstrated well-defined borders, high nuclear-to-cytoplasmic 
ratio, prominent nucleoli, alkaline phosphatase activity, positive 
expression of cell-surface marker SSEA4, embryoid body forma-
tion and teratoma formation. To transition hiPSCs to a feeder-free 
culture system, we manually passaged colonies by mechanical 
dissociation onto Matrigel (1:100 dilution; BD Biosciences) in 
mTeSR1 medium (Stemcell Technologies). hiPSCs used in the 
study were between passages 26 and 48, routinely cultured as 
feeder-free undifferentiated hiPSC colonies in mTeSR1 medium 
on Matrigel and enzymatically passaged with dispase (1 mg mL!1) 
and scraped. To maintain an undifferentiated state in hiPSCs, we 
exchanged the mTeSR1 medium daily. For SHEAR experiments, 
reprogramming was performed on Matrigel, and the entire culture 
was introduced into the devices after 27–30 d. To obtain sponta-
neously differentiated cultures of hiPSCs, we exchanged mTeSR1 
medium every second day and did not clean the cultures.
Human dermal fibroblast–derived hiPSCs (11b, healthy male 
donor) were obtained from Harvard Stem Cell Institute and 
cultured as above. Human peripheral blood mononuclear cell–
derived hiPSCs were a gift from J. Wu (Stanford University) and 
were derived using Sendai virus. hESCs (H1 and H7) used in the 
study were at passage 35 (H1, WiCell) or passage 54 (H7, WiCell) 
and cultured in mTeSR1 medium on Matrigel. IMR90 human fetal 
lung fibroblasts (passage 15–20), human dermal fibroblasts (pri-
mary adult skin, Cell Applications) and MEFs (primary isolated, 
passage 2) were cultured in DMEM with 1% "-glutamine, 1% non-
essential amino acids, 10% FBS and 1% penicillin/streptomycin. 
Immunostaining and flow cytometer measurements were per-
formed using antibodies listed in Supplementary Table 1.
Neural cell and cardiomyocyte derivation. Neural rosettes and 
subsequent neural progenitor cells and differentiated neuro-
nal cells were derived from feeder-free, pluripotent colonies of 
hiPSC (passage 40 or 52) via methods based on those previously 
described for hESCs33. Briefly, hiPSCs were enzymatically pas-
saged 1:2 with dispase (1 mg mL!1), and then cells were scraped 
onto BD Matrigel (diluted 1:100) in mTeSR1 medium (Stemcell 
Technologies). Medium was changed every other day for 4 d. 
On day 5, medium was switched to neural derivation medium 
(DMEM/F-12 supplemented with N-2), 4 ng mL!1 FGF2, 2 mM 
"-glutamine and 50 U mL!1:50 g mL!1 penicillin-streptomycin) 
and changed every other day. After 1 week in neural deriva-
tion medium, neural rosettes were manually isolated and then 
propagated on Matrigel (1:200) in neurobasal medium (Life 
Technologies) supplemented with B-27, 20 ng mL!1 FGF2, 10 ng 
mL!1 LIF, 2 mM "-glutamine and 50 U mL!1:50 g mL!1 penicil-
lin-streptomycin, with medium changed every other day. After 
4 weeks of differentiation, neural progenitor cells were manually 
isolated from neural rosette cultures and propagated as an adher-
ent monolayer on Matrigel in neural proliferation medium. After 
several manual passages with a cell scraper, confluent cultures of 
hiPSC-derived neural progenitor cells on Matrigel (1:200) were 
differentiated for 2 weeks into mature, -III tubulin (TUJ1)/
MAP2-positive neuronal cells through removal of FGF2 from 
the neural proliferation medium and change of medium every 2–3 
d. hiPSC (IMR90)-derived cardiomyocytes were a kind gift from 
C. Xu (Emory University) and were derived as previously reported34. 
Cells were cultured in RPMI/B27 medium and exhibited sponta-
neously contractile activity (Supplementary Video 3).
Design and fabrication of PDMS micropatterned arrays. 
Poly(dimethylsiloxane) (PDMS) micropattern arrays having 
islands with diameters of 10 m, 20 m, 56 m and 170 m were 
fabricated from silicon array masters23,35. Microcontact print-
ing on glass coverslips coated with Ti (100 Å) followed by Au 
(100 Å) was achieved using hexadecanethiol/(HO(CH2CH2O)3-
(CH2)11SH) chemistry23. Coverslips were incubated with ECM 
proteins (fibronectin or laminin, 50 g mL!1 in PBS)23. After 
a blocking step with 1% heat-denatured bovine serum albumin 
(Sigma) for 30 min and protein elution for 2 h in PBS, single-cell 
suspensions of IMR90 cells or hiPSCs were seeded in mTeSR1 
medium with ROCK inhibitors Y27362 (10 M, Calbiochem) or 
thiazovivin (2 M, Stemgent). Briefly, hiPSCs were treated with 
0.05% trypsin for 1 min and scraped as intact colonies. Cells 
were then prepared as single cells in mTeSR1 with Y27362 ROCK 
inhibitor and seeded as 100,000 cells mL!1 on the micropatterned 
islands overnight. For unpatterned surfaces, glass coverslips were 
incubated with ECM proteins as above and single-cell suspensions 
were seeded as 60,000 cells mL!1 and cultured overnight.
Cell adhesion strength measurements. Cell adhesion strength 
was measured using a spinning disk system23. Coverslips with 
adherent cells cultured overnight were spun in PBS with 2 mM 
dextrose for 5 min at a constant speed in a custom-built device 
in compliance with American Society for Testing and Materials 
(ASTM F2664-11). The applied shear stress ( ) is given by the 
formula  = 0.8r( 3)1/2, where r is the radial position,  and 
 are the fluid density and viscosity, respectively, and  is the 
spinning speed. After spinning, cells were fixed in 3.7% formal-
dehyde, permeabilized in 0.1% Triton X-100, stained with DAPI 
(Life Technologies) and counted at specific radial positions using 
a 10# objective lens in a Nikon TE300 microscope equipped with 
a Ludl motorized stage, Spot-RT camera and Image Pro analysis 
system. Sixty-one fields were analyzed, and cell cluster counts were 
normalized to the number of cell cluster counts at the center of the 
disk, where the applied force is 0. The fraction of adherent cell clus-
ters (f) was then fit to a sigmoid curve f = 1/(1 + exp(b(  ! 50))), 
where 50 is the shear stress for 50% detachment and b is the 
inflection slope. 50 represents the mean adhesion strength for a 
population of cells. The adhesion-strength response was analyzed 
on micropatterned islands coated with fibronectin or laminin 
(50 g mL!1) or Matrigel (1:80).
Focal adhesion assembly. Immunofluorescence staining of focal 
adhesion proteins was performed as previously described23. 
Briefly, cells were prewashed with ice-cold PBS with calcium 































buffer (50 mM NaCl, 150 mM sucrose, 3 mM MgCl2, 1 g mL!1 
aprotinin, 1 g mL!1 leupeptin, 1 g mL!1 pepstatin and 1 mM 
phenylmethylsulfonyl fluoride) for 1 min and incubated twice 
(1 min each) in cytoskeleton buffer supplemented with 0.5% 
Triton X-100. Detergent-extracted cells were fixed in 4% para-
formaldehyde in PBS, washed with PBS, incubated with a pri-
mary antibody against vinculin (Upstate) or talin (Sigma) 
and detected with Alexa Fluor 488–conjugated antibodies 
(Life Technologies).
Fabrication of microfluidic devices. PDMS (Sylgard 184, Dow 
Corning) microfluidic devices were fabricated as reported ear-
lier using a negative photoresist (SU-8 2050, 50- m thickness, 
MicroChem) and UV photolithography36. Patterned negative 
molds were then exposed to vapor-phase tridecafluoro-1,1,2,2- 
tetrahydrooctyl-1-trichlorosilane (United Chemical Technologies) 
in a vacuum desiccator to prevent adhesion of PDMS. A 5-mm-
thick layer of degassed PDMS mixture (10:1) was cast onto the 
mold and cured at 70 °C for 2 h. Cast PDMS devices were peeled 
off and then punctured for inlet-outlet holes and bonded to glass 
coverslips by exposure to oxygen plasma for 20 s.
mSHEAR-based isolation. Prior to coating with ECM proteins, 
the microfluidic channels and tubes were cleaned with 70% etha-
nol and rinsed thoroughly with PBS. ECM proteins at 50 g mL!1 
(fibronectin or laminin) or 1:80 Matrigel were flowed through 
sterile devices and incubated for 1 h at room temperature. Small 
colonies of pluripotent stem cells and single-cell suspensions of 
fibroblasts were premixed and pipetted into the inlet reservoir 
using a 200- L pipette tip and were cultured in the device for 
24 h at 37 °C and 5% CO2 before the detachment experiments. 
The device inlet was connected to a syringe pump using polyeth-
ylene tubing (BB31695-PE/4, Scientific Commodities), and outlet 
tubes emptied into collecting tubes. PBS was flowed at predeter-
mined flow rates through the device to match up the desirable 
fluid shear stress, and cell detachment was monitored though 
a Nikon TE microscope. For this microfluidic flow configura-
tion, the applied wall shear stress ( ) is defined by the formula 
 = 12( Q/wh2), where w and h are the width and height of the 
channel, respectively,  is the fluid viscosity and Q is the fluid 
flow rate32. Cells and colonies were plated on Matrigel-coated 
tissue culture plates in 10 M ROCK inhibitor Y27362 (or 2 M 
thiazovivin) containing mTeSR1 medium. For flow cytometry 
studies to determine purification efficiency, collected colonies or 
cells were immediately resuspended in a suspension of StainAlive 
DyLight 488 mouse anti-human TRA-1-60 antibody (Stemgent) 
and CMPTX CellTracker Red dye, stained for 45 min, washed and 
analyzed using an Accuri flow cytometer (BD Biosciences).
Pluripotent stem cell characterization. Karyotype analysis was 
performed on 20 metaphase spreads for each sample by CellLine 
Genetics. To determine population doubling time and survival, we 
dissociated detached colonies from SHEAR into single cells and 
plated them in Matrigel-coated 12-well plates. At predetermined 
times, wells were washed and cells were counted. Embryoid bodies 
(EBs) from detached and expanded hiPSCs were formed using an 
ultrahigh-throughput forced aggregation method37, and after 24 h, 
cell aggregates were transferred to a suspension culture on a rotary 
orbital shaker (65 r.p.m.) for 14 d. After differentiation, we plated 
EBs in cell chambers (BD Falcon), and after 21 d in chambers, 
differentiated cells were fixed with 4% paraformaldehyde, per-
meabilized with 0.05% Triton X-100 and stained with antibodies 
against -fetoprotein, -smooth muscle actin and PAX6.
Gene expression analysis. RNA was isolated from iPSCs using 
QIAshredder and RNeasy Mini kits (Qiagen) according to the 
manufacturer’s protocols. We performed first-strand cDNA syn-
thesis with the RT2 First Strand Kit (SABiosciences) followed by 
real-time PCR, using the Human Embryonic Stem Cells PCR array 
(SABiosciences) according to the manufacturer’s recommended 
protocols and using a BioRad MyCycler and BioRad MyIQ real-
time thermal cycler, respectively. Individual Ct values were first 
internally normalized to GAPDH and subsequently analyzed with 
Genesis software (Graz University of Technology), including log2 
transformation and hierarchical clustering. Heat maps were gener-
ated for the expression of 84 embryonic stem cell–related genes for 
transcription factors, pluripotency and self-renewal, cytokines and 
growth factors; and embryonic stem cell differentiation/lineage 
marker genes extracted from gene expression microarrays. A log 
plot of the relative expression level of each gene (2! Ct) between 
manual (x axis) and SHEAR (y axis) was generated for analysis.
Bisulfite genomic sequencing. Bisulfite treatment of gDNA 
was carried out using a Cells-to-CpG Bisulfite Conversion kit 
(Life Technologies) according to the manufacturer’s protocol and 
plotted as melting curves representing methylation status26,27. 
Converted gDNA was amplified by PCR using primers within 
the OCT4, SOX2 and NANOG promoters. Primer sequences are 
as follows. OCT4 forward: CCCTCCTCTAAAAAAC; OCT4 
reverse: GGGTTGTAGTTGTGTTTATT; NANOG forward: AA 
TTACAAAAATAAACCACC; NANOG reverse: TAGGTGGG 
GAATTAGAAAAT; SOX2 forward: CATATACAACATAATA 
AAAA; SOX2 reverse: GTTTTTTTGGGTTATTTTG.
Teratoma formation. The SHEAR-isolated cells were expanded 
on Matrigel and then collected as pellets resuspended in DMEM-
F12 at 7 million cells per 50 L. Cells were injected intramus-
cularly in the hind limb of SCID mice (Harlan). Seven weeks 
after injection, tumors were dissected, weighted and fixed with 
formalin. Paraffin-embedded tissue was sectioned and stained 
with hematoxylin and eosin (H/E) and imaged using a Nikon 
80i microscope. All experimental and surgical procedures involv-
ing animals were approved by the Georgia Institute of Technology’s 
Institutional Animal Care and Use Committee.
Statistics. Paired two-tailed Student’s t-tests were performed to 
determine the significance of differences between two groups in 
adhesion blocking, adhesion strength and SHEAR assays. For 
integrin profiling, one-way analysis of variance (ANOVA) was 
performed with Bonferroni correction using OriginPro 8.5.1. 
In all tests, P < 0.05 was regarded as statistically significant. All 
experiments were repeated in triplicate unless otherwise stated, 
and bar graph data represent average  s.d.
33. Dhara, S.K. et al. Human neural progenitor cells derived from embryonic 
stem cells in feeder-free cultures. Differentiation 76, 454–464 (2008).
34. Laflamme, M.A. et al. Cardiomyocytes derived from human embryonic  
stem cells in pro-survival factors enhance function of infarcted rat hearts. 
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Focal adhesions mediate force transfer between ECM-integrin
complexes and the cytoskeleton. Although vinculin has been
implicated in force transmission, few direct measurements have
been made, and there is little mechanistic insight. Using vinculin-
null cells expressing vinculinmutants,wedemonstrate that vinculin
is not required for transmission of adhesive and traction forces but
is necessary for myosin contractility-dependent adhesion strength
and traction force and for the coupling of cell area and traction
force. Adhesion strength and traction forces depend differentially
on vinculin head (VH) and tail domains. VH enhances adhesion
strength by increasing ECM-bound integrin–talin complexes, inde-
pendently from interactions with vinculin tail ligands and contrac-
tility. A full-length, autoinhibition-deficient mutant (T12) increases
adhesion strength compared with VH, implying roles for both vin-
culin activation and the actin-binding tail. In contrast to adhesion
strength, vinculin-dependent traction forces absolutely require a
full-length and activated molecule; VH has no effect. Physical link-
age of the head and tail domains is required for maximal force
responses. Residence times of vinculin in focal adhesions, but not
T12 or VH, correlatewith applied force, supporting amechanosensi-
tivemodel for vinculin activation in which forces stabilize vinculin’s
active conformation to promote force transfer.
cell adhesion | fibronectin
Integrin-mediated adhesion to ECM provides mechanical an-chorage and signals that direct cell migration, proliferation,
and differentiation (1, 2), processes central to tissue organiza-
tion, maintenance, and repair. After ligand binding, integrins
cluster into focal adhesion (FA) complexes that transmit adhe-
sive and traction forces (3–6). FAs consist of integrins and actins
separated by a !40 nm core that includes cytoskeleton (CSK)
elements, such as vinculin and talin, and signaling molecules,
including focal adhesion kinase and paxillin (7). FAs mediate
responses to internal and external stresses by modulating force
transfer between integrins and the CSK (8–10). This function has
been likened to a “mechanical clutch” between an engine and
transmission (11).
On the basis of its structure and binding partners, vinculin
represents an attractive candidate for orchestrator of clutch
function. Vinculin consists of a globular head (VH) linked to a tail
domain (VT) by a proline-rich strap (12). VH contains talin,
!-actinin, and !- and "-catenin binding sites; actin, paxillin, and
phosphatidylinositol 4,5-bisphosphate (PIP2) binding sites are in
VT; and vasodilator-stimulated phosphoprotein (VASP), actin-
related protein 2/3 (Arp2/3), and vinexin binding sites reside in
the proline-rich region. Interactions with these partners are reg-
ulated by an autoinhibited conformation arising from high-affinity
intramolecular head–tail binding (13, 14). Activation of vinculin
can occur by simultaneous binding to talin and actin or !-catenin
and actin (15, 16). Vinculin is activated when localized to FAs
(17). Vinculin forms a complex with "1 integrin and talin (18) and
interacts with talin to enhance integrin activation (19). Therefore,
vinculin has the required molecular properties to mechanically
link integrin–ECM complexes to the actomyosin CSK in a regu-
lated manner.
In addition to studies on vinculin’s effects on muscle function
(20–22), which may or may not be related to its mechanical
functions, vinculin’s role in force transmission has largely been
inferred from studies with vinculin-deficient cells showing altered
FA assembly and aberrant migration (23, 24). For instance, VH
drives FA growth via interactions with talin, whereas VT coloc-
alizes to actin filaments (25), but whether these interactions
mediate force transfer is unknown. Vinculin-deficient cells do
exhibit reduced cortical CSK stiffness and adhesive force (26, 27),
and vinculin is a force-carrying component between FAs and the
CSK (28). Although these studies implicate vinculin in force
transmission, few such measurements have been made, and some
have provided evidence against a role of vinculin in force coupling
(29). Moreover, possible roles played by vinculin domains and
autoinhibition in mechanotransduction are largely unexplored.
In this study we used stable lines of vinculin-null cells ex-
pressing vinculin mutants and two force-measuring platforms
to directly analyze whether and how vinculin transmits force. We
found that although vinculin is not essential for transmission of
traction and adhesive forces, it regulates the coupling of cell area
and traction force and is required for myosin contractility-
dependent traction forces and adhesion strength. In addition,
we found that adhesion strength and traction forces depend to
different extents on VH and VT, but maximal force transmission
requires the talin/!-actinin–binding site on VH, physical con-
nection of VH and VT, and release of the autoinhibitory head–
tail interaction. Finally, we discovered a linear relationship
between the traction force at an FA and the residence time for
vinculin at that FA, providing evidence for a mechanosensitive
model for vinculin activation in which forces applied across vin-
culin maintain the molecule in its active conformation to increase
residence times at FAs to promote force transfer.
Results
Stable Expression of Vinculins in Vinculin-Null Cells. We expressed
WT and mutant vinculins fused to enhanced green fluorescent
protein (eGFP) in vinculin-null cells using a tetracycline-regu-
lated retroviral system (Fig. 1A and Fig. S1A). This strategy has
major advantages over routine approaches using transient ex-
pression in vinculin-expressing cells: (i) experiments are based on
the same cell population, eliminating batch-to-batch variability in
expression levels; (ii) reexpression of target vinculins in cells
lacking endogenous expression avoids confounding effects of
endogenous vinculin; and (iii) the retroviral system has high
transduction efficiencies, resulting in a polyclonal population of
engineered cells and avoiding issues associated with clonal lines.
We applied this system to two vinculin-null mouse embryonic fi-
broblast lines [MEF1 (15, 30) and MEF2 (13, 23, 31)] to rule out
artifacts of a particular line. After transduction,WT vinculin-eGFP
positive cell populations were enriched by FACS. Western blotting
confirmed expression of vinculin constructs in both lines of
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transduced vinculin-null MEFs (Fig. 1B). Expression levels for WT
were comparable to levels in vinculin+/+ cells derived from litter-
mate controls. Culturing MEF2 cells in the presence of anhy-
drotetracycline significantly repressed levels of vinculin-eGFP
expression. eGFP-vinculin localized to FAs, demonstrating proper
function for the expressed proteins (Fig. 1C).
To investigate the contributions of vinculin domains to force
transmission, cell lines expressing eGFP-vinculin mutants were
derived from MEF1 vinculin-null cells. We first examined two
mutants: (i) a molecule comprising only VH (1–851) and lacking
most of the proline-rich strap and actin-binding tail, and (ii) a full-
length variant (T12) with mutations along the head–tail interface
that reduce head–tail binding affinity 100-fold and render the
molecule in an active conformation that can readily bind talin and
actin (Fig. 1A). These mutants have been characterized for their
binding to talin and actin and recruitment to FAs (13, 25, 31).
Equivalent expression levels were observed among cell lines (Fig.
S1B). VH-expressing cells were more round than WT-expressing
cells, and the VH construct localized to large radial FAs (Fig.
S1C). T12-expressing cells displayed more and larger FAs than
WT-expressing cells (Fig. S1C). These phenotypes are consistent
with observations for transiently transfected cells (13, 25).
Vinculin Activation Increases Traction Forces and Regulates Coupling
Between Cell Area and Total Traction Force. We used microfabri-
cated postarray deflection devices (mPADs) to measure traction
forces. When seeded overnight onto fibronectin (FN)-coated
mPADs, cells spread and developed FAs (Fig. 2A and Fig. S2A).
T12-expressing cells exhibited higher spread areas compared with
other lines, and VH-expressing cells spread more than null but
not WT-expressing cells (Fig. 2B). Treatment with blebbistatin
(20 μM, 30 min), an inhibitor of myosin contractility, reduced cell
area for null,WT-, andT12-expressing cells but notVH-expressing
cells. We measured post deflections for null and vinculin-
expressing lines. Fig. 2A and Fig. S2A present images (Upper) for
FN-coated posts (red) and eGFP-vinculin (green) recruited to
FAs, with the cell outlined in yellow and force vectors (cyan,
Lower) calculated from post deflections. The magnitude of trac-
tion forces varied significantly across a single cell, with the highest
forces at the cell periphery (Fig. 2A and Fig. S2A). Fig. 2C presents
box-whisker plots for the total traction force per cell, which rep-
resents the sum of themagnitudes of the force vectors for each cell
and is commonly used for reporting traction forces (32). Traction
forces are dynamic, and the data in Fig. 2C represent a “snapshot”
of the traction forces in a cell population at equilibrium (overnight
culture). Vinculin-null cells generate considerable traction forces
(!100 nN), indicating that vinculin is not required for force
transmission at FAs. WT expression increased the total traction
force by 40% compared with vinculin-null controls. This result
demonstrates that vinculin enhances the transmission of traction
forces. In contrast, VH expression had no effect on the total
traction force compared with null cells, showing that, despite lo-
calization to FAs, VH by itself does not influence traction forces.
T12-expressing cells exhibited twofold higher total traction forces
than null cells, and the total traction force was 40% higher than
that generated by WT-expressing cells. This result shows that
disruption of vinculin head–tail inhibition enhances the trans-
mission of traction forces. Blebbistatin reduced traction forces by
30% in WT- and T12-expressing cells, but the total traction force
in null andVH-expressing cells was insensitive to blebbistatin. This
result shows that transmission of myosin contractility-dependent
traction forces at FAs requires a full-length vinculin molecule
containing both VH and VT.
We examined the relationship between cell area and traction
force because Fu et al. (32) showed tight coupling between cell
area and CSK tension, suggesting that cell area–traction force
coupling represents a robust metric to analyze force responses to
vinculin expression. Fig. 2D and Fig. S2B plot cell area and
corresponding traction force for individual cells as well as re-
gression lines. There is a strong correlation between cell area and
traction force for null, WT-, and T12-expressing cells. Vinculin-
null cells displayed a linear relationship between cell area and
traction force, indicating that vinculin is dispensable for cell
area–traction force coupling. This result supports a role for other
FA components in the transmission of traction forces, such as
direct talin–actin force transfer (33). However, WT expression
significantly enhances coupling between cell area and traction
force, as demonstrated by the twofold increase in the regression
slope compared with null cells. T12 expression results in stronger
coupling between cell area and traction force compared with
WT, showing that vinculin head–tail inhibition plays a critical
role in regulating traction forces. VH-expressing cells showed no
coupling between cell area and traction force. This result indi-
cates that VH disrupts basal cell area–traction force coupling,
demonstrating that both VH and VT are required for vinculin-
enhanced coupling between cell area and total traction force.
Although blebbistatin reduces cell area and traction force, it
Fig. 1. Vinculin-null cells engineered to express vinculin variants. (A) Vin-
culin variants fused to eGFP: WT, head domain (VH), auto-inhibition mutant
(T12), talin-binding mutant (A50I), and tail domain (VT). (B) Western blot
analysis of engineered cell lines confirmed expression of vinculin constructs.
Vinculin expression was repressed in presence of anhydrotetracycline (aTc,
100 ng/mL). (C) eGFP-vinculin localized to FAs for both MEF1- and MEF2-
derived lines. (Scale bar, 10 μm.)
Fig. 2. Vinculin regulates traction forces. (A) Cells spread on mPADs (posts
labeled red) showing localization of vinculin (eGFP) to FAs (Upper) and
spreading (yellow outline) and force vectors (cyan arrows) (Lower). (Scale
bar, 4 μm.) (B) Box-whisker plot (mean, 10th, 25th, 75th, and 90th percentile)
for cell area (>24 cells per condition). Kruskal-Wallis P < 0.0001, *P < 0.05 vs.
null, #P < 0.05 vs. WT, †P < 0.05 vs. VH; §P < 0.05 blebb vs. control. (C) Box-
whisker plot (mean, 10th, 25th, 75th, and 90th percentile) for total traction
force per cell (>24 cells). Kruskal-Wallis P < 0.0001, *P < 0.022 vs. null, #P <
0.01 vs. WT, †P < 0.01 vs. VH;
§P < 0.05 blebb vs. control. (D) Relationship
between traction force and cell area (>24 cells per condition) showing linear
regression fits.




does not disrupt the relationship between cell area and traction
force (Fig. S2C).
How Vinculin Head and Tail Domains and Autoinhibition Contribute
to Adhesion Strength. We measured the steady-state (16 h after
seeding) adhesion strength of cells expressing WT to FN using
a spinning disk device. Whereas traction force measurements
report on forces applied to the substrate arising from actomyosin
contractility or actin polymerization, the adhesion strength assay
measures the amount of force required to detach the cell from
the ECM. The spinning disk exposes cells to a hydrodynamic
shear force that increases linearly with radial position from the
disk center and provides sensitive measurements of adhesion
strength (Fig. S3A).
WT-expressing cells were cultured overnight on FN-coated
micropatterned islands to eliminate differences in adhesive area
and cell shape. This is an important consideration because ex-
pression of these constructs produces changes in cell area, a pa-
rameter that also regulates adhesion strength (6). Cells remained
constrained to the micropatterned area as single cells. Expres-
sion of WT in vinculin-null MEF1 and MEF2 cells increased
adhesion strength by 25% and 27%, respectively, over null
controls (Fig. 3A). To test whether the increases in adhesion
strength were caused by vinculin expression, we cultured WT-
MEF2 cells in anhydrotetracycline to suppress expression. Under
these conditions, the adhesion strength returned to the levels of
null cells (Fig. 3A). Studies with blocking antibody demon-
strated that adhesion to FN was mediated by !1 integrin (Fig.
S3B). These results demonstrate that vinculin directly modu-
lates adhesion strength and that this system provides direct
measurements of !1 integrin–FN-mediated adhesion strength.
We next examined the adhesion strength of vinculin-null cells
expressing vinculin mutants. VH expression increased adhesion
strength by 25% compared with null controls (Fig. 3B), in-
dicating that recruitment of VH to adhesive complexes increases
adhesion strength independently from VT. VH increased adhe-
sion strength to equivalent levels as WT. T12 expression in-
creased adhesion strength by 50% over null cells (Fig. 3B),
doubling the increase in adhesion strength by either WT or VH.
This result indicates that regulation of vinculin autoinhibition
plays an important role in the generation of adhesion strength
and that the active vinculin conformation presenting head and
tail domains results in maximal adhesion strength.
We hypothesized that binding of VH to talin or "-actinin was
essential for vinculin-dependent increases in adhesion strength.
We examined the effect of expressing a full-length, talin-/
"-actinin-binding deficient mutant (A50I). No differences in
adhesion strength were observed between A50I-expressing and
null cells (Fig. S3C), indicating that vinculin binding to one or
both of these ligands is essential for vinculin-mediated adhesion
strength.
Physical Linkage Between Vinculin Head and Tail Domains Is Required
for Maximal Adhesion Strength. We postulated that the increased
adhesion strength for T12-expressing cells relative to VH-expressing
cells arises from differences in load transfer from the integrin–
ECM complexes to the actin CSK via vinculin. We tested this
model by independently expressing VH and VT in the same cell.
We transiently transfected MEF1 cells with plasmids encoding
for VH, T12, or VT or cotransfected plasmids for VH and VT.
Transfected cells were enriched by flow cytometry sorting and
seeded on FN islands. Image analysis demonstrated that vinculin
mutants localized to FN patterns in a similar way as those in the
stable lines (Fig. S4A). Cotransfected VH and VT localized to the
FN island, but there was no strong colocalization because these
two domains are not physically linked (Fig. S4B). Coexpression
of separate VH and VT did not alter adhesion strength compared
with expression of either domain, and adhesion strength was
25% lower than that for T12 expression (Fig. S4C). Expression
of VT resulted in similar levels of adhesion strength as VH. This
result was unexpected because VT does not bind to the integrin–
talin complex or "-actinin-rich lamellopodia protrusions (14, 34).
A likely explanation for the effects of VT is that this domain
enhances adhesion strength by cross-linking actin to increase
cortical CSK stiffness and load sharing among integrin bonds.
Indeed, there is evidence that VT enhances actin cross-linking
and cortical CSK stiffness (29). These data show that the physical
linkage between vinculin head and tail domains is required for
maximal adhesion strength, indicating that force transfer from
the adhesive clusters to the actin CSK via vinculin contributes to
adhesion strength.
Vinculin Head–Tail Autoinhibition Regulates the Number of Integrin–
FN Complexes and Recruitment of Vinculin and Talin. Because ad-
hesion strength is regulated by the number/distribution of
integrin–ECM complexes, FA assembly, and CSK interactions
(6), we analyzed integrin binding and FA assembly to gain
insights into possible reasons for the differences in adhesion
strength. We first examined the effects of vinculin mutants on the
levels and distribution of integrin–FN complexes using a cross-
linking and detergent extraction method to selectively retain
integrin–FN complexes. Fig. 4A presents images of single cells
adhering to FN islands and immunostained for !1 integrin, and
Fig. 4 B and C plot the fraction of the adhesive area occupied by
integrin–FN complexes and the intensity of integrin staining over
the micropatterned area. Vinculin-null cells assembled integrin
!1–FN complexes along the periphery of the adhesive area, with
minimal staining in the interior. WT expression did not change
the spatial distribution or area occupied by integrin–FN com-
plexes but resulted in a 15% increase in intensity. In contrast, VH
expression resulted in a fourfold increase in the area occupied by
integrin–FN complexes, mostly localized to the periphery of
the adhesive area, and a 40% increase in intensity compared
with the null control. T12 expression yielded a fourfold increase
in the area of integrin–FN complexes and a 50% increase in
intensity compared with the null control. These results demon-
strate that WT has a modest effect in regulating the number and
spatial distribution of integrin–FN complexes and that presen-
tation of VH, either alone or in a mutant with disrupted head–tail
binding, significantly increases the number and spatial distribu-
tion of integrin–FN complexes. Furthermore, the lack of differ-
ences in integrin–FN complexes between VH and T12 indicates
that VT does not contribute significantly to the assembly or
stability of integrin–FN complexes. These results indicate that
vinculin head–tail inhibition to control exposure of VH plays a
major regulatory role in controlling the number and spatial
distribution of ECM–integrin complexes.
We examined the role of vinculin autoinhibition on FA as-
sembly by measuring recruitment of talin and the vinculin con-
structs to FAs. For all cells, talin and vinculin staining was
Fig. 3. Vinculin head and tail domains have distinct contributions to ad-
hesion strength. (A) Expression of WT in vinculin-null cells increased adhe-
sion strength over controls (*P < 0.03 vs. null, #P < 0.05 vs. null, +aTc). aTc-
induced suppression of WT expression returned adhesion strength to null
levels. (B) VH expression increased adhesion strength by 25%, whereas T12
increased adhesion strength by 50% compared with null controls. ANOVA
P < 0.0001, *P < 0.05 vs. null, #P < 0.05 vs. WT, and †P < 0.05 vs. VH.











restricted to the circumference of the micropatterned area (Fig.
4 D and E), consistent with the staining patterns for integrin–
FN complexes. In addition to circumferential staining, T12- and
VH-expressing cells exhibited small vinculin and talin clusters in
the interior of the adhesive area. Analysis of the adhesive area
occupied by talin showed that WT expression had modest effects
compared with null cells (Fig. 4D). In contrast, expression of VH
or T12 significantly enhanced the area occupied by talin and
vinculin compared with WT and null cells (Fig. 4 D and E).
These results demonstrate that WT has a modest effect in regu-
lating FA assembly and that presentation of VH, either alone or in
a mutant with disrupted head–tail binding, significantly increases
the area occupied by FAs. Furthermore, the lack of differences
between VH and T12 indicates that VT does not contribute sig-
nificantly to FA assembly. These results suggest that vinculin
head–tail autoinhibition plays an important function in regulating
FA assembly by controlling the exposure of VH, resulting in an
increase of both talin and vinculin recruitment to FAs.
Because there were no major differences in integrin–FN
complexes and FA assembly between null and WT-expressing
cells, we attribute the increased adhesion strength for WT to
enhanced force distribution at the adhesive interface due to WT-
mediated local cortical CSK stiffening and load transfer to the
CSK. In contrast, the increased adhesion strength for VH com-
pared with the null control likely results from the higher number
of integrin–FN complexes and enhanced FA assembly. Com-
pared with VH, T12 further increases adhesion strength without
altering the levels of integrin–FN complexes or talin/vinculin
recruitment to FAs. We attribute this additional increase in
adhesion strength for T12 to VT binding to the actin CSK to
enhance load transfer.
Effect of Contractility on Adhesion Strength Is Mediated by Vinculin
Autoinhibition. The increase in adhesion strength for T12 com-
pared with VH suggests that force transfer from FAs to the CSK
via VT is required for maximal adhesion strength. Because
myosin contractility is critical to force generation (4, 5, 26, 35),
we analyzed the contributions of myosin contractility to adhesion
strength in the context of vinculin expression. Cells were seeded
overnight on FN islands and exposed to blebbistatin (20 μM) for
30 min before measuring adhesion strength. Blebbistatin had no
effect on adhesion strength for vinculin-null cells (Fig. 5). In
contrast, blebbistatin reduced adhesion strength by 30% in WT-
expressing cells. This result is consistent with our work demon-
strating that vinculin is required for contractility-dependent ad-
hesion strength (26). In this earlier study, we showed that the
reductions in adhesion strength in response to contractility in-
hibition were associated with loss of vinculin and talin from FAs,
in agreement with contractility-dependent FA assembly (36).
We hypothesized that the adhesion strength of VH-expressing
cells would be insensitive to blebbistatin treatment because
this mutant cannot interact with the actin CSK because it lacks
binding sites for Arp2/3, paxillin, and actin. Indeed, blebbistatin
treatment had no effect on the adhesion strength of VH-expressing
cells (Fig. 5), indicating that the potential VASP-binding site in
VH is not capable of mediating interaction with actomyosin.
Moreover, integrin–FN complex assembly and recruitment of
talin and VH to FAs were insensitive to blebbistatin (Fig. S5).
This response differs from the effects of blebbistatin on WT
vinculin-expressing cells and indicates that contractility-mediated
changes in adhesion strength and FA assembly require a full-
length, actin-binding vinculin molecule. We next analyzed the
adhesion strength of T12-expressing cells with blebbistatin
treatment. Surprisingly, blebbistatin enhanced adhesion strength
for T12-expressing cells by 25% compared with untreated con-
trols, in stark contrast to the effects of blebbistatin on WT-
expressing cells (Fig. 5). Blebbistatin did not alter integrin–FN
complex formation or vinculin and talin recruitment to FAs for
T12-expressing cells (Fig. S5), so this enhancement in adhesion
strength cannot be attributed to changes in integrin–FN bonds or
FA assembly. These results indicate that vinculin autoinhibitory
regulation is critical to contractility-mediated changes in adhe-
sion strength, demonstrating a role for activated vinculin in force
transfer. Furthermore, these data suggest that T12 promotes
adhesion strength better than VH through the ability of VT to
interact with the actin CSK and by the inability of T12 to sub-
stantially regain the autoinhibited conformation.
Vinculin Residence Times in FAs Correlate with Applied Force and
Require Autoinhibitory Head–Tail Interactions. The striking differ-
ence in the effects of blebbistatin on the adhesion strength of WT-
vs. T12-expressing cells implicates head–tail interactions in the
regulation of contractility-mediated enhancements in adhesive
force. We hypothesized that forces applied across vinculin main-
tain the molecule in its active conformation and counterbalance
the high-affinity head–tail inhibition. For WT, inhibition of con-
tractility unloads the vinculin molecule and promotes rebinding
between VH and VT, resulting in vinculin inactivation and FA
disassembly. For the T12 mutant, the head–tail interaction is re-
duced 100-fold, resulting in a molecule that, although not consti-
tutively open (13), is much easier to open and harder to reclose.
This mutant retains the WT affinity of VH for talin and VT for
actin. Because of the !100-fold reduced head–tail autoinhibition,
Fig. 4. Vinculin head–tail interaction regulates integrin–FN complexes and
FA assembly. (A) Immunostaining for β1 integrin for cells adhering to FN
micropatterned islands. Staining is shown as grayscale on white background
to facilitate visualization. (Scale bar, 5 μm.) (B) Fraction of adhesive area
occupied by integrin–FN complexes. ANOVA P < 0.0001, *P < 0.05 vs. null,
#P < 0.05 vs. WT. (C) Intensity of integrin staining over micropatterned area.
ANOVA P < 0.0001, *P < 0.05 vs. null, #P < 0.05 vs. WT (>60 cells per con-
dition). (D) (Upper) Immunostaining for talin for cells adhering to FN islands.
(Scale bar, 5 μm.) (Lower) Area of talin staining normalized to total adhesive
area. ANOVA P < 0.0001, *P < 0.05 vs. null, #P < 0.05 vs. WT. (E) (Upper)
Immunostaining for vinculin for cells on FN islands (Scale bar, 5 μm.) (Lower)
Area of vinculin staining normalized to total adhesive area. ANOVA P <
0.0001, *P < 0.05 vs. null, #P < 0.05 vs. WT (>20 cells per condition).
Fig. 5. Effect of contractility on adhesion strength is mediated by vinculin
autoinhibition. *P < 0.05 vs. control.




the T12 mutant would not reclose significantly when unloaded,
and it would therefore transmit adhesive forces even during
blebbistatin-mediated inhibition of contractility.
To test this model, we examined the relationship between
vinculin residence times at FAs and applied force by performing
fluorescence recovery after photobleaching (FRAP) experiments
on cells on mPADs. We examined recovery times after photo-
bleaching for eGFP-vinculin–containing FAs associated with posts
with known deflections. In this fashion we could monitor vinculin
dynamics at FAs under force. FRAP movies for WT-vinculin FAs
under different traction forces are provided (Movies S1–S4),
and Fig. S6A presents images of WT-containing FAs on
mPADs before and after photobleaching. Fig. 6A displays FRAP
recovery curves for WT in FAs transmitting different forces. The
applied force remained constant over the 3-min FRAP experi-
ment (Fig. S6 B and C). The half-life recovery time (t1/2) vs. trac-
tion force for individual FAs in WT-expressing cells is plotted in
Fig. 6B. Strikingly, we observed a linear relationship between
applied force and recovery time for WT. A simple explanation
for the strong correlation between vinculin residence time in FAs
and applied force is that tension applied across the vinculin
molecule maintains vinculin in the active conformation to
increase its residence time in FAs. Blebbistatin (20 μM) elim-
inates the linear relationship between recovery time and force
(Fig. 6C), consistent with our model. We also examined the re-
covery time vs. force relationship for cells expressing T12 and VH
(Fig. 6D). Both VH and T12 exhibited twofold slower recovery
times compared with WT, consistent with previous data (25, 31).
However, in stark contrast to WT, recovery times for T12 and
VH did not correlate with applied forces at FAs. These results
demonstrate that the vinculin head–tail interaction is critical to
the coupling of vinculin residence time at FAs and applied force.
Importantly, the lack of correlation of recovery times with force
for VH demonstrates that VT is required for FA residence time–
force coupling. Additionally, this result rules out the explanation
that this phenomenon arises from force-mediated exposure of
vinculin binding sites on talin (37). These findings support a
mechanosensitive model for vinculin activation in which forces
applied across vinculin maintain the molecule in its active con-
formation to increase residence times at FAs to transfer force.
Discussion
How vinculin and its interactions with binding partners transmit
force remains poorly understood. Here we clearly demonstrate
that vinculin regulates both traction forces and adhesion strength
to ECM and dissect the contributions of different vinculin
domains to these force outputs. The vinculin-dependent en-
hancements in traction force and adhesion strength quantify
vinculin’s contributions in force transmission and provide a me-
chanical basis to explain the effects of vinculin deletion on im-
paired cell spreading, migration, and muscle contraction. We
show that vinculin regulates the coupling between cell area and
traction force. The coupling between cell area and traction force
reflects an integrated feedback response regulating cell shape
and has been implicated in rigidity sensing (32). Our finding that
full-length vinculin enhances cell area–traction force coupling
but VH completely disrupts this coupling indicates that vinculin is
a key regulator of these mechanical responses and identifies
a unique function for vinculin in mechanosensing.
Although VH drives FA growth and VT localizes to actin fil-
aments (25), we demonstrate distinct contributions to force
transmission for each domain. Vinculin transmits force by in-
creasing ECM-bound integrin–talin complexes via VH, whereas
VT transfers force to the actin CSK (Fig. S7). These mechanical
functions require the talin/α-actinin-binding site on VH. We note
that vinculin-dependent changes in force transmission do not
scale proportionally with changes in integrin-FN binding and FA
assembly owing to biomechanical considerations, including spa-
tial location of integrin–FN complexes and cortical CSK stiffness
that result in nonlinear bond loading (6, 38). We also discovered
an important role for vinculin’s head–tail autoinhibitory in-
teraction in regulating traction forces, adhesion strength, and the
coupling between cell area and traction force. Finally, maximal
adhesion strength requires VH and VT to be physically coupled,
indicating that force transfer occurs through the vinculin mole-
cule rather than independent contributions from each domain.
Although myosin contractility is critical to traction forces and
adhesion strength, the contribution of vinculin to myosin con-
tractility-dependent adhesive forces is unknown. We demonstrate
that a full-length vinculin molecule containing both VH and VT is
required for myosin contractility-dependent effects on traction
force and adhesion strength, suggesting that force transfer occurs
through the vinculin molecule. For WT-expressing cells, bleb-
bistatin treatment reduced adhesion strength to vinculin-null
levels, whereas blebbistatin did not alter adhesion strength in
vinculin-null cells. Surprisingly, blebbistatin enhanced adhesion
strength for T12-expressing cells, indicating that head–tail auto-
inhibition regulates the vinculin-dependent effects of myosin
contractility on adhesion strength. One explanation for the
blebbistatin-dependent increases in adhesion strength for T12 is
that inhibition of contractility reduces the internal force applied
to FAs, thereby increasing the force that can be supported by the
external ECM–integrin linkage at FAs (39). The requirement for
vinculin in myosin contractility-dependent adhesive forces estab-
lishes a unique function for vinculin in mechanotransduction
beyond regulation of FA assembly (25, 28).
By applying FRAP to an FA under force, we discovered that
vinculin residence time at an FA correlates linearly with the
force applied to that FA. Vinculin residence time–force coupling
requires a full-length molecule, head–tail autoinhibition, and
myosin contractility. These results directly relate vinculin dy-
namics to force and complement studies showing that contrac-
tility influences FA dynamics (40). Our data support a model for
vinculin stabilization in which forces applied across vinculin
maintain the molecule in its active conformation to increase
residence times at FAs to promote force transfer (Fig. S7). Di-
rect measurements of the forces experienced by vinculin in the
context of adhesion strength and traction forces are still needed
to fully validate this model. Vinculin’s binding partners and
Fig. 6. Vinculin residence times in FAs correlate with applied force and
require head–tail interactions. FRAP was performed on FAs on mPAD posts
with known applied forces. (A) FRAP recovery curves for WT localized to FAs
transmitting different forces. (B) Correlation between recovery time (t1/2)
and applied force (>15 cells analyzed per condition) for WT. Linear re-
gression: t1/2 = 1.56 ! force + 20.0, P < 0.0001. (C) Blebbistatin treatment
(20 μM) eliminates linear relationship between recovery time and force (no
linear dependence, P = 0.75). (D) No correlation between t1/2 and applied
force was observed for T12 (P = 0.45) or VH (P = 0.35). Different y axis scales
were used between WT and VH, T12 for ease of visualization.











phosphorylation sites could provide indirect mechanisms for its
force-regulated recruitment and activity.
Our findings support a mechanosensitive model for vinculin
activation. Structural and biochemical data support a role for
talin and actin binding in vinculin activation (13, 15, 41, 42). Given
the requirements for the talin-binding site on VH and the actin-
binding VT for force transmission, it is likely that coordinated
activation by talin and actin provides a major mechanism driving
vinculin activation and that force transmission across vinculin
stabilizes its active conformation. This mechanism provides an
explanation for the observation that vinculin recruitment to FAs is
separable from mechanical loading (28). Force-dependent vincu-
lin activation identifies another mechanism that complements
mechanosensitive pathways at FAs, such as integrin–FN binding
(43, 44) and talin stretching to expose binding sites (37).
The improved understanding of vinculin’s contributions to
force transmission provided by this work has several implica-
tions. First, vinculin regulates the transmission of adhesive forces
by modulating ECM–integrin complexes via VH and transmitting
forces from these complexes to the actin CSK via VT. Second,
vinculin regulates cell area–traction force coupling and myosin
contractility-dependent adhesion strength and traction forces. As
such, vinculin likely provides “fine tuning” control required for
coordinated processes like migration and contraction. Finally,
force-based regulation of vinculin activation provides a mecha-
nism to generate local mechanosensitive responses at FAs such
as force-dependent FA growth (8, 36). Mechano-regulation of
vinculin residence times at FAs represents a pathway for co-
ordinated assembly of FAs at the leading edge and disassembly
of FAs at the rear of the cell. In fact, experiments with a force
sensor revealed high forces across vinculin at the leading edge
and low forces at the trailing edge (28), consistent with our
model. Collectively, this work provides these important insights
into how vinculin’s structure and binding partners interact with
contractility to regulate force transmission.
Methods
Vinculin lines were generated by retroviral transduction of vinculin-null cells
and FACS selection. Cell adhesion strength and traction forces weremeasured
with a spinning disk device and mPADs, respectively. FRAP was performed on
cells on mPADs. Detailed methods are presented in SI Methods.
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a b s t r a c t
Integrin-mediated cell adhesion plays a central role in cell behavior on biomaterial surfaces and influ-
ences various cell functions. Photoactivatable RGD adhesive peptides were used to investigate the effect
of the density and time point of bioadhesive ligand presentation on cell adhesion, proliferation and dif-
ferentiation. PEGylated self-assembled monolayers were functionalized with RGD and caged RGD ligands
and seeded with C2C12 myoblasts. The cultures were irradiated at various time points between 1 and
48 h after cell seeding in order to increase RGD surface concentration at defined time points. Attachment,
spreading and myogenic differentiation of C2C12 myoblasts strongly varied with the density of RGD at
the surface. Proliferation and myogenesis were further regulated by the time point at which RGD was
presented to the cell, reaching highest levels when RGD exposure occurred !6 h after cell seeding. These
results provide fundamental insights in cell–biomaterial interactions of C2C12 myoblasts in terms of
temporal integrin-mediated cell responses.
! 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
1. Introduction
A promising strategy for successful integration of implanted
substrates in living organisms is the engineering of application-spe-
cific biointerfaces that mimic characteristics of the extracellular
matrix (ECM) [1–5]. Such substrates should allow on-demand reg-
ulation of the properties of the cellular microenvironment over
time and space and, consequently, of the cell–biomaterial interac-
tions and concomitant cell responses. Although the relevance of
the temporal presentation of signaling factors at the cellular micro-
environment has now been recognized by the biomaterials commu-
nity, experimental studies in this context are still scarce [6,7]. At
first sight, this fact appears surprising, since attempts to control
the pharmacokinetic profile of soluble factors have a long history
in therapeutics, and gradients of chemotactic factors have been
widely applied for studies of directed migration. However, the com-
plexity and interplay of biochemical and physical signaling factors
involved in cell–ECM interactions (i.e. different matrix-anchored li-
gands or the mechanical properties and morphology of the matrix)
involved in cell–ECM regulation, as well as the different spatial and
temporal scales at which they occur, cannot easily be addressed
with encapsulation strategies developed for soluble factors and re-
quire design and development of new and specific materials.
The presence of cell-adhesive ligands at the biomaterial surface
is crucial for the regulation of cell–material communication and
therefore cellular function, well beyond initial cell attachment
and survival [8–13]. Cell attachment is mainly mediated by inte-
grin receptors at the cell membrane and their interactions with
components of the ECM [14]. The study of this interaction and
the related signaling cascades can be performed using biointerfac-
es containing synthetic peptides mimicking the active domains of
the ECM matrix components [15–17]. RGD-modified substrates
have been used for this purpose and the role of a static RGD con-
centration in adhesion [18,19], migration [20], proliferation [21]
and differentiation [22,23] processes has been demonstrated.
Although relevant information has been gained from these studies
on ‘‘static’’ surfaces, more sophisticated synthetic biointerfaces are
required for mimicking the ‘‘dynamic’’ presence of adhesive factors
in the ECM and its role in guiding cellular function.
Photoremovable protecting groups (‘‘cages’’) are light-triggers
that allow accurate spatiotemporal control and in situ regulation
of molecular factors involved in signalling pathways. The ‘‘cage’’
can be attached to the active site of a biomolecule in order to
inhibit its activity (latent state). Function is restored at a later
time point by light exposure and photocleavage of the cage.
Caged RGD derivatives (Scheme 1A) were developed by our
groups for the controlled activation and deactivation of inte-
grin-associated regulatory signals and concomitant modulation
of cell response [24–28]. Caged cyclo[RGD(DMNPB)fK] peptide,
where the 3-(4,5-dimethoxy-2-nitrophenyl)-2-butyl (DMNPB)
chromophore is attached to the carboxylic side group of the
1742-7061/$ - see front matter ! 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
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aspartic acid to inhibit biological activity, has allowed phototrig-
gering of cell attachment [24,25] and migration [29] events over
surfaces with light-dose-controlled RGD density. Light-triggered
cell detachment from cultured cells was also realized using
RGD-modified surface linkers with an intercalated photocleav-
able group that allowed release of the surface-anchored RGD
functionality by light exposure [30]. A similar strategy has been
extended to 3-D cell cultures, and joint influence of the decrease
in the concentration of bioadhesive ligand and in the matrix
stiffness in chondrogenic differentiation while photodegrading
the hydrogel matrix was demonstrated [6].
The latent functionality of caged RGD can be activated at differ-
ent time points using sequential illumination steps of controlled
dose. This represents a unique strategy for the dynamic regulation
of the RGD presentation at the surface and the generation of tun-
able bioadhesive states with temporal and spatial resolution
(Scheme 1B). In this work we apply this strategy to study, for the
first time, the influence of the temporal presentation and concen-
tration of RGD ligands on the proliferation and differentiation of
C2C12 myoblasts.
2. Materials and methods
2.1. Reagents and antibodies
All reagents and chemicals were used as received unless stated
otherwise. Cell culture reagents, fetal bovine serum (FBS), goat ser-
um (GS), insulin-transferrin-selenium-X (ITS) and Dulbecco’s phos-
phate-buffered saline (DPBS) were obtained from Invitrogen
(Carlsbad, CA). Cyclic RGD peptide (cyclo[RGDfK]) was purchased
from Peptides International Inc. (Louisville, KY), GRDGSPC from
Aapptec (Louisville, KY) and caged cyclic RGD peptide (cy-
clo[RGD(DMNPB)fK]) was synthesized and characterized as previ-
ously reported [24,25]. Tri(ethylene glycol)-terminated thiols
(HS-(CH2)11-(OCH2CH2)3-OH; EG3 and HS-(CH2)11-(OCH2CH2)6-
OCH2COOH; EG6) for the preparation of self-assembled monolayers
were purchased from ProChimia Surfaces (Sopot, Poland). Peptide
tethering reagents, N-(3-dimethylaminopropyl)-N0-ethylcarbodi-
imide hydrochloride (EDC) and N-hydroxysuccinimide (NHS), as
well as additives for cytoskeleton buffer, 1,4-piperazinediethane-
sulfonic acid (PIPES) and phenylmethanesulfonyl fluoride (PMSF),
were obtained from Sigma-Aldrich (St Louis, MO). Triton X-100
was acquired from EMC Chemicals (Elkhorn, WI). Monoclonal MF
20 IgG2b anti-mouse sarcomeric myosin antibody was purchased
from the Developmental Studies Hybridoma Bank (Iowa City, IA).
Monoclonal anti-vinculin antibody, bovine serum albumin (BSA)
and the protease inhibitors leupeptin, aprotinin and pepstatin A
were obtained from Sigma-Aldrich (St Louis, MO). Alexa Fluor
555-conjugated phalloidin, 40,6-diamidino-2-phenylindole dihy-
drochloride (DAPI), Alexa Fluor 488-conjugated goat anti-mouse
IgG antibody and a Click-it! Alexa Fluor 488-conjugated EdU Imag-
ing Kit (including Hoechst 33342 dye) for evaluation of cell prolif-
eration were acquired from Invitrogen (Carlsbad, CA). Fluoromount
G was obtained from Electron Microscopy Sciences (Hatfield, PA).
2.2. Model biomaterial surfaces/RGD functionalized self-assembled
monolayers
Self-assembled monolayers (SAMs) of alkanethiols on gold were
used as well-defined, ordered surfaces presenting anchoring
groups within a non-fouling background. Gold-coated substrates
were prepared by successive deposition of titanium (100 Å) and
gold (200 Å) films on glass coverslips using an electron beam evap-
orator (Thermionics Laboratories, Hayward, CA, 2 ! 10"6 torr) at a
deposition rate of 2 Å s"1. Mixed SAMs were prepared by immers-
ing the gold-coated coverslips in a 1.2 mM mixed solution of EG6/
EG3 = 1/49 in ethanol overnight. The solution was aspirated, and
following rinsing with ethanol and ultrapure water, the substrates
were equilibrated in ultrapure water for 1 h. Peptides were teth-
ered to the carboxylic acid groups of the SAMs using standard pep-
tide chemistry [31]. For this purpose, substrates were immersed in
0.2 M EDC and 0.1 M NHS in 0.1 M 2-(N-morpho)-ethanesulfonic
acid. After 20 min, substrates were rinsed with ultrapure water
and then incubated in an 0.12 mM peptide solution: either cy-
clo[RGDfK], or cyclo[RGD(DMNPB)fK], or GRDGSPC, or a mixed
solution of cyclo[RGDfK]/cyclo[RGD(DMNPB)fK] in 1:5 molar ratio.
Substrates with different surface densities of cyclo[RGDfK] were
prepared by incubation in 1, 5, 20, 50, 72 lg ml"1 (= 1.7, 8.3, 33,
83, 120 lM) solutions of cyclo[RGDfK]. After coupling for 1 h the
substrates were rinsed with ultrapure water.
For cell-adhesion experiments, surfaces were immersed in 2 ml
Dulbecco’s Modified Eagle’s Medium (DMEM) in a 35 mm culture
dish, and irradiated using an X-Cite 120 fluorescence illumination
system equipped with a bandpass filter (center wavelength
Scheme 1. (A) Chemical structure of cyclo[RGD(DMNPB)fK] before and after irradiation, including photolytic byproducts. (B) SAM functionalized with a mixture of caged RGD
and RGD allows photomodulation of RGD surface density by light exposure at defined time points.




355 nm, full width half maximum 53 nm). Irradiation conditions
were 3 min and 3.5 mW cm!2. Finally, to reduce non-specific pro-
tein adsorption, surfaces were blocked in 1.0 wt.% bovine serum
albumin (BSA) in DPBS for 30 min at room temperature, and rinsed
with DPBS prior to immediate cell seeding [32].
2.3. Cell culture
Murine C2C12 myoblasts (ATCC, CRL-1772) were used for all
experiments to study the effects of surface modifications on cell
adhesion, proliferation and differentiation. Cells were maintained
in DMEM supplemented with 20% fetal bovine serum and 1% pen-
icillin–streptomycin at 37 !C in a humidified atmosphere and 5%
CO2. Cells were subcultured prior to reaching confluence (approx-
imately every 1–2 days). Cells were seeded at a density of
5,000 cells cm!2 on peptide-presenting SAMs for all experiments.
For myogenic differentiation experiments, C2C12 cells were seeded
in DMEM supplemented with 1% penicillin–streptomycin and 1%
ITS and for cell-adhesion assays in DMEM supplemented with
10% fetal bovine serum and 1% penicillin–streptomycin.
2.4. Myogenic differentiation assay
C2C12 cells were seeded on peptide-modified SAMs and cul-
tured for 3 days at 37 !C under differentiation conditions followed
by immunostaining for sarcomeric myosin. For experiments inves-
tigating a temporal threshold of the RGD surface density on myo-
genic differentiation, surfaces modified with both peptides
cyclo[RGDfK] and cyclo[RGD(DMNPB)fK] (tethering ratio: 1/5)
were irradiated for 3 min at 1, 6, 24 or 48 h after cell seeding (X-
Cite 120 fluorescence illumination system, bandpass filter with
center wavelength: 355 nm, full width half maximum: 53 nm,
3.5 mW cm!2) to uncage the caged peptide at the prescribed time
point. Cultures were fixed in 70% ethanol/37% formaldehyde/gla-
cial acetic acid (20:2:1) and then blocked in 5% goat serum in DPBS
for 1 h. Substrates were successively incubated in MF 20 anti-
mouse sarcomeric myosin antibody (1:500 in 5% goat serum),
and Alexa Fluor 488-conjugated goat anti-mouse IgG antibody
(1:200 in 5% goat serum) for 1 h each. Cell nuclei were counter-
stained with DAPI (1 lg ml!1 in 5% goat serum) for 10 min, and
samples were mounted on slides (Fluoromount G, Electron Micros-
copy Sciences, Hatfield, PA). Cultures were scored for differentia-
tion as the percentage of cells stained positive for sarcomeric
myosin determined as the number of sarcomeric myosin-positive
cells divided by the total number of nuclei, and the percentage of
multinucleated/fused cells determined as the number of sarco-
meric myosin-positive cells having two or more nuclei divided
by the total number of nuclei, using fluorescence microscopy and
an in-house image-analysis routine.
2.5. Cell adhesion and immunofluorescence staining for focal adhesion
components
C2C12 cells were seeded on SAMs modified with either cy-
clo[RGDfK], or cyclo[RGD(DMNPB)fK], or GRDGSPC (non-irradiated
and irradiated) and cultured for 2.5 h at 37 !C in DMEM supple-
mented with 1% penicillin–streptomycin and 5% fetal bovine ser-
um followed by immunostaining for F-actin and the focal
adhesion component vinculin. Cultures were gently washed with
ice-cold DPBS, followed by permeabilization in ice-cold cytoskele-
ton buffer (10 mM PIPES, 50 mM NaCl, 150 mM sucrose, 3 mM
MgCl2"6H2O, pH 6.8) and twice in ice-cold supplemented cytoskel-
eton buffer (10 mM PIPES, 50 mM NaCl, 150 mM sucrose, 3 mM
MgCl2"6H2O, 0.5% Triton X-100, 1 lg ml!1 leupeptin, 1 lg ml!1
aprotinin, 1 lg ml!1 pepstatin, 1 mM PMSF, pH 6.8) for 1 min each.
Cells were then fixed in 3.7% formaldehyde in DPBS for 10 min.
Surfaces were blocked in 5% goat serum in DPBS for 1 h, and
sequentially incubated in anti-vinculin antibody (1:200 in 5% goat
serum) for 1 h and combined Alexa Fluor 488-conjugated goat
anti-mouse IgG antibody (1:200 in 5% goat serum) and Alexa Fluor
555-conjugated phalloidin (1:50 in 5% goat serum) for 1 h. Cell nu-
clei were counterstained with DAPI (1 mg ml!1 in 5% goat serum)
for 10 min, and samples were mounted on slides (Fluoromount
G). Samples were scored for the total number of cells per given area
using fluorescence microscopy.
2.6. Proliferation assay and EdU incorporation
C2C12 cells were seeded on peptide-modified SAMs (tethering
ratio cyclo[RGDfK]/cyclo[RGD(DMNPB)fK] = 1:5) and cultured for
3 days at 37 !C under differentiation conditions. Surfaces were irra-
diated for 3 min at 1, 6, 24 or 48 h after cell seeding to uncage the
caged peptide at the prescribed time point. EdU (10 lM final con-
centration) was added to cultures 54 h post cell-seeding and incu-
bated for 14 h at 37 !C. Cultures were gently washed with DPBS
and fixed in 3.7% formaldehyde in DPBS for 15 min followed by
permeabilization in 0.5% Triton X-100 for 20 min and washing with
3% BSA. Proliferated cells were stained with a Click-it" Alexa Fluor
488-conjugated EdU Imaging Kit (Invitrogen, Carlsbad, CA). Sur-
faces were incubated with Alexa Fluor 488-conjugated azide in
Click-it" reaction buffer supplemented with CuSO4 and reaction
buffer additive for 30 min. After washing with 3% bovine serum
albumin and DPBS cell nuclei were counterstained with Hoechst
33342 (5 lg ml!1 in DPBS) for 30 min. After washing, samples
were mounted on slides (Fluoromount G). Cultures were scored
by fluorescence microscopy for proliferation as the percentage of
cells positive for EdU incorporation relative to the total number
of cell nuclei using an in-house image-analysis routine.
2.7. Statistical analysis
Data represent characteristic results from a particular experi-
mental run with at least three independent runs performed. Data
are represented as mean ± standard error. Results were analyzed
by Wilcoxon test using JMP Pro 9. A 95% confidence level was con-
sidered significant.
3. Results
SAMs of mixed alkanethiols on gold with oligo(ethylene glycol)
groups (EG6-COOH and EG3) were used as model non-fouling sur-
faces presenting moieties for peptide tethering [31]. RGD peptides
(cyclic and caged RGD) were tethered to the COOH groups of the
SAM using EDC/NHS coupling chemistry [31]. The density of
anchoring groups is an important parameter to optimize in order
to balance between sufficient ligand densities for cells to attach
while preventing non-specific protein adsorption and cell adhe-
sion. Based on our previous results [31], a solution ratio of
EG6-COOH/EG3 of 0.02 generates SAMs with functional surface
densities of single adhesive ligands, while maintaining low
background levels of non-specific adsorption. This ratio was also
used in the present experiments.
3.1. Density of tethered RGD regulates myogenic differentiation
RGD-functionalized SAMs with different surface densities of the
cell-adhesive ligand were prepared following the strategy of Petrie
et al. [31] who controlled the tethered peptide densities by varying
the coating concentrations of a linear RGD peptide [31] SAMs were
incubated with solutions of cyclo[RGDfK] of different concentra-
tions (0, 1, 5, 20, 50 and 72 lg ml!1) to generate different tethered




densities. Pilot experiments demonstrated similar tethering behav-
ior for the cyclic RGDfK and the linear RGD peptide (GRGDSPC). The
effect of the density of c[RGDfK] on the extent of myogenic differ-
entiation of C2C12 cells was evaluated by quantification of the per-
centage of cells stained positive for sarcomeric myosin after 3 days
in culture. Because the available spreading area and the number of
cell–cell contacts influence cell behavior [33], a seeding cell den-
sity of 5,000 cells cm!2 was chosen to minimize cell–cell interac-
tions. The absence of adherent cells on non-modified and
surfaces modified with 1 lg ml!1 cyclic RGD at 3 days after cell
seeding indicates that there is a minimum RGD concentration re-
quired for cells to attach to the non-adhesive SAM. Cells spread
on SAMs modified with higher RGD concentrations. On SAMs mod-
ified with RGD concentrations above 20 lg ml!1, cells showed dis-
tinct markers of myogenesis, including expression of sarcomeric
myosin and fusion into myotubes at 3 days in culture (Fig. 1A).
Myogenic differentiation increased up to 80% with increasing con-
centrations of RGD and could be described by a hyperbolic profile
(Fig. 1B). This result demonstrates that myogenic differentiation is
regulated by the surface density of bioadhesive RGD ligand. The va-
lue obtained with 72 lg ml!1 (120 lM) was considered as a conve-
nient ligand density to maximize the degree of differentiation for
the engineered surfaces and was used for subsequent experiments.
According to previous experiments with the linear RGD peptide
[31], this coating concentration corresponds to a surface density
of cyclic RGD of "3.0 pmol cm!2.
3.2. Light-controlled changes in RGD density using a photoactivatable
caged RGD
SAMs were modified with the photoactivatable caged cyclic
RGD peptide c[RGD(DMNPB)fK] (‘‘caged RGD’’) [24] to generate
surfaces with phototunable densities of tethered cell adhesive pep-
tide (Scheme 1B). Initially, control surfaces modified with a
72 lg ml!1 (120 lM) solution of either c[RGDfK], photoactivatable
c[RGD(DMNPB)fK] or the negative control peptide GRDGSPC were
prepared and incubated with cells for 2.5 h. A surface concentra-
tion of peptide of "3.0 pmol cm!2 is expected under these coupling
conditions [31]. SAMs modified with GRDGSPC and non-modified
SAMs without tethered peptides did not show cell attachment,
whereas RGD-modified SAMs showed effective cell spreading
(Fig. 2). This result indicates that cell attachment to the RGD-mod-
ified SAMs is specific and mediated by integrin–RGD interactions.
Few cells attached to SAMs modified with caged RGD that were
not exposed to light. After light exposure, a 6-fold increase in cell
density was observed. Comparable cell densities and cell spreading
were obtained for irradiated caged cyclic RGD and cyclic RGD,
demonstrating effective light-mediated restoration of the function-
ality of the caged RGD. No differences in cell density and spreading
were observed between irradiated and non-irradiated cyclic RGD-
modified substrates, demonstrating that the irradiation conditions
did not cause photodamage of the surface layer to influence adhe-
sion. In contrast to cells spreading on irradiated caged RGD, the few
cells that attached to caged RGD were rounded but some showed
an outstretched, polarized morphology. Nevertheless, these results
show significant differences in the number and spreading of cells
on irradiated caged RGD compared to control caged RGD.
The assembly and distribution of focal adhesions of adherent
cells on modified SAMs were examined after staining for F-actin
and the focal adhesion component vinculin (Fig. 2A). Cells on caged
RGD showed poor organization of the cytoskeleton and diffuse dis-
tribution of vinculin, and thus no assembly of focal adhesions,
which is consistent with the overall low number of adherent cells
and poor spreading. Cells on surfaces modified with cyclic RGD
(irradiated and non-irradiated) showed comparably high organiza-
tion of F-actin stress fibers terminating at vinculin clusters at the
cell edges, indicating distinct assembly and organization of focal
adhesion complexes. Similar findings were observed for surfaces
presenting irradiated caged RGD, which further demonstrates that
irradiation of caged RGD provides restoration of functional bioad-
hesive RGD units to support integrin-mediated cell adhesion.
3.3. Temporal presentation of tethered RGD influences cell
proliferation
We next determined whether an increase of the RGD surface
density, i.e. adhesion promotion, at defined time points during cell
culture modulates the proliferation of C2C12 myoblasts. For this
purpose, SAMs were reacted with a 120 lM mixture of cyclic
RGD and caged cyclic RGD in a 1:5 ratio. In this way, surfaces pre-
senting a basal level of RGD and a light-tunable density of RGD
were obtained. The density of basal cyclic RGD to obtain sufficient
cell-adhesive surface properties is required to ensure initial cell
adhesion. The optimum basal density was investigated in pilot
experiments during which cells were cultured on surfaces present-
ing various ratios of cyclic RGD and caged cyclic RGD under differ-
entiation conditions (data not shown). The optimum basal density
was selected to allow sufficient cell adhesion levels for cells to at-
tach, remain adherent and spread throughout the entire culture
time in order to examine the effects of temporal RGD presentation
in cell functions (e.g. proliferation, differentiation) rather than sim-
ply controlling gross levels of number of adherent cells. C2C12 cells
were seeded on mixed RGD-modified SAMs and cultured under dif-
ferentiation conditions. At selected time points after cell seeding
Fig. 1. (A) Fluorescence images of myoblasts on modified SAMs showing sarcomeric myosin (green) and nuclei (blue) (bar 100 lm). (B) Myogenic differentiation of myoblasts
as a function of the coating concentration of cyclo[RGDfK] tethered to 2% EG6-COOH:EG3-OH SAM surfaces (hyberbolic curve fit, R2 = 0.98).
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(1, 6, 24 and 48 h), substrates were irradiated in order to increase
the surface density of RGD from initially !17% to the maximum
available surface density (referred to as 100%). The proliferation
rate of the cells after 3 days culture on the different substrates
and corresponding controls was quantified by EdU incorporation
and staining (Fig. 3A). EdU is an analogue of thymidine used to
determine cell proliferation, as it is incorporated into DNA during
the synthesis phase of the cell cycle and can easily be visualized
via immunostaining. After 1 day in culture, cells became round
on the non-modified SAMs (no RGD), while they remained well
spread on different RGD-modified surfaces. Higher levels of prolif-
eration were observed for cells cultured on surfaces that presented
the maximum level of active RGD at early stages of cell culture (i.e.
irradiation after 1 or 6 h) (Fig. 3B). Lower levels of cell proliferation
were found for surfaces presenting the basal level of cyclic RGD
throughout the whole culture time (DARK substrates). Similarly,
low proliferation levels were observed for cells cultured on low
densities of RGD until 24 and 48 h after cell seeding. These results
demonstrate a significant impact of the density and the time scale
of the availability of the cell-adhesive ligand at the surface on the
proliferation of C2C12 myoblasts.
3.4. Temporal RGD presentation regulates the extent of myogenic
differentiation
We next evaluated the impact of temporal RGD presentation on
myogenic differentiation by evaluating the expression of sarco-
meric myosin and fusion into myotubes. Cells were cultured on
Fig. 2. Ligand tethering and irradiation of 2% EG6-COOH:EG3-OH SAM surfaces affects the extent of cell adhesion of C2C12 myoblasts. (A) Fluorescence images of myoblasts
on modified SAMs showing actin (red), vinculin (green) and nuclei (blue) (bar 100 lm, 50 lm in inset images). (B) Cultures were incubated for 2.5 h and analyzed for cell
density by immunostaining. Wilcoxon test revealed surface-dependent differences: ⁄caged RGD irr. vs. caged RGD (P < 0.0001); ⁄⁄caged RGD vs. RGD irr. (P < 0.0001); ⁄⁄⁄caged
RGD vs. RGD (P < 0.0001).
Fig. 3. Presentation of uncaged cell-adhesive RGD peptide at different time points modulates proliferation after 3 days in culture. (A) Fluorescence images showing nuclei
with incorporated EdU (green) and all nuclei (blue) of myoblasts on modified SAMs (bar 100 lm). (B) Cells were incubated in EdU for 14 h and analyzed for EdU incorporation
by immunostaining. Statistical significance: a vs. 1 h (P < 0.013); b vs. 6 h (P < 0.021); c vs. 24 h (P < 0.019); d vs. 48 h (P < 0.015); e vs. 24 h (P < 0.027); f vs. 48 h (P < 0.011), as
determined using the Wilcoxon test.
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surfaces under the same conditions described in the proliferation
assay. At day 3 cells were immunostained for sarcomeric myosin.
Fig. 4A shows representative microscopy images for myogenic dif-
ferentiation (sarcomeric myosin-positive cells, green) and cell nu-
clei (blue) as a function of temporal presentation of high levels of
RGD ligand. Quantification of the percentage of sarcomeric myo-
sin-positive cells is shown in Fig. 4B. Myogenic differentiation
was low on surfaces with only basal levels of RGD throughout
the entire duration of culture (DARK). Surfaces irradiated at late
time points of culture (24, 48 h) also demonstrated low levels of
differentiation, reaching a minimum for 48 h, which showed simi-
lar differentiation levels as the DARK substrates. Differentiation
significantly increased on substrates with high levels of active
RGD presented at 1 and 6 h after cell seeding, with 74% differenti-
ated cells on substrates irradiated at 6 h after cell seeding. As a sec-
ond marker for myogenic differentiation, cell fusion into myotubes
was characterized by scoring cell nuclei for multinucleated (fused,
two or more nuclei) and mononucleated (non-fused) sarcomeric
myosin-positive cells (Fig. 5). The results for cell fusion follow
the same trend as sarcomeric myosin expression with a signifi-
cantly stronger impact of the time points of ligand density increase
on the fusion of cells. This demonstrates the necessity of a suffi-
cient density of bioadhesive ligand in early stages of cell culture
for cells to differentiate and fuse into myotubes. This data indicates
that the RGD density and the time point of RGD presentation influ-
ence myogenic differentiation in terms of expression of sarcomeric
myosin and cell fusion to myotubes. These results indicate an
important role for integrin-mediated cell adhesion at early stages
of cell attachment on the cell’s differentiation potential.
4. Discussion
Gaining a better fundamental understanding of cell–surface
interactions and hence substrate-controlled cell behavior is a crit-
ical prerequisite to improving designs of biomaterials for biotech-
nological applications and biomedical devices. Although
modifications of biomedical surfaces with biologically active fac-
tors have improved cell–surface interactions, previous studies lack
insights into the influence of the temporal control over bioactive
ligand presentation on cell adhesion and modulation of cell func-
tion as desired in the integration process of implants. The applica-
tion of a photoactivatable bioadhesive derivative (caged cyclic
Fig. 4. Temporal activation and resulting RGD density-dependent differences in myogenic differentiation after 3 days. (A) Fluorescence images showing sarcomeric myosin-
positive cells (green) and cell nuclei (blue) on modified SAMs (bar 100 lm). (B) Myogenic differentiation of myoblasts depending on time point of peptide presentation as
determined by the percentage of sarcomeric myosin-positive cells after 3 days in culture. Statistical significance of myogenic differentiation: a vs. 1 h (P < 0.0001); b vs. 6 h
(P < 0.0001); c vs. 24 h (P < 0.003); d vs. 24 h (P < 0.0001); e vs. 48 h (P < 0.0001); f vs. 24 h (P < 0.0001), g vs. 48 h (P < 0.001); h vs. 48 h (P < 0.005), as determined using the
Wilcoxon test.
Fig. 5. Myogenic differentiation of myoblasts depending on time point of peptide
presentation as determined by the percentage of multinucleated and mononucle-
ated sarcomeric myosin-positive cells after 3 days in culture. Statistical significance
of myogenic differentiation (non-fused cells): a vs. 6 h (P < 0.021); b vs. 24 h
(P < 0.0006); c vs. 48 h (P < 0.05); d vs. 24 h (P < 0.0003); e vs. 48 h (P < 0.005).
Statistical significance of myogenic differentiation (fused cells): a vs. 1 h
(P < 0.0001); b vs. 6 h (P < 0.0001); v vs. 24 h (P < 0.0001); d vs. 6 h (P < 0.035); e
vs. 48 h (P < 0.0001), c vs. 24 h (P < 0.0006); h vs. 48 h (P < 0.0001); p vs. 48 h
(P < 0.0001), as determined using the Wilcoxon test.
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RGD) allows precise light-triggered control of the density and the
time point of ligand presentation on surfaces, and thus modulation
of integrin-mediated cell–surface interactions. In this work, we
engineered biointerfaces with coexisting active and temporarily
inactivated concentrations of cyclic RGD. These substrates allow
in situ modulation of surface-tethered RGD concentration via a
one-step light exposure. This strategy allowed us to evaluate the
response of myoblasts to a temporally defined increase in RGD
density at the surface. In particular, the impact of RGD exposure
to the attachment, proliferation and differentiation of myoblasts
was studied.
We applied two strategies to change the concentration of cyclic
RGD at the surface. The total surface RGD density was defined by
the RGD solution concentration during the tethering reaction, as
has been previously reported for linear RGD peptide [31]. The
time-regulated RGD surface density was achieved by surface co-
modification with the non-adhesive caged cyclic RGD. Light expo-
sure at cell-compatible UV doses uncages the RGD and activates its
biological activity [24]. Non-cell adhesive caged RGD surfaces be-
come cell adhesive after irradiation. Similar cell densities and cell
spreading were obtained for uncaged RGD and cyclic RGD, indicat-
ing that the caging group effectively inhibits RGD–integrin interac-
tions, while the uncaging reaction successfully restores bioactivity.
Amongst available strategies for modulated RGD exposure, caged
RGD has been demonstrated to enable precise spatial control of cell
adhesion (i.e. cell patterns) and direct control of the RGD–integrin
molecular interaction [25]. In this work, we further demonstrate
the flexibility of this approach and its applicability to study time-
and concentration-dependent RGD–integrin interactions and their
effects on cell behavior.
Our results demonstrate that changes in the temporal presenta-
tion and concentration of surface-tethered RGD modulate cell
behavior beyond cell attachment and spreading. Myogenic differ-
entiation of C2C12 cells has been used in previous studies to eval-
uate the influence of surface properties on cell behavior [34–37].
We observed a clear increase in myogenic differentiation of
C2C12 cells with increasing densities of surface-tethered RGD. This
result demonstrates a strong correlation between integrin-medi-
ated cell adhesion and myogenic differentiation, in agreement with
studies using surface-tethered linear RGD [22]. Moreover, both
proliferation and myogenic differentiation were promoted when
a high density of RGD was available at the surface at early stages
of cell attachment (<6 h incubation). Proliferation levels showed
a similar trend as myogenic differentiation in relation to timed li-
gand presentation. These findings are in contrast to reported
molecular mechanisms controlling myogenic differentiation of this
cell type, which suggest a down-regulation of proliferation (cell cy-
cle withdrawal) during myogenesis [37,38]. Taken together, our re-
sults demonstrate an integrin-mediated mechanism for the
regulation of C2C12 proliferation and myogenic differentiation by
using biointerfaces which allow a timed onset of integrin-binding
using a photoactivatable cell-adhesive RGD peptide.
5. Conclusions
SAMs of alkanethiols and tethered cyclic RGD and caged cyclic
RGD were used to present defined densities of RGD in a temporally
controlled manner to cell cultures after light exposure. Attach-
ment, spreading and myogenic differentiation of C2C12 myoblasts
strongly depended on the density and timed presentation of cyclic
RGD available to the cells at the surface. Proliferation and myogen-
esis were further regulated by the time point at which RGD was
presented to the cell, reaching highest levels when RGD exposure
occurred !6 h after cell seeding. Beyond basic studies of interac-
tions between cells and RGD-modified supports, this work
provides new insights into the influence of a kinetic profile of li-
gand presentation and identifies a possible strategy applicable to
improve the in vivo performance of biomedical devices in terms
of time-controlled cell–surface interactions.
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